Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,rRNA binding (GO:0019843),0.7932754284092806,2.0648528173788336,0.0,0.0,0.0,17/42,7.76%,RPL23;RPS3;RPS9;RPL11;RPS14;RPS5;RPL5;RPS13;RPLP0;RPL12;CAVIN1;ANG;DDX28;EMG1;SBDS;MRPS11;MRPL11
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.7638877958793931,2.0607289580269557,0.0,0.0,0.0,39/57,15.41%,COX4I1;UQCR11;UQCR10;NDUFA2;COX6B1;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA4L2;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;UQCRC1;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX5A
prerank,MHC protein binding (GO:0042287),0.855686617128878,2.0285109922541493,0.0,0.00028038859958963463,0.001,8/20,6.05%,CD74;TUBB;CD81;ATP5F1B;TUBB4B;ATP5F1A;TAPBP;TAP2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.7729865293340934,1.9775232409885999,0.0,0.0003364663195075616,0.001,28/34,18.06%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;NDUFS3;NDUFV1;NDUFB2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.7729865293340934,1.9775232409885999,0.0,0.0003364663195075616,0.001,28/34,18.06%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;NDUFS3;NDUFV1;NDUFB2
prerank,nucleotidyltransferase activity (GO:0016779),-0.6479715139616068,-1.9391644517223372,0.0,0.34905369819979365,0.169,13/19,20.66%,REV1;NUDT5;TENT4B;CRPPA;TUT7;PAPSS2;TERT;PAPSS1;TUT1;CGAS;TUT4;TENT2;YRDC
prerank,histone demethylase activity (GO:0032452),-0.5771411728400198,-1.9334209264196989,0.0,0.18127184809892666,0.174,12/27,14.04%,KDM3B;KDM2A;KDM7A;JMJD1C;KDM5B;JARID2;KDM3A;FBXL19;KDM5C;KDM4C;PHF8;KDM4D
prerank,mRNA 5'-UTR binding (GO:0048027),0.7869478453563377,1.9107320324880748,0.0,0.0016823315975378077,0.011,6/24,0.56%,RPL41;RPL26;RPS14;RPS7;RPL5;RPS13
prerank,amyloid-beta binding (GO:0001540),0.6730947887106271,1.893143622574949,0.0,0.002283164310944168,0.018,40/79,18.26%,APOE;CST3;CD74;CLU;PFDN5;ITM2A;C1QA;ITM2C;ITM2B;PGRMC1;NLGN1;PRNP;ITGB2;TREM2;CRYAB;GRIA2;PFDN6;SORL1;GRIN1;CACNA1A;LRPAP1;ATP1A3;GSAP;GRIA4;GRIN2A;APBB1;RAMP3;GRIA1;MSR1;LILRB3;LILRB1;VBP1;TLR6;PFDN1;MAPK8IP2;ACHE;BACE1;CLSTN1;APBA2;GRIN2B
prerank,proton transmembrane transporter activity (GO:0015078),0.7384396690724867,1.8896156216144449,0.0,0.00210291449692226,0.019,16/39,10.32%,COX4I1;UQCR11;UQCR10;COX6B1;COX5B;COX8A;NDUFA4;ATP6V1F;COX6A1;COX7A2L;UQCRH;UQCRQ;NDUFA4L2;UQCRC1;SLC33A1;MFSD3
prerank,I-SMAD binding (GO:0070411),-0.7198799121416697,-1.8868573818114653,0.0,0.20010163697121827,0.273,11/13,13.79%,SMAD3;SMAD6;AXIN1;SMAD9;TGFBR1;SMURF1;SMAD1;SMAD7;SMAD4;TGFB1I1;SMAD2
prerank,MHC class II protein complex binding (GO:0023026),0.8931461297837684,1.882989957123274,0.0,0.002149645930187199,0.022,7/11,5.43%,HSPA8;CD74;CD81;HSP90AA1;HSP90AB1;PKM;YWHAE
prerank,MHC class I protein binding (GO:0042288),0.8555523905511847,1.87257641364523,0.0,0.003364663195075616,0.037,6/13,6.05%,TUBB;ATP5F1B;TUBB4B;ATP5F1A;TAPBP;TAP2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.5247275902478425,-1.86081391110879,0.0,0.18717372222307777,0.326,21/44,15.66%,NSD1;KMT2C;SETD5;ASH1L;SETD2;SMYD3;EHMT1;KMT2A;KMT5C;KMT5B;ASH2L;NSD3;SETDB1;KMT2D;WDR82;SETD7;EHMT2;EZH2;SETD4;PRDM9;SETD1B
prerank,cytochrome-c oxidase activity (GO:0004129),0.851288975288315,1.8516967669282238,0.0,0.0044352378480542205,0.052,8/15,4.90%,COX4I1;COX6B1;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L;NDUFA4L2
prerank,R-SMAD binding (GO:0070412),-0.625793849771247,-1.8444900063187233,0.004366812227074236,0.17132297457535764,0.361,8/18,13.79%,LDLRAD4;SMAD3;SMAD6;SMURF1;PMEPA1;DROSHA;SMAD4;SMAD2
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.505760681489149,-1.828485353277222,0.006896551724137931,0.16384726735143293,0.397,11/38,11.62%,SORBS1;GAB2;LRRK2;FRS2;IRS1;AXIN1;DLG5;SPAG9;MMS19;NCK1;SAV1
prerank,tau-protein kinase activity (GO:0050321),-0.6054407664501502,-1.827175012158314,0.009216589861751152,0.1416449789796264,0.4,9/20,14.72%,ROCK2;ROCK1;SIK3;MARK1;DYRK1A;MARK3;GSK3B;MARK2;TAOK1
prerank,ligand-gated ion channel activity (GO:0015276),0.7211286478106449,1.7954408964346622,0.0,0.015631664427122133,0.177,19/30,22.37%,GABRB1;GRIA2;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;CNGA3;GRIA4;GRIN2A;GRID1;GRIA1;CHRNA4;CNGB1;GRIN2B;ANXA6;GRIA3;GRIK1;CHRNA3
prerank,glutamate receptor activity (GO:0008066),0.7749778971853587,1.7941173149915495,0.0012626262626262627,0.015140984377840271,0.184,11/19,11.80%,GRM5;GRIA2;GRID2;GRIK5;GRIK2;GRM8;GRM7;GRIA4;GRID1;GRM1;GRIA1
prerank,ligand-gated channel activity (GO:0022834),0.7242755224166328,1.7936656479109259,0.0,0.01411956876504946,0.185,19/29,22.37%,GABRB1;GRIA2;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;CNGA3;GRIA4;GRIN2A;GRID1;GRIA1;CHRNA4;CNGB1;GRIN2B;ANXA6;GRIA3;GRIK1;CHRNA3
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.7583131709019484,1.7930382707946009,0.0012285012285012285,0.013290419620548683,0.186,10/22,11.32%,APOE;CLU;SNX17;HSP90B1;AP2M1;SYT1;LRPAP1;CLTC;APBB1;DNAJA1
prerank,active ion transmembrane transporter activity (GO:0022853),0.7051868490258602,1.7880080202578756,0.0,0.013458652780302463,0.201,15/37,9.48%,COX4I1;UQCR11;UQCR10;COX6B1;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L;SLCO1C1;UQCRH;UQCRQ;NDUFA4L2;UQCRC1;SLCO4C1
prerank,lipoprotein particle receptor binding (GO:0070325),0.7290326560251328,1.786158067002981,0.0011918951132300357,0.013359692098094357,0.211,10/27,11.32%,APOE;CLU;SNX17;HSP90B1;AP2M1;SYT1;LRPAP1;CLTC;APBB1;DNAJA1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.7412850538677556,-1.7769222898865464,0.006688963210702341,0.20129606387729646,0.565,7/10,18.12%,NSD1;SETD5;ASH1L;SETD2;NSD3;PRDM9;SETD3
prerank,acetylation-dependent protein binding (GO:0140033),-0.5681994597125414,-1.7708866854949161,0.005,0.16913084990067298,0.585,12/20,20.19%,MLLT3;BRD4;BAZ2A;ATAD2B;KMT2A;PSME4;TRIM24;BRD7;PHIP;CARM1;DPF2;TAF1
prerank,lysine-acetylated histone binding (GO:0070577),-0.5681994597125414,-1.7708866854949161,0.005,0.16913084990067298,0.585,12/20,20.19%,MLLT3;BRD4;BAZ2A;ATAD2B;KMT2A;PSME4;TRIM24;BRD7;PHIP;CARM1;DPF2;TAF1
prerank,poly(U) RNA binding (GO:0008266),-0.5708567371848777,-1.7481305441369883,0.009216589861751152,0.18794019938205841,0.66,14/20,26.78%,RBMS3;RBMS1;ATXN1;DAZAP1;PATL1;PABPC4;PABPC4L;RBMS2;FMR1;KHDRBS1;DIS3L2;HNRNPH1;PABPC5;PABPC1L
prerank,translation elongation factor activity (GO:0003746),0.7953357049639896,1.7420586755644678,0.0,0.0293940715236467,0.418,6/14,5.39%,EEF1A1;EEF2;EEF1B2;EIF5A;EIF5AL1;EEF1A2
prerank,SUMO transferase activity (GO:0019789),-0.6152428198138771,-1.7412940135240047,0.003816793893129771,0.18604955572323945,0.683,7/16,9.56%,RANBP2;NSMCE2;HDAC4;PIAS1;PIAS2;TOPORS;CBX4
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.7112481729143251,-1.728612568923282,0.010526315789473684,0.18847083741519888,0.714,5/10,13.97%,SETD5;ASH1L;EHMT1;SETDB1;EHMT2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.5112445201858464,-1.718275981646413,0.0,0.19054622172259267,0.736,11/25,10.18%,GAB2;FCHSD2;ZFYVE1;MAPKAP1;PLEKHA4;ADAP2;PLEKHA2;SESTD1;HIP1;DAPP1;KIF16B
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.47926503493085576,-1.7146833063565876,0.008064516129032258,0.18335155612362752,0.746,11/38,10.18%,PARD3;ZFYVE1;PLA2G4A;PLEKHA4;SNX12;SESTD1;DENND1A;ATG2B;HIP1;ATG2A;KIF16B
prerank,cell adhesion mediator activity (GO:0098631),0.7142490031126785,1.7114664147345566,0.0012360939431396785,0.04750373168837021,0.6,13/24,15.44%,BSG;DSCAM;CNTN4;SIRPA;LRRC4C;BCAM;ESAM;ROBO4;EMB;NINJ1;JAM3;IGSF9;DSCAML1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6485262999296223,-1.6914322008372529,0.014705882352941176,0.20709254739208774,0.806,7/12,14.04%,KDM3B;KDM7A;JMJD1C;KDM3A;KDM4C;PHF8;KDM4D
prerank,tau protein binding (GO:0048156),0.6509887905529982,1.6706990951722251,0.0022753128555176336,0.08428481303664419,0.824,9/40,4.81%,APOE;ACTB;CLU;HSP90AA1;HSP90AB1;LGMN;S100B;MAP1A;PIN1
prerank,transmitter-gated ion channel activity (GO:0022824),0.6643080711153813,1.6655172589787797,0.002442002442002442,0.08804202027114529,0.859,12/29,11.99%,GABRB1;GRIA2;GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRIA4;GRID1;GLRA2;GABRA3;GABRB3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.4852369726976287,-1.660833201463352,0.0136986301369863,0.24281996396507385,0.878,14/32,20.10%,FTO;KDM2A;TET2;KDM7A;TET3;TMLHE;P4HTM;KDM4C;PHF8;EGLN1;ALKBH3;EGLN3;PHYHD1;ALKBH4
prerank,thyroid hormone receptor binding (GO:0046966),-0.4820722960433359,-1.6522150709444479,0.011904761904761904,0.24235156125680787,0.889,12/28,22.22%,NSD1;MED13;TRIP12;JMJD1C;THRAP3;NCOR1;BRD8;TACC1;TAF7;MED1;NCOA6;NCOA3
prerank,phosphatidylinositol binding (GO:0035091),-0.37948347422902623,-1.6500761747457475,0.0,0.23261371547969978,0.893,35/91,16.95%,PARD3B;ITPR1;PARD3;FCHO2;PITPNC1;ZFYVE1;ITPR2;APPL2;BCAS3;PITPNM2;EEA1;SNX12;SESTD1;ZFYVE9;DENND1A;ANKFY1;HIP1;SNX24;WDFY3;PICALM;SNX9;TNFAIP8L3;DENND1B;TULP3;ESYT3;NUMA1;SNX2;PIGK;SNX1;ING2;RUBCN;PASK;SH3YL1;SNX13;APPL1
prerank,lipoprotein particle binding (GO:0071813),0.709212010218257,1.6452485921632425,0.006443298969072165,0.11191328604529917,0.912,8/20,12.32%,PLTP;TREM2;SORL1;HSPD1;MAPT;LPL;STAB1;MSR1
prerank,endopeptidase inhibitor activity (GO:0004866),0.5873937619231521,1.6438732730619712,0.0010515247108307045,0.10920526413582378,0.915,21/82,13.02%,CST3;GAPDH;TIMP2;SERPINH1;A2M;SPOCK2;PRNP;SERPINF1;SERPINE2;UBE2Z;PCSK1N;AGT;SPOCK1;CSTB;SPOCK3;TIMP1;SERPING1;ITIH3;TIMP3;SERPINA9;BST2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7237080253690261,1.6372147477368764,0.009162303664921465,0.11369757713359685,0.931,11/17,21.95%,GRIA2;GRIK5;GRIK2;GRIN1;GRIN3A;GRIA4;GRIN2A;GRIA1;GRIN2B;GRIA3;GRIK1
prerank,ubiquitin protein ligase binding (GO:0031625),0.5441956144410568,1.6276247702929907,0.0,0.12361772578707812,0.951,62/254,11.69%,RPL23;RPS27A;ACTG1;RPL11;HSPA8;RPL5;CLU;TUBB;UBC;GABARAP;UBB;TUBA1B;ATP6V0C;ELOB;HSP90AA1;HSP90AB1;CALR;LAPTM5;CKB;UBXN1;HSPA5;TPI1;SLC25A5;MAP1LC3B;TMBIM6;PRDX6;PINK1;MAP1LC3A;TXNIP;CCT2;GABARAPL2;CHEK2;PSMD1;AUP1;RTN4;HSPA1B;GABARAPL1;UCHL1;PRR5L;YWHAE;VCP;RPA2;BAG5;BAG1;UBA52;ARRDC1;ISG15;TRIM28;SCAMP3;HSPD1;SYT11;PRKAR1A;RBX1;NDUFS2;NEDD8;UQCRC1;JUN;MC1R;APBB1;SUMO2;DNAJA1;WFS1
prerank,microtubule minus-end binding (GO:0051011),-0.606215042076622,-1.626023491385677,0.034482758620689655,0.25985108643762417,0.928,8/13,19.04%,MACF1;CEP290;CAMSAP1;NUMA1;TUBGCP6;HAUS7;TUBGCP5;CAMSAP2
prerank,retinoic acid binding (GO:0001972),-0.6189238320273388,-1.6202305251604525,0.0273972602739726,0.2572735332487092,0.936,1/12,3.24%,NR2F2
prerank,retinoid X receptor binding (GO:0046965),-0.6368858683798395,-1.6140987063549113,0.037162162162162164,0.25447041678157994,0.943,6/11,20.70%,NSD1;NRIP1;RARG;PPARG;TACC1;NCOA6
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.629561708188737,-1.6057194199533606,0.04838709677419355,0.2566032227891783,0.953,4/10,13.40%,KDM2A;KDM7A;KDM4C;PHF8
prerank,disordered domain specific binding (GO:0097718),0.6770811908927563,1.6044937131050419,0.008663366336633664,0.15965973911248232,0.978,8/23,8.29%,CALM1;GAPDH;HSP90AA1;HSP90AB1;FKBP8;CALM3;FN1;CLTC
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.5357382375689881,1.6029647007796084,0.0,0.15676838145944907,0.98,64/269,11.69%,RPL23;RPS27A;ACTG1;RPL11;HSPA8;RPL5;CLU;TUBB;UBC;GABARAP;UBB;TUBA1B;ATP6V0C;ELOB;HSP90AA1;HSP90AB1;CALR;LAPTM5;CKB;UBXN1;HSPA5;TPI1;SLC25A5;MAP1LC3B;TMBIM6;PTPRN;PRDX6;PINK1;MAP1LC3A;TXNIP;CCT2;GABARAPL2;CHEK2;PSMD1;AUP1;RTN4;HSPA1B;GABARAPL1;UCHL1;PRR5L;YWHAE;VCP;RPA2;BAG5;BAG1;UBA52;ARRDC1;ISG15;TRIM28;SCAMP3;HSPD1;SYT11;PRKAR1A;RBX1;NDUFS2;NEDD8;UQCRC1;JUN;MC1R;APBB1;SUMO2;SUMO3;DNAJA1;WFS1
prerank,retinoic acid receptor binding (GO:0042974),-0.5660073946722184,-1.6015731722467963,0.02666666666666667,0.25195381677626005,0.961,6/17,9.60%,NSD1;NRIP1;RARG;CNOT1;ASXL1;PPARG
prerank,monocarboxylic acid binding (GO:0033293),0.6934387729399086,1.5937595899945454,0.015810276679841896,0.16946486681626383,0.985,1/18,0.23%,PSAP
prerank,poly-purine tract binding (GO:0070717),-0.47560007960827533,-1.5934148433770137,0.017341040462427744,0.25502841215331784,0.968,11/27,15.12%,RBMS3;RBMS1;RBPMS;ATXN1;DDX1;DAZAP1;PATL1;ZC3H14;PABPC4;PABPC4L;RBMS2
prerank,ribosome binding (GO:0043022),0.6027989818970878,1.5884312685403628,0.004540295119182747,0.174962486143932,0.991,13/46,12.71%,RPSA;EEF2;RACK1;SEC61B;SHFL;TMEM147;EIF3C;SBDS;NOMO1;TMCO1;NAA10;SEC61A1;NCLN
prerank,poly-pyrimidine tract binding (GO:0008187),-0.4940530159687188,-1.5859957412383114,0.015384615384615385,0.2576719329148607,0.972,10/23,19.05%,RBMS3;RBMS1;ATXN1;DAZAP1;PATL1;PABPC4;PABPC4L;RBMS2;FMR1;KHDRBS1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6403162537224459,1.584040921274192,0.00850546780072904,0.1786636156585152,0.995,9/28,12.57%,CHRNA9;GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRID1;GABRA3;CHRNA4
prerank,histone methyltransferase activity (GO:0042054),-0.4566092719314749,-1.5824633624804876,0.017857142857142856,0.2534370920191023,0.975,13/32,16.75%,KMT2C;SETD2;SMYD3;EHMT1;KMT5B;NSD3;SETDB1;SETD7;EHMT2;CARM1;EZH2;PRDM9;PRMT6
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6785306429929181,1.580485973895737,0.011597938144329897,0.18150187186984512,0.996,7/19,11.90%,GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRID1;GABRA3
prerank,RNA binding (GO:0003723),0.5191508566466522,1.5786493498194512,0.0,0.18003576736775698,0.996,300/1321,14.53%,TMSB4X;RPL41;TPT1;FAU;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL17;MRPL23;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPL11;HSPA8;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;PPIA;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;CMSS1;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;ALDOA;EEF2;RPS20;RPS18;RPL36;RPL22;UBC;VIM;RPS25;RACK1;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;CAVIN1;TUBA1B;PCBP1;RPL23A;HSP90AA1;RPL7A;HSPB1;HSP90AB1;RPL14;GRN;SNRPG;RPL31;CALR;RPL36A;LGALS1;TUBB4B;RPS28;PPIB;RPL35;EIF1;RPL4;PARK7;SEC61B;RPL10;HNRNPAB;RPS6;SERPINH1;NDUFV3;SF3B5;RCAN3;RPL10A;TXN;CKAP4;SLC25A5;ATP5F1A;EIF4G2;NME1;EIF3D;RPN1;MAGOHB;MAGOH;POLR2D;SHFL;HNRNPK;NPM1;RPS27L;EIF1B;DDX39B;HSPE1;PEBP1;MRPL43;EIF5A;APOBEC2;RAN;S100A16;CANX;RALY;SYF2;HSP90B1;SRP14;QKI;LGALS3;ELAC2;BTF3;PKM;ANG;SNRPD2;ZFP36L1;PLEC;NCL;LSM4;DDX28;LSM8;MEX3D;LSM6;ENO1;RTN4;NOP10;EMG1;PUF60;HSPA1B;MRPL4;ZFP36L2;PARP1;RBFOX3;FLNA;YWHAE;RBM42;HMGB3;SNRPA;AHNAK;PCBP4;EIF3I;VCP;MANF;NUCKS1;SNRPF;MRPL28;PFN1;TFRC;MSN;EIF3C;SBDS;FBL;RPL22L1;SRSF9;MRPL14;SRFBP1;STRAP;MRPL41;MRPL27;LIN28B;CSTB;P4HB;RIMS1;CORO1A;MRPS11;TRIM28;EDF1;PDIA3;HNRNPA0;MRPL11;MRPS14;HSPD1;MYO5A;DDX49;ZYX;CLTC;NOL12;RBM15B;YWHAG;IFIT1;MAPT;CSRP1;METAP2;YBX1;NPM3;PRPF38B;SLC25A11;RRP1B;RRP1;SARS2;SARS1;JUN;DCN;PRDX1;NELFCD;KARS1;NHP2;EPPK1;HMGB1;AARS2;SLC3A2;ZFP36;POP7;WDR3;RTRAF;H1-0;TARDBP;POLR2G;DEK;EXOSC2;FASN;RNASEH1;KHDRBS3;PRPF8;EIF4A1;SUMO2;SRSF2;RALYL;APEX1;SF3A2;KCTD12;NIP7;ACAA2;PABPC1;FAM50A;SSRP1;NTPCR;DDX11;MRPL54;RTCB;ACTN1;RBM4B;SNW1;L1TD1;SORBS2;SF3B2;PRMT1;BST2;HSPA1A;ATXN2L;IMP4;TOE1;CARS1;YWHAZ;EIF3B;MRPL2;MRPL37;HNRNPU;MRPL44;MTCL1;POP4;NOL7;ZC3H8;SND1;TSN;RO60;NUFIP2;RRP7A;HEXIM1;MRPS24;PIN4;HNRNPA1;SUCLG1;GTPBP10;NONO;TUFM;CHCHD1;ARF1;TRUB2;CTU1
prerank,Toll-like receptor binding (GO:0035325),0.7573939837198496,1.5732796774108306,0.01881331403762663,0.18666233770862678,0.997,8/11,16.24%,TOLLIP;S100A8;S100A9;TIRAP;TLR6;UNC93B1;TLR1;DAB2IP
prerank,mannose binding (GO:0005537),0.7567453014227097,1.571611447878878,0.013623978201634877,0.18475959368253456,0.997,6/12,13.96%,MBL2;LMAN2;LMAN1;CLEC6A;CLN5;CLEC4D
prerank,nucleosomal DNA binding (GO:0031492),0.6706798754192329,1.5681807535309822,0.020253164556962026,0.18729157342303052,0.998,3/21,3.83%,ACTB;H3-3A;MBD3
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.35487815352131447,-1.559978053114915,0.0,0.28045946730787424,0.987,65/232,14.77%,RNF220;PDZRN3;HECTD1;RNF216;UBR4;RNF152;NSMCE2;SMURF2;TRIP12;KCMF1;WWP1;RNF38;RNF19A;UBR5;COP1;PIAS1;CBLB;PIAS2;PRKN;BIRC2;TRAF3IP2;PELI2;SH3RF1;SH3RF3;ARIH2;RNF144A;UBR3;UBR1;SMURF1;RNF24;RNF135;BIRC3;ARIH1;TRIM5;HUWE1;RNF8;UFL1;UHRF2;UBR2;RNF41;NEURL2;ZNRF1;SH3RF2;NFX1;TOPORS;RNF138;CBX4;TRIM24;RC3H2;ASB2;ITCH;RNF217;RNF115;UBE3C;PPIL2;RNF43;RNF14;HECW2;SIAH3;UBE3B;TRIM41;DTX1;WWP2;TRIM7;RNF185
prerank,endopeptidase regulator activity (GO:0061135),0.5943236147836187,1.5352132935197673,0.013856812933025405,0.26188295201671874,1.0,9/40,11.79%,CST3;PSME1;A2M;PSME2;PCSK1N;PSENEN;CSTB;VSIR;ITIH3
prerank,Tat protein binding (GO:0030957),0.7517057188111275,1.532897885229662,0.037142857142857144,0.26135248709857617,1.0,6/10,16.94%,ACTB;NPM1;GABARAPL1;DNAJA1;DLL1;TRIM32
prerank,alanine transmembrane transporter activity (GO:0022858),0.7083021287173851,1.530280554639286,0.03212290502793296,0.2619788744323679,1.0,4/12,9.99%,SLC38A5;SLC1A4;SLC6A6;SLC3A2
prerank,ubiquitin protein ligase activity (GO:0061630),-0.3413654170809957,-1.5292010649517476,0.0,0.3223062883760547,0.993,62/228,14.77%,RNF220;PDZRN3;HECTD1;RNF216;UBR4;RNF152;SMURF2;TRIP12;KCMF1;WWP1;RNF38;RNF19A;UBR5;COP1;CBLB;PRKN;BIRC2;TRAF3IP2;PELI2;SH3RF1;SH3RF3;UBE4B;ARIH2;RNF144A;UBR3;UBR1;SMURF1;RNF24;RNF135;BIRC3;ARIH1;TRIM5;HUWE1;RNF8;UHRF2;UBR2;RNF41;NEURL2;ZNRF1;SH3RF2;NFX1;TOPORS;RNF138;TRIM24;RC3H2;ASB2;ITCH;RNF217;RNF115;UBE3C;PPIL2;RNF43;RNF14;HECW2;SIAH3;UBE3B;TRIM41;DTX1;WWP2;TRIM7;UBOX5;RNF185
prerank,cholesterol binding (GO:0015485),0.5745026662754151,1.5268820615427223,0.013392857142857142,0.2644927228282838,1.0,17/47,18.96%,APOD;TSPO;CD81;NPC2;SCP2;ABCG1;TSPO2;STARD4;OSBPL6;PROM1;SYP;CAV1;SOAT2;STARD3NL;OSBPL3;ANXA6;VDAC2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.595122032512798,1.524863820056017,0.015873015873015872,0.2635793030442361,1.0,8/38,12.85%,SERPINH1;A2M;SERPINF1;SERPINE2;AGT;SPOCK1;SERPING1;SERPINA9
prerank,copper ion binding (GO:0005507),0.5830264661174807,1.5237900088478271,0.007963594994311717,0.2599817805365744,1.0,13/42,16.09%,ATOX1;MT3;PARK7;SOD1;PRNP;S100A13;COX17;ANG;ATP13A2;AOC3;CUTA;HEPH;RNF7
prerank,protease binding (GO:0002020),0.5364650733961298,1.5201707965003375,0.005175983436853002,0.262223423887649,1.0,26/99,13.50%,CST3;PSAP;UBC;COL1A1;PARK7;TIMP2;A2M;PRNP;PINK1;TNF;NTRK2;ECM1;FLOT1;ADAMTS4;VCP;TNFAIP3;FN1;SELL;CSTB;CLTC;COL3A1;TIMP1;SYVN1;TIMP3;COL1A2;RIPK2
prerank,bHLH transcription factor binding (GO:0043425),-0.5092545659386415,-1.5191098295728274,0.05069124423963134,0.3311794508523646,0.996,5/19,6.23%,SMAD3;FHL2;TCF12;CREBBP;SP1
prerank,glutathione transferase activity (GO:0004364),0.6283401800313448,1.5189483469304512,0.02236024844720497,0.2589812560442214,1.0,9/23,17.02%,GSTM1;MGST1;GSTO1;GSTM5;MGST3;GSTM2;HPGDS;ALOX5AP;LTC4S
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.5106768808264044,-1.5187942772891263,0.021645021645021644,0.32104019429253267,0.996,8/18,14.11%,TGFBR3;SMAD3;SMAD6;TGFBR1;SMAD7;FERMT2;SMAD2;TGFB3
prerank,peptidase inhibitor activity (GO:0030414),0.6113306935461176,1.5177480628623554,0.01820388349514563,0.25634527717482347,1.0,7/33,11.79%,CST3;TIMP2;A2M;PCSK1N;CSTB;TIMP1;ITIH3
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5991964012657902,-1.5158767507776068,0.06440677966101695,0.31722573417312167,0.996,6/10,18.18%,CFLAR;CASP12;CASP3;CASP8;CASP7;CASP4
prerank,phospholipase binding (GO:0043274),-0.5700322422774456,-1.509496892682752,0.07116104868913857,0.3190077935677517,0.997,5/13,11.31%,ARHGAP6;PAFAH1B1;PRKN;PDPK1;DGKQ
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6862793014821961,1.505914380274514,0.03369272237196765,0.2818279277341948,1.0,7/13,22.39%,ARHGDIA;ARHGDIB;ARHGDIG;GDI1;CCDC88A;GDI2;RANBP1
prerank,peptidase activator activity (GO:0016504),0.623573478855973,1.5008986575765768,0.044444444444444446,0.28901359672918536,1.0,8/22,9.55%,PSME1;PSME2;PINK1;PSENEN;MAL;VCP;VSIR;PCOLCE
prerank,ligand-gated anion channel activity (GO:0099095),0.6578409369996298,1.499275248403318,0.03830911492734478,0.28696281739277885,1.0,9/17,18.83%,GABRB1;GABRG3;GABRA2;GLRA2;GLRA1;GABRA3;GABRB3;GABRB2;GLRA3
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.32716478536440896,-1.4970852272581412,0.0,0.33164564931259166,0.998,49/147,15.00%,AKAP13;DOCK5;PLCE1;RAPGEF4;DOCK11;SBF2;DENND4A;ARHGEF11;DENND4C;FARP1;ARFGEF1;RAPGEF2;DENND2A;IQSEC2;MON1A;ITSN1;ARHGEF18;FGD4;FNIP1;ANKRD27;EIF2B3;DENND5A;RAPGEF6;DENND1A;ARFGEF2;RAPGEF1;RIC8B;BCR;VAV2;RAPGEF5;GAPVD1;ARHGEF6;ALS2;CCZ1;DNMBP;DENND1B;RAPGEF3;DENND5B;DOCK1;RIC1;DENND3;ARHGEF2;ARHGEF17;DENND2C;EIF2B2;RAB3GAP2;RGL1;PREX2;NGEF
prerank,calcium ion binding (GO:0005509),0.4963189878380909,1.4938545199581763,0.0,0.29568730255474407,1.0,100/323,20.40%,TPT1;SPARC;S100A6;CALM1;GSN;S100A1;SPARCL1;CALR;KCNIP4;S100A11;HSPA5;NRXN1;SPOCK2;RCN3;S100B;PRNP;S100A10;CALM3;TGM2;ANXA5;GJB2;S100A13;S100A16;CANX;HSP90B1;LTBP4;S100A8;S100A9;BNIP2;CDH20;SLC25A13;ADGRL3;SPOCK1;GRIN1;SYT1;F9;SELL;CLEC6A;CALB1;ENPP2;CDH18;SDF4;SYT12;SYT11;TUBB4A;CLEC3B;LCP1;LPL;CDK5R1;RPH3A;SYT6;SYT4;DNER;AOC3;RASGRP3;PLA2G4F;PDCD6;TRPM2;MAN1B1;AIF1;CDH12;PCDHB8;HPGDS;PCP4;CDH19;DCHS1;CETN3;FKBP9;DHH;KCNIP1;SLC8A1;SYT10;CDH7;RASGRP1;CDH24;EFHD1;CPNE6;RYR2;SYT2;EFHD2;CDH10;CETN2;CDH5;SLIT3;SLIT1;SRI;SCIN;S100A4;GCA;TKT;NCS1;ANXA6;PPP3CA;CALM2;SNCA;S100G;PKD2L1;AGRN;CANT1;CAPN3
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.42654502490942725,-1.481490765249296,0.028368794326241134,0.3492464124569088,0.998,16/34,20.46%,SETD2;SMYD3;EHMT1;KMT5B;NSD3;SETDB1;CAMKMT;SETD7;EHMT2;EZH2;SETD4;PRDM9;SETD3;VCPKMT;METTL21A;SETD6
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.7223248421112701,1.4783334601155798,0.04602510460251046,0.3352818207297033,1.0,5/11,15.93%,CNGA3;CNGA4;AQP1;HCN1;CNGB1
prerank,insulin-like growth factor I binding (GO:0031994),0.7006497982363958,1.4783071938041297,0.04709141274238227,0.32862665426303544,1.0,4/13,4.18%,IGFBP6;IGFBP3;IGFBP4;IGFBP5
prerank,low-density lipoprotein particle binding (GO:0030169),0.6604723896739186,1.473397804281236,0.051451187335092345,0.33681268189528996,1.0,5/16,12.32%,PLTP;TREM2;SORL1;STAB1;MSR1
prerank,triglyceride lipase activity (GO:0004806),0.6331954572929165,1.4699749737293426,0.0403530895334174,0.3409147924818202,1.0,4/20,8.93%,PNPLA2;LIPG;LIPE;LPL
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5666275227662436,-1.4646339038314196,0.06440677966101695,0.3714901879257332,0.999,4/11,5.63%,AKAP13;KSR1;SH3RF1;SPAG9
prerank,water transmembrane transporter activity (GO:0005372),0.6949435315672975,1.4645561942225056,0.05673758865248227,0.3510518170371582,1.0,2/11,8.40%,AQP4;AQP1
prerank,ferrous iron binding (GO:0008198),0.6218944320058802,1.4591223439269145,0.057692307692307696,0.36065762479437835,1.0,2/21,0.08%,FTH1;FTL
prerank,chemokine activity (GO:0008009),0.5843210417154878,1.4587246009585415,0.03891509433962264,0.35535431517082694,1.0,9/31,17.61%,CXCL12;CCL19;CXCL16;CXCL10;CCL2;PF4;CCL3;CCL28;CCL8
prerank,GABA receptor binding (GO:0050811),0.6986267938911617,1.45846412733494,0.054441260744985676,0.3496696183846663,1.0,5/11,5.53%,GABARAP;GABARAPL2;SHISA7;GABARAPL1;LHFPL4
prerank,metal ion binding (GO:0046872),0.48277428981858156,1.4564398464594281,0.0,0.35011681711916226,1.0,127/477,19.23%,APOE;TPT1;SPARC;MT1G;MT1A;MT1B;MT1F;MT1H;MT1M;MT1E;MT1X;S100A6;CALM1;GSN;S100A1;SPARCL1;CALR;MT3;KCNIP4;MT2A;S100A11;HSPA5;NRXN1;SPOCK2;RCN3;S100B;PRNP;S100A10;CALM3;NME1;TGM2;ANXA5;PINK1;GJB2;IGFBP3;S100A13;HSPE1;RAN;S100A16;CANX;HSP90B1;LTBP4;S100A8;S100A9;BNIP2;CDH20;SLC25A13;NT5C3A;ADGRL3;SPOCK1;GRIN1;SYT1;F9;SELL;CLEC6A;CALB1;ENPP2;CDH18;MAST1;SDF4;SYT12;SYT11;TUBB4A;CLEC3B;LCP1;LPL;CDK5R1;RPH3A;SYT6;SYT4;NUDT3;DNER;AOC3;RASGRP3;PLA2G4F;GNAI1;PDCD6;APEX1;TRPM2;MAN1B1;AIF1;NUDT22;CDH12;PCDHB8;HPGDS;CDC42BPA;STK11;PCP4;CDH19;DCHS1;CETN3;FKBP9;TSSK6;TSSK4;DHH;KCNIP1;RRAGC;SLC8A1;SYT10;CDH7;RASGRP1;CDH24;EFHD1;CPNE6;RYR2;PPA1;NUDT16;SYT2;EFHD2;CDH10;CETN2;CDH5;BRSK2;SLIT3;SLIT1;SRI;SCIN;S100A4;GCA;TKT;NCS1;ANXA6;YDJC;PPP3CA;CALM2;SNCA;S100G
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.43698058132796774,-1.4528435299726206,0.023121387283236993,0.3848295374851884,0.999,14/27,14.61%,DCUN1D3;RNF19A;ZMYM2;PRKN;PPARA;ARIH2;RNF144A;ARIH1;RNF217;RNF14;DCUN1D4;SIAH3;DCUN1D1;DCUN1D2
prerank,fibroblast growth factor binding (GO:0017134),0.6198981977428489,1.4511775391162165,0.06186868686868687,0.3594243446705129,1.0,3/21,3.22%,RPS19;RPS2;S100A13
prerank,protein phosphatase activator activity (GO:0072542),0.6813614024608567,1.4484205905686744,0.058423913043478264,0.3608886417667333,1.0,8/13,21.19%,CALM1;CALM3;IGFBP3;B3GAT3;PPP2R5D;PPP1R15A;CALM2;PPP2R5A
prerank,chemokine receptor binding (GO:0042379),0.5664920683216772,1.4464979110550458,0.047398843930635835,0.36069189451210604,1.0,10/35,17.61%,CXCL12;CCL19;CXCL16;CXCL10;CX3CR1;CCL2;PF4;CCL3;CCL28;CCL8
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.6730998836107682,1.4458485296657846,0.07260273972602739,0.35658535066172276,1.0,6/12,16.30%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.6302114753145713,1.4453837399772076,0.06946264744429882,0.3523263649714462,1.0,3/16,10.52%,RPS3;DNPH1;NEIL1
prerank,manganese ion binding (GO:0030145),-0.3842657306525013,-1.4392577476802735,0.024096385542168676,0.4012386904554455,0.999,10/48,13.90%,MPPED2;LARGE1;ABL1;B4GALT1;XPNPEP3;NEK4;ABL2;GALNT1;MGAT5;ME1
prerank,insulin-like growth factor binding (GO:0005520),0.6601558727029596,1.4381403480978636,0.0625,0.3677496761189194,1.0,4/15,4.18%,IGFBP6;IGFBP3;IGFBP4;IGFBP5
prerank,sodium:proton antiporter activity (GO:0015385),-0.537420649606668,-1.434470993137583,0.0880281690140845,0.40111125457692137,0.999,4/11,12.18%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,nuclear receptor binding (GO:0016922),-0.3470945369773137,-1.4343521972779805,0.0,0.3912520981874741,0.999,33/111,13.79%,FOXP1;NSD1;SMAD3;TCF7L2;NRIP1;STAT5B;MED13;BCAS3;TACC2;NCOA1;TRIP12;BAZ2A;JMJD1C;THRAP3;ARID1A;CNOT1;NCOR1;KDM3A;ASXL1;LCOR;SMARCE1;STRN;MMS19;DCAF1;ESR1;PPID;DCAF13;KDM4C;BRD8;RNF14;TGFB1I1;SIRT1;PPARGC1B
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.600424442325156,1.431074852589024,0.062034739454094295,0.382244139462438,1.0,5/21,12.57%,CHRNA9;GRIK2;P2RX7;P2RX6;CHRNA4
prerank,ribosomal small subunit binding (GO:0043024),0.625636276477205,1.4290940911137764,0.06835443037974684,0.3826010283169638,1.0,4/17,3.18%,EIF1;NME1;NPM1;EIF1B
prerank,purinergic nucleotide receptor activity (GO:0001614),0.6407867137656129,1.4275006487709831,0.06157965194109773,0.3819912321318423,1.0,5/15,10.80%,P2RX7;GPR34;P2RY1;P2RY12;P2RX6
prerank,cadherin binding (GO:0045296),0.4765215691152004,1.4273544951224066,0.0,0.3768548325618834,1.0,91/315,17.27%,BSG;HSPA8;RPL24;RPL34;ALDOA;EEF2;RACK1;RPL29;RPL6;RPL15;RPS2;RPS26;PCBP1;RPL23A;RPL7A;HSP90AB1;RPL14;PPP1CA;TAGLN2;PARK7;FXYD5;S100A11;HSPA5;PSMB6;EEF1G;EIF4G2;HNRNPK;PRDX6;CTNNA2;ANK3;CNN2;CTNNA3;RAN;LYPLA2;EEF1D;YWHAB;PKM;PLEC;ENO1;LDHA;RTN4;TRIM29;CDH20;PUF60;CTNNB1;FLNA;YWHAE;AHNAK;CHMP2B;GLOD4;PFN1;NDRG1;CDH18;KDR;YKT6;CDK5R1;PRDX1;CCT8;SLC3A2;FASN;CHMP5;LASP1;FNBP1L;PLIN3;PTPRB;CLIC1;ANLN;HSPA1A;ATXN2L;CDH12;SHTN1;YWHAZ;EVPL;PROM1;CAPG;SND1;CDH19;DCHS1;EHD1;SH3GLB2;DNAJB1;CDH7;CDH24;DAB2IP;SPTBN2;EFHD2;CDH10;USP8;CDH5;NUDC;RANGAP1
prerank,estrogen receptor binding (GO:0030331),-0.39535406426207337,-1.4254920764126695,0.050724637681159424,0.39902427005236224,0.999,11/32,11.27%,NSD1;NRIP1;NCOA1;CNOT1;LCOR;STRN;MMS19;DCAF1;ESR1;PPID;DCAF13
prerank,sodium channel regulator activity (GO:0017080),0.5547400837728321,1.4202583515241523,0.04225352112676056,0.39275020751342204,1.0,12/37,15.84%,FXYD5;FXYD1;YWHAH;FGF14;SGK1;SCN4B;FGF11;FXYD7;FGF12;RSC1A1;PRSS8;FGF13
prerank,carboxypeptidase activity (GO:0004180),0.5503925185282794,1.4166627578915252,0.06,0.39855410810364894,1.0,9/35,11.66%,CTSZ;CPXM1;CPD;CPE;VASH1;AGBL4;AEBP1;CPXM2;CTSA
prerank,GABA-A receptor activity (GO:0004890),0.6125318808856877,1.4153247392238033,0.07345360824742268,0.39724655679574894,1.0,6/18,16.30%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2
prerank,ligand-gated cation channel activity (GO:0099094),0.5020761750543322,1.4152991978970513,0.03171247357293869,0.39173446670836354,1.0,16/75,12.57%,ASIC2;CHRNA9;GRIA2;GRIK5;GRIK2;GRIN1;KCNJ10;GRIN3A;P2RX7;GRIA4;GRIN2A;P2RX6;TRPM2;KCNN2;GRIA1;CHRNA4
prerank,hormone activity (GO:0005179),0.5220231792581883,1.4129314705116898,0.0416210295728368,0.393665593823847,1.0,18/54,22.33%,NPPC;TRH;POMC;AGT;AMH;PENK;CRH;CALCB;PPY;HCRT;CCK;ADCYAP1;NMB;EDN3;INHBA;SST;INHBB;ERFE
prerank,amino acid binding (GO:0016597),0.5628004922690932,1.4124474105472966,0.06323185011709602,0.38987458631980637,1.0,13/31,20.45%,AGXT;GRIN1;GRIN3A;GRM7;AARS2;GLRA2;GLRA1;DDAH1;DDAH2;NOS2;GRIN2B;GLRA3;SHMT2
prerank,deoxyribonuclease activity (GO:0004536),0.6441186748210216,1.412397451157138,0.08979591836734693,0.3847765174098297,1.0,2/14,2.69%,RPS3;NME1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4113995127350877,-1.4093875397183473,0.05527638190954774,0.42120109820727347,0.999,7/26,12.56%,SLC6A13;SLC16A12;SLC6A12;SLC16A9;ABCG2;SLC16A6;SLC16A13
prerank,calcium channel regulator activity (GO:0005246),0.549386067993444,1.4073856043057682,0.050808314087759814,0.39469742387033696,1.0,13/37,19.10%,CALM1;SLC30A1;NRXN1;FKBP1A;YWHAE;SGK1;PHPT1;NRXN2;INAFM2;CACNG8;SRI;FKBP1B;CALM2
prerank,cell-cell adhesion mediator activity (GO:0098632),0.54240016086547,1.406137317714423,0.03919372900335946,0.3933114187506812,1.0,14/42,15.44%,BSG;PPP1CA;S100A11;DSCAM;CNTN4;TRIM29;SIRPA;LRRC4C;ESAM;ROBO4;EMB;JAM3;IGSF9;DSCAML1
prerank,retinoid binding (GO:0005501),0.5890380723836314,1.4040355075002684,0.07612903225806451,0.3941899569191835,1.0,3/22,7.26%,PTGDS;RBP4;RBP1
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.40934365073407986,-1.4033198106351983,0.058823529411764705,0.42466043116566293,1.0,9/29,13.42%,ABL1;ATF7;PPM1D;NFATC1;DUSP16;DUSP10;MAPKAPK3;DUSP7;SIRT1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.41191244953479955,-1.4023747570227265,0.05405405405405406,0.4168869267695823,1.0,12/34,11.07%,PARD3;GAB2;FCHSD2;ZFYVE1;MAPKAP1;OGT;MYO1B;ADAP2;GBF1;DAPP1;KIF16B;FERMT2
prerank,GTPase activator activity (GO:0005096),-0.30815482249783516,-1.4017672750358083,0.0,0.40870946712454637,1.0,89/313,13.71%,ARHGAP29;AKAP13;RANBP3L;ARHGAP28;DOCK5;SIPA1L1;ARHGAP20;PLCE1;ARHGAP10;RAPGEF4;DOCK11;ASAP3;ALDH1A1;SBF2;DENND4A;ARHGEF11;ASAP1;ARHGAP17;LRRK2;ARHGAP42;DENND4C;FARP1;ARFGEF1;RANBP2;RAPGEF2;DENND2A;SGSM2;IQSEC2;NRP1;MON1A;ITSN1;USP6NL;TBC1D12;ERRFI1;RALGAPB;SMAP1;ARHGEF18;ARHGEF10L;FGD4;FNIP1;ANKRD27;EIF2B3;DENND5A;ASAP2;STARD13;SIPA1L3;TBC1D2B;RAPGEF6;RABGAP1;DENND1A;ARHGAP32;ARFGEF2;RAPGEF1;RIC8B;TBC1D9B;BCR;VAV2;RAPGEF5;TBC1D4;GAPVD1;ARHGEF6;SYDE2;ALS2;ARHGAP31;CCZ1;DNMBP;DENND1B;TBC1D8B;TBCK;OPHN1;RAPGEF3;DENND5B;DOCK1;MYO9B;SIPA1;ARHGAP18;RIC1;DENND3;SMAP2;RALGAPA1;ARHGEF2;STXBP5;ARHGEF17;DENND2C;WNT11;RGS16;EIF2B2;RAB3GAP2;RAP1GDS1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5627245297570018,1.3988342919698737,0.07203907203907203,0.4048703536305251,1.0,6/30,7.36%,CST3;MT3;UBE2Z;PRDX5;SPOCK1;CSTB
prerank,1-phosphatidylinositol binding (GO:0005545),-0.48926036291570935,-1.3956854964457535,0.09917355371900827,0.4134611071198774,1.0,7/15,9.94%,ZFYVE1;EEA1;SESTD1;ZFYVE9;WDFY3;PICALM;SNX9
prerank,U6 snRNA binding (GO:0017070),0.628899033247756,1.3877583263850921,0.1016260162601626,0.43412673351146525,1.0,5/14,10.66%,DDX39B;EIF5A;LSM4;LSM8;PRPF8
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.6629209090702313,1.3868784549688669,0.09465020576131687,0.4312446758838478,1.0,4/11,17.54%,RPS3;NEIL1;APEX1;NEIL2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.5070750996596098,-1.384874038126603,0.11029411764705882,0.4269440855768882,1.0,3/13,9.95%,DICER1;SLX4;DNASE1L1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5854075743854777,1.3805304996464223,0.08196721311475409,0.44552709998498174,1.0,5/21,12.57%,GRM5;DRD5;GRM1;GRIA1;CHRNA4
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5049271398755782,-1.3796582490686777,0.10820895522388059,0.42795613440719465,1.0,4/12,12.18%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,phosphatidic acid binding (GO:0070300),-0.4653875311979385,-1.3761885790600499,0.08520179372197309,0.4261049877856497,1.0,7/19,6.50%,PITPNC1;RAPGEF2;MAPKAP1;PACSIN2;MARK1;SESTD1;RAPGEF6
prerank,transcription corepressor binding (GO:0001222),-0.4133040333059337,-1.3760411286597034,0.06060606060606061,0.41778523799990763,1.0,11/27,14.95%,ZBTB16;PER2;USP11;PER3;EHMT1;LCOR;NEK6;ESR1;RORA;EHMT2;EZH2
prerank,endopeptidase activator activity (GO:0061133),0.6587029006005125,1.3739218201115344,0.1346704871060172,0.4608767927693819,1.0,4/10,8.66%,PSME1;PSME2;PSENEN;VSIR
prerank,cholesterol transfer activity (GO:0120020),0.6219730155839767,1.3731572208067697,0.10435931307793923,0.45776648150111593,1.0,4/16,9.19%,PLTP;NPC2;ABCG1;STARD4
prerank,poly(A) binding (GO:0008143),-0.43659685156316236,-1.3729524296926454,0.07106598984771574,0.41620611470484065,1.0,8/21,15.12%,RBMS3;RBMS1;RBPMS;DDX1;ZC3H14;PABPC4;PABPC4L;RBMS2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.6475392878138965,1.3711178103327075,0.10190217391304347,0.45925649837070803,1.0,4/13,12.81%,MIF;DDT;ECH1;HSD3B2
prerank,CoA-ligase activity (GO:0016405),-0.5096388397087612,-1.3710201995203462,0.1037344398340249,0.411898929258062,1.0,10/14,38.04%,ACSS3;ACSL1;SLC27A2;ACSS1;AACS;ACSBG1;ACSM3;SLC27A5;ACSM2B;ACSM2A
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.6089141713676853,1.3700885623394943,0.1122715404699739,0.45167669094592117,1.0,12/16,28.13%,PTPRC;PTPRN2;PTPRD;PTPRB;PTPRR;PTPRZ1;PTPN6;PTPRU;PTPRO;PTPRE;PTPRT;PTPRG
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.6089141713676853,1.3700885623394943,0.1122715404699739,0.45167669094592117,1.0,12/16,28.13%,PTPRC;PTPRN2;PTPRD;PTPRB;PTPRR;PTPRZ1;PTPN6;PTPRU;PTPRO;PTPRE;PTPRT;PTPRG
prerank,ATPase regulator activity (GO:0060590),0.5306348780767047,1.366589901145689,0.10618436406067679,0.45708176019310265,1.0,15/38,18.89%,ATP5IF1;BAG5;PFN1;BAG1;ATP1B2;PLN;DNAJA1;DNAJB2;HSPBP1;DNAJB1;ATP1B1;BRSK2;ATP1B3;AHSA1;DNAJC10
prerank,glycine binding (GO:0016594),0.6566693682338456,1.361559427418108,0.11444921316165951,0.4675161274748533,1.0,6/11,18.83%,GRIN1;GRIN3A;GLRA2;GLRA1;GRIN2B;GLRA3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.6189862788239558,1.360404892866098,0.11348464619492657,0.46576956999022867,1.0,7/14,13.02%,TIMP2;SPOCK2;SPOCK1;SPOCK3;TIMP1;TIMP3;BST2
prerank,chemorepellent activity (GO:0045499),0.5675771402674632,1.3600988719152869,0.09732360097323602,0.4615102886378857,1.0,8/25,13.41%,NRG3;NRG1;SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,sterol transfer activity (GO:0120015),0.6072923238310424,1.3591866472214558,0.11518324607329843,0.4593782055100903,1.0,4/17,9.19%,PLTP;NPC2;ABCG1;STARD4
prerank,sterol binding (GO:0032934),0.5015750330707784,1.3573959633592791,0.06755260243632337,0.46040112822834955,1.0,20/56,22.21%,APOD;TSPO;CD81;NPC2;SCP2;ABCG1;TSPO2;STARD4;OSBPL6;PROM1;SYP;CAV1;SOAT2;STARD3NL;OSBPL3;ANXA6;VDAC2;GPR183;OSBPL1A;GRAMD1A
prerank,protein tyrosine kinase activator activity (GO:0030296),0.593122258864213,1.356490844776222,0.08494208494208494,0.458154971729463,1.0,7/19,18.23%,NRG3;NRG1;GRM5;CD24;GAS6;ERCC6;ERBB3
prerank,semaphorin receptor binding (GO:0030215),0.562293808531474,1.3555009822846211,0.10596833130328867,0.4563950858384217,1.0,6/23,13.41%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,fatty acid synthase activity (GO:0004312),0.6642957705273689,1.355490540490362,0.12303290414878398,0.4516351989242683,1.0,4/10,11.14%,ELOVL1;ELOVL2;OXSM;ELOVL7
prerank,phospholipase inhibitor activity (GO:0004859),0.6658226912882621,1.3550989012482986,0.12056737588652482,0.44820117644403096,1.0,2/10,3.07%,APOC1;ANXA5
prerank,metallocarboxypeptidase activity (GO:0004181),0.5486780098647864,1.3543247817769517,0.10362047440699126,0.44554904716440735,1.0,7/26,11.06%,CPXM1;CPD;CPE;VASH1;AGBL4;AEBP1;CPXM2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6127675675030356,1.3521360018153226,0.11772486772486772,0.4474057883758073,1.0,8/15,12.67%,SLC17A8;SLC1A4;SLC1A2;SLC25A13;SLC17A7;SLC17A6;SLC1A1;SLC25A22
prerank,ATPase activator activity (GO:0001671),0.5863529657124291,1.3521180600187117,0.12239583333333333,0.4429120278608629,1.0,8/20,18.89%,ATP1B2;DNAJA1;DNAJB2;DNAJB1;ATP1B1;ATP1B3;AHSA1;DNAJC10
prerank,adenylate cyclase binding (GO:0008179),0.6633807265498854,1.3520687955933246,0.13668061366806136,0.4386427290840204,1.0,3/10,2.58%,CALM1;AKAP6;CALM3
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5363322008684203,1.351927907437165,0.08941176470588236,0.43469949373012806,1.0,11/32,24.20%,KCNQ3;KCNQ2;KCNC3;KCNC1;KCNE4;KCNA2;KCNE5;KCNA1;KCNQ5;KCNC2;KCNG3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.5129416467733218,-1.3519049210232854,0.10801393728222997,0.44237012303071105,1.0,4/12,18.06%,TENT4B;TUT1;PAPOLB;TENT2
prerank,transaminase activity (GO:0008483),0.6538280352806481,1.345940065007167,0.11328671328671329,0.44798676163258006,1.0,3/11,6.28%,AGXT;OAT;BCAT2
prerank,acetyltransferase activity (GO:0016407),-0.38437394781164214,-1.3437319712480809,0.06382978723404255,0.4531640068237078,1.0,12/31,19.32%,KAT6B;CREBBP;KAT2B;PAFAH2;SMARCE1;NAA16;NAA15;ESCO1;KAT6A;SPHK1;KAT8;DBT
prerank,leak channel activity (GO:0022840),-0.4525999422047323,-1.34189570233112,0.13004484304932734,0.4494928651126197,1.0,3/18,2.21%,KCNK2;NALCN;KCNK5
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6269795223312317,1.34149114930596,0.1115819209039548,0.4567938620227172,1.0,10/13,32.99%,GABRG3;GABRA2;GLRA2;GLRA1;GABRA3;GLRA3;GABRA4;GABRG2;GABRA1;GABRG1
prerank,protein kinase inhibitor activity (GO:0004860),0.508503350836492,1.339332581883654,0.0894854586129754,0.45921990919905825,1.0,15/42,19.11%,RACK1;NPM1;CAMK2N2;YWHAB;PPP1R1B;CDKN1C;INKA2;ITPRIP;CAMK2N1;MAPK8IP1;HEXIM1;GMFB;PRKRIP1;QARS1;SNCA
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4758417227731573,1.3376090263495934,0.06485355648535565,0.4598292922241554,1.0,31/85,28.06%,PNPLA2;PRDX6;LYPLA2;CA2;PLAAT3;PGLS;LIPG;ENPP2;LIPE;PNPLA7;LPL;AARS2;PLA2G7;PLA2G4F;GDE1;MRPL58;ABHD8;ACHE;GDPD1;FAAH;NOTUM;ESD;BCHE;APMAP;ABHD16A;GDPD3;ABHD12;PLA2G6;PON2;PGAP1;MGLL
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.50475428046219,-1.335424099270966,0.1111111111111111,0.45420341473824083,1.0,6/11,18.18%,CFLAR;CASP12;CASP3;CASP8;CASP7;CASP4
prerank,tRNA methyltransferase activity (GO:0008175),-0.48049321527823274,-1.331585023412617,0.13765182186234817,0.45460701586882185,1.0,6/16,15.30%,TRMT13;ALKBH8;THUMPD3;TRMT5;FTSJ1;TRMT9B
prerank,actin monomer binding (GO:0003785),0.5631805644262777,1.3304777630501246,0.12468513853904283,0.4775837855406504,1.0,5/22,7.45%,TMSB4X;TMSB10;MRTFA;PFN1;CORO1A
prerank,translation initiation factor activity (GO:0003743),0.520885565633096,1.3295796338339632,0.09736540664375716,0.4758561398624348,1.0,18/36,25.32%,EIF1;EIF3F;EIF4G2;EIF3D;EIF1B;EIF3K;EIF3I;EIF3C;EIF4A1;EIF3B;EIF2B5;EIF3M;EIF5B;EIF4E2;EIF3H;EIF2S1;EIF2A;EIF3G
prerank,gap junction channel activity (GO:0005243),0.5654842491112833,1.3240494333319754,0.12743823146944083,0.48708951749267115,1.0,5/22,13.23%,GJA4;GJB2;GJB5;GJD2;GJA1
prerank,kinase activator activity (GO:0019209),0.5283468749534684,1.3217548494297404,0.12895662368112543,0.48923437595186636,1.0,5/30,9.33%,RPLP1;MT3;TREM2;IL2;CDK5R1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.5249953848849116,-1.3196187025514166,0.12627986348122866,0.4708125594409011,1.0,2/11,3.46%,EGFR;MAP3K13
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.6038508657852926,1.3196024188238273,0.15696887686062247,0.49169964418945933,1.0,5/14,15.07%,RACK1;RPS27L;MAL;CTSH;BAD
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.635697349090077,1.3182133986604967,0.1379800853485064,0.4916651984155539,1.0,7/10,32.99%,GABRG3;GABRA2;GABRA3;GABRA4;GABRG2;GABRA1;GABRG1
prerank,pentosyltransferase activity (GO:0016763),-0.36882941170446715,-1.3132642402882166,0.08450704225352113,0.47660848859246374,1.0,10/36,15.22%,LARGE1;PARP4;PARP9;PARP16;PARP3;UPP2;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,glucuronosyltransferase activity (GO:0015020),-0.4397360998208625,-1.3127755915292696,0.11842105263157894,0.4696205553074519,1.0,2/19,1.07%,LARGE1;EXT1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.603109072401219,1.3100672914654208,0.15261044176706828,0.5128708041636689,1.0,6/14,17.36%,NME1;AK4;NME4;NME2;CMPK2;NME3
prerank,mRNA binding (GO:0003729),0.43904032477242916,1.3079495439805633,0.013039117352056168,0.5147785809563256,1.0,28/249,5.63%,RPL41;RPL26;MRPL13;RPS3;RPS14;RPS5;RPS7;RPL5;RPS13;RPS2;RPL13A;RPS26;RPL7;PCBP1;CALR;RPL35;PARK7;HNRNPAB;EIF4G2;EIF3D;SHFL;HNRNPK;QKI;PKM;ZFP36L1;NCL;RBFOX3;PCBP4
prerank,endodeoxyribonuclease activity (GO:0004520),0.5496463903046676,1.3078372821525253,0.12718204488778054,0.5106023971474399,1.0,2/20,3.47%,RPS3;ENDOG
prerank,phosphatase activator activity (GO:0019211),0.6059088067065939,1.3075177536854035,0.17367706919945725,0.5072814925393025,1.0,8/14,21.19%,CALM1;CALM3;B3GAT3;BMP2;PPP2R5D;PPP1R15A;CALM2;PPP2R5A
prerank,GABA receptor activity (GO:0016917),0.5512224482459704,1.3065047221174801,0.12404092071611253,0.5056639193582068,1.0,10/21,29.77%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2;GABBR2;GABRA4;GABRG2;GABRA1
prerank,snRNA binding (GO:0017069),0.4997962559004065,1.3064057498141097,0.13124274099883856,0.5017374253374723,1.0,19/42,23.25%,DDX39B;EIF5A;LSM4;LSM8;SNRPA;PRPF8;TOE1;HNRNPU;HEXIM1;MEPCE;PRPF31;SNRPD3;LSM7;RBM7;SNRNP35;CDK9;SNU13;ISG20;SNRPB2
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.30426906282077937,-1.3049751211199896,0.03125,0.47850792079182924,1.0,24/100,11.07%,PARD3;GAB2;FCHSD2;OSBPL8;ZFYVE1;MAPKAP1;PLA2G4A;OGT;MYO1B;PLEKHA4;ADAP2;SNX12;SESTD1;DENND1A;ANKFY1;ATG2B;GBF1;HIP1;DAPP1;ATG2A;SNX24;KIF16B;DENND1B;FERMT2
prerank,protein tyrosine kinase binding (GO:1990782),0.4722932996806363,1.3047208712698437,0.07327586206896551,0.5027605208099428,1.0,12/71,6.27%,RACK1;HSP90AA1;NRG3;NRG1;TREM2;GRM5;GRB14;LRP4;DUSP3;SIRPA;HYAL2;SHC3
prerank,platelet-derived growth factor binding (GO:0048407),0.6383077411127337,1.3023118276562962,0.1652542372881356,0.5057880467656316,1.0,7/11,15.48%,COL1A1;PDGFB;COL6A1;COL4A1;COL3A1;COL1A2;PDGFA
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.5768685259626751,1.301582164588859,0.1364221364221364,0.5038513037475838,1.0,7/17,17.36%,NME1;AK4;AK3;NME4;NME2;CMPK2;NME3
prerank,wide pore channel activity (GO:0022829),0.5513377987460055,1.3000011892664178,0.15741935483870967,0.504518732891359,1.0,5/23,13.23%,GJA4;GJB2;GJB5;GJD2;GJA1
prerank,GTPase regulator activity (GO:0030695),-0.26642716735736005,-1.2984895712433462,0.0,0.48370889999090927,1.0,54/212,13.71%,ARHGAP29;RANBP3L;ARHGAP28;SIPA1L1;ARHGAP20;ARHGAP10;ASAP3;ALDH1A1;ASAP1;ARHGAP17;LRRK2;ARHGAP42;ARFGEF1;RANBP2;RAPGEF2;SGSM2;SLIT2;NRP1;USP6NL;TBC1D12;ERRFI1;RALGAPB;SMAP1;ARHGEF10L;ASAP2;STARD13;SIPA1L3;TBC1D2B;RABGAP1;ARHGAP32;RIC8B;TBC1D9B;BCR;TBC1D4;ARHGEF6;SYDE2;ALS2;ARHGAP31;KRIT1;TBC1D8B;TBCK;OPHN1;PDE6D;DOCK1;MYO9B;SIPA1;ARHGAP18;SMAP2;RALGAPA1;STXBP5;WNT11;RGS16;RAB3GAP2;RAP1GDS1
prerank,carboxylic acid binding (GO:0031406),0.5050450148007843,1.2915223487438097,0.1175115207373272,0.5259906266924766,1.0,13/38,21.81%,PSAP;GRIN1;EPDR1;GRIN3A;GRM7;GLRA2;GLRA1;NOS2;GLUD1;GRIN2B;GLRA3;SHMT2;MAG
prerank,histone methyltransferase binding (GO:1990226),0.6219954456556176,1.2914116003856997,0.17712691771269176,0.5220015074799222,1.0,6/11,21.93%,HSP90AB1;CTNNB1;PRDM12;CBX3;PHF1;NOP56
prerank,acid-thiol ligase activity (GO:0016878),-0.4832441943169075,-1.2855484819471805,0.14,0.5040013140941734,1.0,9/13,38.04%,ACSS3;ACSL1;SLC27A2;ACSS1;AACS;ACSM3;SLC27A5;ACSM2B;ACSM2A
prerank,CCR chemokine receptor binding (GO:0048020),0.5205475326035434,1.2854402852512696,0.14845605700712589,0.5359718529091217,1.0,7/28,18.30%,CCL19;NES;NARS1;CCL2;CCL3;CCL8;CCR2
prerank,SUMO binding (GO:0032183),-0.47166244433602167,-1.2817759486792142,0.17073170731707318,0.5048737141383187,1.0,5/13,20.35%,PML;TDG;CBX4;RNF111;HERC2
prerank,ion channel activity (GO:0005216),0.4507561998192051,1.2804517845604146,0.09309623430962342,0.5471682581095868,1.0,27/80,22.37%,GABRB1;GRIA2;LRRC8A;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;TMEM63B;CNGA3;GRIA4;GRIN2A;GRID1;TRPM2;GRIA1;CHRNA4;TRPC1;KCNK3;CNGB1;UNC80;GRIN2B;ANXA6;CALHM6;PKD2L1;GRIA3;GRIK1;CHRNA3
prerank,aspartic-type peptidase activity (GO:0070001),0.6354389673722941,1.2796890960426084,0.18063583815028902,0.5450754376022497,1.0,4/10,22.15%,CTSD;NAPSA;BACE1;CTSE
prerank,GTP binding (GO:0005525),0.4330011799964765,1.2780202503499498,0.05146316851664985,0.5460556938086891,1.0,48/172,19.61%,EEF1A1;TUBB;TUBA1A;TUBA1B;TUBB4B;RHOB;NME1;TGM2;TUBAL3;RAN;RHOC;ARF5;RAC1;TUBA4A;RHOG;RAB14;ADSS1;ARL11;TUBB4A;TUBB2B;SCG5;ARF6;RHOV;GNAI1;ARL4C;ARL4D;ARL1;HRAS;RHEBL1;RHOA;RHOU;GTPBP10;RRAS;ARF1;ARL2;RAB26;RRAGC;ARF4;RRAGD;NUDT16;RAC2;TUBB2A;GLUD1;AGAP2;TSR1;ANXA6;RAB31;RAB4A
prerank,anion channel activity (GO:0005253),0.4719707356583364,1.2768946458389352,0.11978021978021978,0.5453054438753506,1.0,16/61,18.96%,GABRB1;FXYD1;LRRC8A;SLC1A4;GABRG3;GABRA2;GLRA2;GLRA1;GABRA3;GABRB3;CLIC1;TTYH3;GABRB2;ANO4;GLRA3;VDAC2
prerank,potassium channel activity (GO:0005267),0.4469112973553376,1.2759143737360388,0.10269709543568464,0.5442212304732674,1.0,29/89,21.95%,KCNQ3;KCNQ2;KCNC3;KCND2;GRIK5;GRIK2;AQP1;KCNC1;KCNA2;KCNN2;KCNK9;ABCC8;KCNE5;KCNF1;HCN1;KCNK3;KCNA1;LRRC55;KCNK10;HCN3;KCNH7;KCNMA1;KCNH8;KCNK13;KCNQ5;PKD2L1;TMEM38B;KCNC2;GRIK1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.5873186690842436,1.2730006272783148,0.19008264462809918,0.5494106767189819,1.0,7/14,12.67%,SLC17A8;SLC1A2;SLC25A13;SLC17A7;SLC17A6;SLC1A1;SLC25A22
prerank,metalloendopeptidase activity (GO:0004222),-0.3133666857972414,-1.272281432557308,0.07936507936507936,0.519131442190715,1.0,17/76,11.77%,ADAMTS10;TRABD2B;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;ADAMTSL5;ADAMTS9;ADAMTSL4;NRDC;ADAMTS5;ADAM9;ADAM33;ADAM19;ADAMTS6;NLN;ADAMTS14
prerank,chloride channel activity (GO:0005254),0.4727547620319829,1.2710099404984119,0.11886586695747,0.5514002338754358,1.0,15/59,18.83%,GABRB1;FXYD1;SLC1A4;GABRG3;GABRA2;TTYH1;GLRA2;GLRA1;GABRA3;GABRB3;CLIC1;TTYH3;GABRB2;ANO4;GLRA3
prerank,hexosaminidase activity (GO:0015929),0.5987960362579099,1.268680233218796,0.1875,0.5542772816433278,1.0,3/12,5.82%,HEXB;HEXA;HYAL2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.5702376567724755,1.2679138053932184,0.17783505154639176,0.5484401007973253,1.0,4/16,11.17%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.5702376567724755,1.2679138053932184,0.17783505154639176,0.5484401007973253,1.0,4/16,11.17%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2
prerank,histone acetyltransferase activity (GO:0004402),-0.3797250091287605,-1.2643565865213835,0.10429447852760736,0.5300700539123935,1.0,9/30,13.32%,KAT6B;CREBBP;NAA40;EPC1;KAT7;KAT2B;ATF2;MCM3AP;KAT6A
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.37464422069129083,-1.2635424755611875,0.14743589743589744,0.5238951461336004,1.0,5/27,6.28%,ITPR1;ITPR2;CNNM2;SLC9B2;TUSC3
prerank,ankyrin binding (GO:0030506),0.5427310398329909,1.261568416865336,0.17737789203084833,0.5636994714727701,1.0,6/19,15.65%,KCNQ2;PTPRC;PLEC;NRCAM;SLC8A1;SPTBN4
prerank,neuropeptide hormone activity (GO:0005184),0.5287649099498497,1.2611591911319648,0.17237008871989862,0.5607978159880627,1.0,8/22,18.27%,PENK;CRH;CALCB;PPY;HCRT;CCK;ADCYAP1;NMB
prerank,ATP hydrolysis activity (GO:0140603),0.47776789756185656,1.2610404375849498,0.1564310544611819,0.5570052561935489,1.0,21/41,32.13%,CLU;HSP90AA1;HSPA1B;ABCB6;VCP;KIF26A;ATP2B1;HSPA1A;ABCB10;CHD3;TDRD9;ABCA3;KIF20B;RUVBL2;DHX9;RHOBTB3;TOR3A;ABCD2;MYO1E;DNA2;DDX3X
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.27378491854519743,-1.260839940751102,0.0,0.5223902533586853,1.0,78/346,13.10%,RNF220;PDZRN3;UBE2E2;HECTD1;CNOT4;BIRC6;TTC3;MIB1;RNF216;UBR4;RNF152;SMURF2;TRIP12;KCMF1;WWP1;RNF38;RNF19A;UBR5;COP1;CBLB;PRKN;BIRC2;TRAF3IP2;PELI2;SH3RF1;SH3RF3;RNF146;ARIH2;RNF144A;UBR3;UBR1;RNF213;SMURF1;TRAF5;UBE2R2;BCOR;UBE2Q2;RNF24;RNF135;BIRC3;ARIH1;TRIM5;HUWE1;RNF8;UHRF2;PML;UBR2;DDB2;RNF41;FBXO10;FBXO11;NEURL2;ZNRF1;SH3RF2;NFX1;BTRC;TOPORS;RNF138;FBXO4;UBE2J2;TRIM24;RC3H2;ZFP91;ASB2;ITCH;RNF217;FBXW11;CUL4B;RNF115;UBE3C;CUL4A;PPIL2;RNF43;RNF14;HECW2;SIAH3;UBE3B;ERCC8
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4739106111563814,1.2606983600156203,0.1453551912568306,0.5539442509153567,1.0,24/49,31.22%,ANXA5;SYT1;SYT12;SYT11;RPH3A;SYT6;SYT4;PLA2G4F;CPNE5;SYT10;CPNE6;SYT2;DOC2B;ANXA6;CPNE4;C2CD5;SYT3;SYT5;SYT17;CPNE3;PCLO;CPNE9;SYT7;MCTP1
prerank,growth factor activity (GO:0008083),0.45168025530649203,1.2575111601576916,0.12098501070663811,0.5593328953137573,1.0,21/74,25.43%,MDK;GRN;NRG3;NRG1;AGT;PDGFB;IL2;IL11;IGF2;PDGFA;JAG2;INHBA;HGF;IL6;OSGIN1;THPO;TGFA;PTN;FGF22;INHA;CSPG5
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.478955422243804,-1.2515440503876598,0.18450184501845018,0.5351521307273739,1.0,4/12,10.33%,PAN3;CNOT1;PARN;CNOT7
prerank,calcium channel inhibitor activity (GO:0019855),0.599211096768955,1.2515015334727684,0.19747899159663865,0.5737772163216716,1.0,6/11,19.10%,CALM1;SLC30A1;FKBP1A;PHPT1;FKBP1B;CALM2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4888462417751824,1.2463415752226565,0.17093023255813952,0.5857914416915957,1.0,12/37,18.78%,LARS2;GARS1;SARS2;SARS1;KARS1;AARS2;WARS1;NARS1;CARS1;TARS3;EPRS1;QARS1
prerank,CXCR chemokine receptor binding (GO:0045236),0.595049665587189,1.2456418943055811,0.21726618705035972,0.5836624376950712,1.0,3/11,14.72%,CXCL12;CXCL10;PF4
prerank,single-stranded telomeric DNA binding (GO:0043047),0.5953355377855353,1.2443665053906259,0.209366391184573,0.5836867124492364,1.0,5/11,18.53%,TERF1;RPA2;HNRNPA1;CTC1;TERF2IP
prerank,ATPase binding (GO:0051117),0.44895187527300656,1.2411509691269396,0.15100316789862725,0.5896221763620529,1.0,27/71,21.40%,S100A1;UBXN1;GABARAPL2;ATP6V1G1;ATP5IF1;FBL;ATP1B2;PLN;PIH1D1;TAF9;SVIP;WFS1;SYVN1;TMEM106B;TRPC1;BBC3;DNAJB1;ATP1B1;NR1H2;CAV1;BRSK2;ATP1B3;DNAJC10;PPP3CA;SNU13;RALB;SELENOS
prerank,zinc ion binding (GO:0008270),0.4150354374108965,1.2400803656743256,0.024024024024024024,0.5889958945848661,1.0,38/293,9.76%,CRIP1;RPS29;MT1G;MT1A;MT1B;MT1F;MT1H;MT1M;MT1E;MT1X;RPS27;CRIP2;CALR;MT3;TIMM8B;TIMM13;SOD1;MT2A;TIMP2;S100B;S100A13;CA2;GLO1;CZIB;S100A8;S100A9;GALT;TRIM28;CALB1;ENPP2;GRIN2A;CSRP1;TIMP1;TRIM2;EGR1;ATP13A2;RPH3A;ALAD
prerank,chemoattractant activity (GO:0042056),0.5114507377875183,1.2359871558283098,0.20192307692307693,0.5980285530576264,1.0,6/26,9.82%,GPNMB;PDGFB;LGALS3;MIF;CXCL10;HMGB1
prerank,iron ion binding (GO:0005506),0.4683453693464898,1.2356107616164942,0.1580110497237569,0.59503038605975,1.0,4/48,3.05%,FTH1;FTL;SCD5;DOHH
prerank,AMP binding (GO:0016208),-0.4706691238463968,-1.233913230314017,0.1935483870967742,0.5697115225966267,1.0,2/11,0.48%,PRKAG2;MPPED2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5843817170708323,1.2335259763142197,0.21861777150916784,0.5973413881798095,1.0,4/12,15.07%,RACK1;RPS27L;CTSH;BAD
prerank,acylglycerol lipase activity (GO:0047372),0.5886752566680212,1.2306279775039868,0.22772277227722773,0.602336811407035,1.0,5/11,28.06%,LIPE;FAAH;ABHD16A;ABHD12;MGLL
prerank,potassium channel regulator activity (GO:0015459),0.46050938795209284,1.2295222688217962,0.16294642857142858,0.6018092668432165,1.0,12/49,17.39%,KCNIP4;AKT1;DPP10;FLNA;YWHAE;SGK1;DPP6;KCNE4;KCNE5;KCNIP1;ARPP19;LRRC55
prerank,phosphate ion binding (GO:0042301),0.607158435491751,1.2247705093655696,0.24369747899159663,0.6127475046449296,1.0,6/10,24.94%,ADSS1;RPH3A;PNP;CHST14;RELA;PDE2A
prerank,exopeptidase activity (GO:0008238),0.46121450149432675,1.2243307024326253,0.164079822616408,0.6101661752675119,1.0,13/50,16.28%,CTSZ;RCE1;METAP1;DPEP3;DPP10;CPE;DPEP2;DPP6;METAP2;CTSA;LAP3;CTSH;NUDT16
prerank,guanyl ribonucleotide binding (GO:0032561),0.4134193880627296,1.2242631442407341,0.07839195979899498,0.6064585496496668,1.0,55/196,19.61%,EEF1A1;TUBB;TUBA1A;TUBA1B;TUBB4B;RHOB;NME1;TGM2;TUBAL3;RAN;RHOC;ARF5;RAC1;TUBA4A;RHOG;RAB14;CNGA3;ADSS1;CNGA4;ARL11;TUBB4A;TUBB2B;SCG5;ARF6;RHOV;GNAI1;ARL4C;ARL4D;ARL1;HRAS;RHEBL1;RHOA;SLC19A1;NME2;RHOU;GTPBP10;RRAS;ARF1;ARL2;RAB26;RRAGC;ARF4;CNGB1;RRAGD;NUDT16;RAB5C;RAC2;TUBB2A;GLUD1;AGAP2;TSR1;ANXA6;RAB18;RAB31;RAB4A
prerank,transition metal ion binding (GO:0046914),0.40889827012265045,1.2230372436982753,0.015,0.60625113205817,1.0,59/397,13.12%,FTH1;FTL;CRIP1;RPS29;MT1G;MT1A;MT1B;MT1F;MT1H;MT1M;MT1E;MT1X;RPS27;ATOX1;SCD5;CRIP2;CALR;MT3;TIMM8B;TIMM13;PARK7;SOD1;MT2A;TIMP2;S100B;PRNP;DOHH;S100A13;COX17;CA2;GLO1;CZIB;ANG;S100A8;S100A9;GALT;TRIM28;CALB1;ENPP2;GRIN2A;CSRP1;TIMP1;TRIM2;EGR1;ATP13A2;RPH3A;ALAD;SMPD1;AOC3;SCD;MGAT2;LCN2;GLRA1;ISCU;ZCCHC4;KLF4;THAP11;CUTA;MSRB1
prerank,DNA polymerase binding (GO:0070182),0.5374851876789541,1.2228348935621418,0.24102564102564103,0.6029530714336714,1.0,5/18,14.87%,HSP90AA1;HSP90AB1;HMGB1;PCNA;PTGES3
prerank,kinesin binding (GO:0019894),0.5055061549708477,1.2223662340045165,0.20722891566265061,0.6005222831711,1.0,8/27,19.11%,ACTB;NEFH;MAPK8IP1;MAPK8IP2;CLSTN1;FAM83D;ATCAY;SNCA
prerank,neuropeptide receptor activity (GO:0008188),0.4911353106551494,1.2191356767225787,0.2014218009478673,0.6062287269471432,1.0,8/29,22.01%,NPY1R;SORCS1;SSTR4;TACR1;SORCS3;GRPR;NPY5R;SSTR2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.47718900336322445,-1.2189400027764492,0.2159090909090909,0.5984761611850447,1.0,3/12,4.53%,GAB2;FRS2;IRS1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.407277611561808,1.2162680319094652,0.06306306306306306,0.6112027818206583,1.0,68/248,23.21%,EEF1A1;MYL6;CLU;EEF2;HSP90AA1;GNAI2;RHOB;GNB2;GNG5;RAN;RHOC;GNG11;RAC1;GNA11;PIN1;HSPA1B;ABCB6;EEF1A2;VCP;DNM3;ARHGDIB;RHOG;SAR1A;RAB14;RAB3C;RHOV;KIF5A;GNG3;KIF26A;GNAI1;NKIRAS1;GNAO1;MYL6B;ARL1;HRAS;ATP2B1;RHEBL1;HSPA1A;RHOA;NKIRAS2;RHOU;GTPBP10;RRAS;ARL2;ABCB10;RRAGC;RRAGD;RAB20;RAB5C;DNM1L;RAC2;AGAP2;TSR1;RAB18;RAB31;RAB4A;CHD3;GPN3;RAB6B;RALB;RERG;TDRD9;RAB27B;RAB28;DNM1;MTG2;KIF1A;NUGGC
prerank,outward rectifier potassium channel activity (GO:0015271),-0.47038548720373463,-1.2146397635730926,0.20388349514563106,0.6011948760593602,1.0,2/11,2.98%,KCNK2;KCNT2
prerank,protein kinase activator activity (GO:0030295),0.4528660430816711,1.213496944331654,0.17278617710583152,0.6162147866339821,1.0,17/60,19.10%,RPLP1;CALM1;MT3;CALM3;NRG1;GRM5;CD24;CDK5R1;GAS6;STK11;IGF2;FGF13;ERCC6;AGAP2;ERBB3;MAP2K2;CALM2
prerank,potassium:proton antiporter activity (GO:0015386),-0.4803768544018788,-1.2133184608937229,0.20905923344947736,0.5960315382601599,1.0,3/10,12.18%,SLC9A1;SLC9A2;SLC9A8
prerank,protein kinase regulator activity (GO:0019887),0.43127615666988506,1.2119992038949567,0.15778474399164055,0.6167427636573605,1.0,28/95,19.11%,RPLP1;MT3;CCNI;CCND2;NPM1;CSNK2B;YWHAB;PPP1R1B;CDKN1C;CCND1;CXCL10;PRKAR1A;CDK5R1;PRKAR1B;ELP3;ITPRIP;CCNG1;MAPK8IP1;STK11;HEXIM1;FGF13;GMFB;PRKAR2B;CCNJL;PRKRIP1;AGAP2;QARS1;SNCA
prerank,small GTPase binding (GO:0031267),-0.2803223266660111,-1.211681566209948,0.0,0.59153185478316,1.0,41/169,13.60%,AKAP13;STRN3;AFDN;PLCE1;RAPGEF4;GOLGA4;LRRK2;RANBP2;EXOC4;RNF152;SGSM2;BRAF;MAPKAP1;USP6NL;EPS8;FGD4;RAF1;ANKRD27;EXOC2;NOX1;DOCK7;UNC13B;NCKAP1;RAPGEF6;CDC42EP5;RABGAP1;ANKFY1;NUTF2;GGA2;TRIOBP;RNF41;PICALM;ALS2;OPTN;GOLGA5;PDE6D;MYO9B;RIC1;ARHGEF2;DVL3;RAB3GAP2
prerank,receptor ligand activity (GO:0048018),0.40708002815550903,1.2114917049432068,0.07537688442211055,0.6143122647158245,1.0,64/245,23.41%,MDK;GRN;GPNMB;NBL1;NRG3;NPPC;NRG1;POMC;AGT;TAFA1;TNF;SEMA3F;PDGFB;LGALS3;SEMA7A;AMH;MIF;SEMA4C;LRPAP1;LEFTY2;SEMA6D;CXCL10;TNFSF12;IL2;CRH;TIMP1;HMGB1;KITLG;SEMA4A;WNT5A;IL11;PPY;NTS;SEMA4G;BMP2;CCK;GAS6;WNT10B;LEFTY1;SLURP1;GDF15;IGF2;PDGFA;JAG2;CCL3;NMB;SCGB3A1;EDN3;INHBA;HGF;IL6;TGFB1;OSGIN1;THPO;GDF11;CRLF1;SST;INHBB;TGFA;SCG2;ERFE;WNT7A;PTN;FAM3C
prerank,peptidoglycan binding (GO:0042834),0.600126663302252,1.2107986462531222,0.2443820224719101,0.6125348577109264,1.0,8/10,36.12%,PGLYRP1;NLRP3;RNASE7;TLR2;NOD2;JCHAIN;NOD1;HK1
prerank,methylated histone binding (GO:0035064),-0.3014561054643294,-1.2104470075456844,0.07142857142857142,0.586635046275621,1.0,26/62,23.60%,KDM7A;ZMYND11;TDRD3;CDYL;PYGO1;CHD1;MBTD1;TRIM24;MORC3;ZCWPW2;LRWD1;PHF8;ING2;FMR1;TAF7;KAT8;L3MBTL2;MORC4;ZCWPW1;DPF2;TAF1;CHD5;NCAPD3;RRP8;CBX8;ZMYND8
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.44969531297428816,-1.2064618879610118,0.22591362126245848,0.5883680376851086,1.0,5/12,10.49%,TGFBR3;ACVR1;BMPR1A;TGFBR1;LTBP1
prerank,transferrin receptor binding (GO:1990459),0.5837672072322787,1.2062015512973747,0.2606774668630339,0.6227413595131209,1.0,1/10,1.05%,CD81
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.5082545237670272,1.2050834187106927,0.2334963325183374,0.6222780449380396,1.0,8/22,23.58%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2;ATP6V1A;ATP2A2;ATP6V0A1;ATP6V0B
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.39467064875559504,-1.2024059312985582,0.19574468085106383,0.590669198057898,1.0,5/21,7.04%,PDE1A;PDE7B;PDE5A;PDE8B;PDE7A
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4884617133477933,1.1986588533053528,0.23995271867612294,0.6381032769715526,1.0,9/27,21.89%,POLR2E;POLR2D;POLR2F;POLR1B;POLR2G;MED21;POLR1D;POLR1H;POLR3K
prerank,ion channel inhibitor activity (GO:0008200),0.47166717937311287,1.1979121564317747,0.22880371660859466,0.6364584738371799,1.0,7/35,12.48%,RACK1;CALM1;SLC30A1;FKBP1A;PHPT1;VAMP8;RSC1A1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3781572951009136,-1.1969189133669549,0.21714285714285714,0.5949651200394228,1.0,8/25,15.22%,PARP4;PARP9;PARP16;PARP3;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5073274500732624,1.194089810412577,0.22804718217562253,0.6440005650742334,1.0,4/20,7.01%,SLC30A1;SLC39A1;SLC39A10;SLC39A7
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5731691255930478,1.191697063462652,0.25176803394625175,0.647477359723807,1.0,4/10,22.24%,LAPTM5;DNAJB2;ANKRD13D;FAAP20
prerank,G protein-coupled receptor binding (GO:0001664),0.40882132224620404,1.1906036500530266,0.16155419222903886,0.6471451833735747,1.0,25/132,14.29%,HSPA8;GNAI2;CXCL12;CCL19;POMC;HOMER2;GNA11;HSPA1B;FLNA;S1PR1;PENK;INSL5;PDYN;REEP2;GNAI1;GNAO1;CALCB;WNT5A;DNAJA1;PPY;NTS;GPRASP2;HSPA1A;WNT10B;SDCBP
prerank,anion:anion antiporter activity (GO:0015301),0.5237548163487549,1.1880587229286035,0.2574385510996119,0.651309729952652,1.0,6/17,18.49%,SLC25A5;SLC25A4;SLC26A4;SLC25A11;SLC19A1;SLC4A2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5717005085410612,1.1879340523426418,0.2646657571623465,0.6479436199639769,1.0,4/12,27.18%,H3-3A;TBP;RELA;RUVBL2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.41575603074432166,-1.1849811824836567,0.2235294117647059,0.6164843705379099,1.0,5/16,12.80%,MTMR3;MTMR11;PTEN;SACM1L;MTMR10
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.25549493034733795,-1.1822249128546394,0.07692307692307693,0.6155654711489598,1.0,29/173,11.42%,ZBTB20;FOXP1;FOXP2;ZEB1;ZNF148;PRDM5;KLF12;MXI1;ZBTB16;SKI;PPARA;ZFP90;FOXO3;NFATC4;FOXP4;NFKB1;FOXK2;ZFHX3;KCNIP3;ZBTB1;ZBTB26;NFX1;PPARG;ETV6;KLF8;FOXK1;ZKSCAN3;MZF1;NFATC3
prerank,voltage-gated potassium channel activity (GO:0005249),0.4158323443157886,1.1810686636114427,0.20167189132706373,0.6655186427887647,1.0,23/80,24.68%,KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;KCNC1;KCNE4;KCNA2;KCNN2;KCNE5;KCNF1;HCN1;KCNA1;LRRC55;HCN3;KCNH7;KCNMA1;KCNH8;KCNQ5;KCNC2;KCNJ3;KCNG3;KCNJ6
prerank,semaphorin receptor activity (GO:0017154),-0.4677863640850603,-1.1780271246365077,0.23550724637681159,0.6184581180962289,1.0,4/11,15.29%,PLXNA2;NRP1;NRP2;PLXNA4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.26339152671668226,-1.172690610500082,0.2,0.6239329714315976,1.0,38/188,11.45%,ZBTB20;PBX1;SMAD3;BNC2;TCF7L2;SMAD6;PRDM5;TCF12;SOX5;GABPB2;DHX36;HDAC4;PER2;NFYC;YAP1;PER3;FOXO3;NCOR1;TBL1X;SP1;NFKB1;BCOR;FOXK2;ARID4B;STAT3;VSX1;ARID5B;ASH2L;TBL1XR1;PPARG;FOXK1;SMAD4;ATF6;CREB3L2;HNRNPL;BRD7;MZF1;KMT2D
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4880941721979149,1.1722513328571968,0.26658624849215923,0.689371838816497,1.0,10/26,23.31%,B4GALNT1;B4GALNT4;B3GNT9;CHPF2;CHPF;B3GNT3;CSGALNACT2;CHSY3;B3GALT5;B3GALT2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.461120683100315,-1.1708813005781955,0.2807017543859649,0.6206618054830159,1.0,6/11,20.60%,PRMT9;FBXO11;CARM1;PRMT6;NDUFAF7;PRMT8
prerank,potassium ion antiporter activity (GO:0022821),-0.40905830564032125,-1.1707402910795583,0.25101214574898784,0.6135941648938862,1.0,3/15,2.68%,SLC24A3;SLC9A1;SLC9A2
prerank,phospholipase activity (GO:0004620),0.42480715242867556,1.1692972576647205,0.22835497835497837,0.6950204926621066,1.0,14/67,14.12%,PRDX6;LYPLA2;PLD3;PLAAT3;LIPG;PDIA3;ENPP2;PNPLA7;LPL;SMPD1;PLA2G4F;GDE1;SMPDL3A;PLBD2
prerank,kinase binding (GO:0019900),0.385098364478788,1.1647224334642916,0.073,0.7058534650480844,1.0,78/434,13.60%,ACTB;EEF1A1;RPS3;RPS7;RPS19;EEF2;CALM1;GSN;HSPB1;HSP90AB1;ACTA2;PGAM1;PARK7;RHOB;ATF4;RPS6;CALM3;ITGB2;CCND2;NPM1;PEBP1;CAMK2N2;PFKL;RHOC;EMP2;TOLLIP;PTPRC;HCLS1;RAC1;TUBA4A;ACVRL1;DLG2;CHEK2;CAV2;PARP1;DUSP3;CTNNB1;NEFH;FLNA;EEF1A2;SNAP91;BAG5;ADD2;SHC3;BTG1;FRMD5;TFRC;RHOG;MSN;CCND1;INKA2;HNRNPA0;CEBPA;CLTC;THY1;MAPT;CD24;UNC5C;CDK5R1;CADPS;ZFP36;ARHGEF7;PIH1D1;PIK3IP1;CDC37;ATF5;WARS1;FBXW5;ATP1A4;DOK7;CAMK2N1;SYN1;PTPRR;DCTN1;RHOA;SRCIN1;FBXO5;YWHAZ
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5575687545687336,1.164449452440645,0.290633608815427,0.702856156436101,1.0,4/11,27.91%,CHRNA9;CHRNA4;CHRNA3;CHRNA7
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5500155793902507,1.1642132391531335,0.30563002680965146,0.6996265841658854,1.0,3/13,9.10%,SLC38A5;SLC25A29;SLC15A4
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.29400648862641426,-1.1617405859974768,0.11475409836065574,0.6301614506005369,1.0,17/71,11.93%,EYA2;PTPN13;EYA1;PTPN21;PTPN9;PTPN14;TNS2;MTMR3;PTPN3;PALD1;CDC14A;EYA4;PTPN12;CDC25B;PTEN;EYA3;PTPN2
prerank,acetylcholine receptor activity (GO:0015464),0.4845356653192533,1.1600228753092356,0.2883895131086142,0.7088853884366615,1.0,7/22,27.91%,CHRM3;CHRM2;CHRNA4;CHRM5;CHRNA3;CHRFAM7A;CHRNA7
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4209432443758531,-1.1575033886002632,0.2289156626506024,0.6336181472489795,1.0,4/13,12.18%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5738334832474609,1.1563431974924934,0.30603448275862066,0.716692057552196,1.0,5/10,27.73%,APOBEC2;APOBEC1;CDA;GDA;ADA
prerank,galactosyltransferase activity (GO:0008378),-0.4507467706762728,-1.1555154208029836,0.2698961937716263,0.6310062856678595,1.0,2/11,1.61%,A4GALT;B4GALT1
prerank,neurexin family protein binding (GO:0042043),0.5671662132358154,1.155446863680847,0.32770745428973275,0.7155703987260537,1.0,4/10,18.58%,NLGN1;CPE;SYTL2;SYTL1
prerank,lysine N-methyltransferase activity (GO:0016278),-0.37543991939523247,-1.155353320588138,0.24347826086956523,0.624314807918724,1.0,9/20,20.46%,SETD2;EHMT1;SETD7;EHMT2;SETD4;SETD3;VCPKMT;METTL21A;SETD6
prerank,voltage-gated cation channel activity (GO:0022843),0.4047939949714573,1.152069991117645,0.23100936524453694,0.7225660684673436,1.0,32/97,25.27%,KCNQ3;KCNQ2;KCNC3;KCND2;GRIN1;CACNA1A;GRIN3A;GRIN2A;HVCN1;KCNC1;KCNA2;KCNE5;KCNF1;HCN1;KCNA1;CACNG8;LRRC55;HCN3;GRIN2B;NCS1;KCNH7;KCNMA1;KCNH8;CACNG5;KCNQ5;CACNB4;KCNC2;CACNA1E;CACNG2;KCNG3;CACNA2D1;CACNA1B
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5315909417253215,1.1462182805021812,0.30235783633841884,0.7372725790407381,1.0,5/13,16.89%,PRKAR1A;PRKAR1B;SOX9;RYR2;PRKAR2B
prerank,adenyl nucleotide binding (GO:0030554),0.5586873469529089,1.144555229394872,0.32408759124087594,0.7342920267927113,1.0,4/11,14.26%,BAG5;PFN1;BAG1;HSPBP1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5586873469529089,1.144555229394872,0.32408759124087594,0.7342920267927113,1.0,4/11,14.26%,BAG5;PFN1;BAG1;HSPBP1
prerank,amino acid:sodium symporter activity (GO:0005283),-0.45181975052323875,-1.1432012864170922,0.2862190812720848,0.6467430922243911,1.0,3/11,3.53%,SLC1A3;SLC6A13;SLC6A12
prerank,FAD binding (GO:0071949),-0.35550661891200297,-1.1424532234321836,0.2702702702702703,0.641336988157753,1.0,6/24,10.15%,MICAL3;MICAL2;DDO;MTHFR;SQOR;PRODH
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3859412432796922,-1.1416690724500984,0.29831932773109243,0.6363461830375917,1.0,8/18,16.73%,TGFBR3;ACVR1;BMPR1A;TGFBR1;LTBP1;ACVR2A;BMPR2;ACVR2B
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.45293410360560415,1.1409783843333319,0.3004750593824228,0.7410670687154043,1.0,12/32,26.36%,SLC38A5;SLC7A5;SLC1A4;SLC6A6;SLC3A2;SLC1A1;MFSD12;SLC7A10;SFXN1;SLC43A2;SLC38A3;SLC6A9
prerank,cAMP response element binding (GO:0035497),-0.46496944660955736,-1.140754033106307,0.2939189189189189,0.6320137377297461,1.0,4/10,11.14%,ATF7;CREB5;ATF2;CREB3L2
prerank,G protein-coupled receptor activity (GO:0004930),0.38080991712157236,1.1402974232268115,0.18218218218218218,0.7391540948827203,1.0,72/239,31.52%,MTNR1A;MTNR1B;GRM5;GPR37L1;ADGRB3;C5AR1;SCTR;ADGRL3;S1PR5;APLNR;S1PR1;DRD5;GPR6;SSTR4;GRM8;ADGRG1;P2RY6;RXFP1;GPR34;TPRA1;VIPR1;LGR6;P2RY1;P2RY12;GRM1;ADGRB1;MC1R;GPR18;ADGRB2;GRPR;CXCR4;CX3CR1;F2RL1;ADGRL4;ADRA1D;ADRA1A;ADGRE1;HCRTR1;ADGRA1;GRM4;GPR83;GPR183;GPR149;NTSR2;GABBR2;ADRA2B;QRFPR;SSTR2;TSHR;MC5R;P2RY13;F2RL3;MRGPRE;RORB;CNR2;C3AR1;NPY;GPR17;FPR3;NMUR2;TAS1R1;GLP1R;NPFFR2;GPR26;CYSLTR1;OPRL1;F2RL2;GPR35;CYSLTR2;GPR37;ELOVL4;DRD2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.46660875861840706,1.1398910923594772,0.3088757396449704,0.7364743934183827,1.0,8/28,16.28%,ELAC2;RNASEH2A;POP7;RNASEH1;APEX1;MRPL44;POP4;NUDT16
prerank,G protein-coupled amine receptor activity (GO:0008227),0.47551103844686965,1.1394423199117472,0.30845771144278605,0.7262536962802426,1.0,5/22,17.09%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.47551103844686965,1.1394423199117472,0.30845771144278605,0.7262536962802426,1.0,5/22,17.09%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,serotonin receptor activity (GO:0099589),0.47551103844686965,1.1394423199117472,0.30845771144278605,0.7262536962802426,1.0,5/22,17.09%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4623373278039091,1.137283658696849,0.3202380952380952,0.7292246873913752,1.0,9/27,21.89%,POLR2E;POLR2D;POLR2F;POLR1B;POLR2G;MED21;POLR1D;POLR1H;POLR3K
prerank,NAD+ binding (GO:0070403),-0.4451218685644271,-1.1368202577657232,0.3107142857142857,0.6356254970698648,1.0,5/12,20.89%,CRYL1;PARP9;SIRT1;ZC3HAV1;SIRT6
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.5181075197489382,1.1351954557489916,0.3324432576769025,0.7319325338693983,1.0,4/14,15.91%,CYBA;CYBB;MICAL1;NCF1
prerank,protein kinase binding (GO:0019901),0.37527102373424825,1.1342647843961398,0.093,0.7310035877342779,1.0,150/479,25.69%,ACTB;EEF1A1;RPS3;RPS7;RPS19;EEF2;RACK1;CALM1;HSP90AA1;HSPB1;ACTA2;PGAM1;RHOB;ATF4;RPS6;CALM3;ITGB2;CCND2;TREM2;HINT1;GRM5;NPM1;PINK1;PEBP1;CAMK2N2;RHOC;EMP2;PTPRC;HCLS1;RAC1;TUBA4A;ACVRL1;CHEK2;PIN1;CAV2;PARP1;DUSP3;TIRAP;SIRPA;NEFH;EEF1A2;PDE3B;CAVIN3;SNAP91;BAG5;ADD2;SHC3;FRMD5;TFRC;RHOG;MSN;CCND1;NELL1;INKA2;HNRNPA0;PKN1;CLTC;THY1;YWHAG;PRKAR1A;MAPT;CD24;UNC5C;CDK5R1;CADPS;ZFP36;ARHGEF7;PIH1D1;PRKAR1B;WARS1;FBXW5;DOK7;CAMK2N1;SYN1;PTPRR;DCTN1;SOX9;RHOA;SRCIN1;FBXO5;YWHAZ;ADCY4;HDAC5;CCDC88A;BAD;DCTN2;MAPK8IP2;MAPRE3;RYR2;DACT3;DAB2IP;HDAC9;CAV1;CDH5;CASS4;SQSTM1;PRKAR2B;SKAP1;RAC2;MAP4K2;PRKRIP1;FAM83D;PPP1R15A;AGAP2;CDC25A;ACSL3;CIR1;QARS1;WDR45;CALM2;ANKRA2;DCX;CNKSR2;ARHGAP33;PTPN6;BANK1;DUSP2;MAP2K7;IRF5;AP2A1;STX1B;TNIP1;RCC2;ADIPOR1;DUSP1;DNM1;TRIM68;PARD6A;LLGL1;TWF2;PTPN1;TBL2;PTN;ELAVL1;LYST;RELA;FOXM1;CAVIN2;TCF3;CCNA2;CDKN2B;PPP1CB;VRK1;DNAJC3;PRKACA;INKA1;MAPRE1;CRK;DUSP8;BLNK
prerank,ubiquitin binding (GO:0043130),0.4118895203109979,1.13300653651912,0.28842105263157897,0.7309947586610737,1.0,25/73,22.19%,HSPB1;UBXN1;TOLLIP;AUP1;UCHL1;TNFAIP3;USP5;UBAP1L;RBCK1;BUB3;VPS28;DNAJB2;FBXW7;CXCR4;RNFT1;OTUB1;SQSTM1;TRIM32;WDR48;RAD23A;RAE1;USP13;SIRT2;UBXN11;VPS36
prerank,GTPase activity (GO:0003924),0.3838065760488988,1.1305602234396577,0.2022132796780684,0.7349891066104537,1.0,52/192,23.21%,EEF1A1;EEF2;GNAI2;RHOB;GNB2;GNG5;RAN;RHOC;GNG11;RAC1;GNA11;EEF1A2;DNM3;ARHGDIB;RHOG;SAR1A;RAB14;RAB3C;RHOV;GNG3;GNAI1;NKIRAS1;GNAO1;ARL1;HRAS;RHEBL1;RHOA;NKIRAS2;RHOU;GTPBP10;RRAS;ARL2;RRAGC;RRAGD;RAB20;RAB5C;DNM1L;RAC2;AGAP2;TSR1;RAB18;RAB31;RAB4A;GPN3;RAB6B;RALB;RERG;RAB27B;RAB28;DNM1;MTG2;NUGGC
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.25951541945505924,-1.1289342748573195,0.0,0.6486321111886186,1.0,60/254,16.61%,NFIA;NFAT5;SMAD3;NFIB;TCF4;HOXB3;PRRX1;TCF12;HLF;ZBTB16;ELF1;NFYC;HOXA5;NRF1;PPARA;HOXC4;NFATC1;FOXO3;TFCP2;MEOX2;SP1;NFKB1;FOXK2;MDM4;STAT3;SMAD1;MEF2A;PRDM15;TFDP1;MYBL1;ATF2;CREBRF;ESR1;NR2C2;SMAD4;ATF6;ELF4;GMEB1;MZF1;NFATC3;RBPJ;AR;RREB1;SIX1;HSF2;KLF7;NFIC;SMAD2;RLF;ZFP62;TFCP2L1;MLXIP;MDM2;IRF2;NFYB;HINFP;FOXO1;TP53;NR3C1;MITF
prerank,nuclear receptor coactivator activity (GO:0030374),-0.28879001260550047,-1.126524123826581,0.2727272727272727,0.6477506538726199,1.0,20/52,22.90%,ZMIZ1;MED13;NCOA1;CCAR1;THRAP3;DCAF6;BRD8;PPARGC1B;CARM1;PRKCB;TACC1;NCOA7;HELZ2;FGF2;MED1;SS18;NCOA6;WDR77;NCOA3;SLC30A9
prerank,snoRNA binding (GO:0030515),0.4539567180837237,1.1263674603136418,0.3305785123966942,0.7438051492236419,1.0,14/30,23.90%,NOP10;NHP2;WDR3;IMP4;NUDT4;GAR1;NUDT16;TSR1;DKC1;SNU13;IMP3;NOP56;ISG20;NOP14
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4494979615669611,-1.1261122571027917,0.31868131868131866,0.6420571573217119,1.0,5/10,15.69%,DSE;RPE;GLCE;GNE;RENBP
prerank,ubiquitin-specific protease binding (GO:1990381),0.48985261147821,1.1248521412326014,0.3239795918367347,0.7447562425739644,1.0,7/19,21.86%,PARK7;VCP;CLTC;SYVN1;RAD23A;SELENOS;AMFR
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5050731037229056,1.124742109827185,0.33161953727506427,0.7413134708180741,1.0,10/16,30.04%,SLC1A4;SLC25A13;SLC25A11;SLC1A1;SLC25A22;SLC25A18;SLC25A14;SLC25A12;SLC13A5;SLC25A30
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.2798488575677712,-1.1241419505602044,0.19402985074626866,0.6403055364207878,1.0,20/72,14.71%,PARD3;SVIL;FCHO2;SLC9A1;ACTN2;FRMPD4;MAPKAP1;MYO1B;PLEKHA4;ADAP2;MARK1;SESTD1;HIP1;PICALM;KRIT1;TULP3;KCNJ2;PLCD1;STXBP6;CGAS
prerank,protein kinase C binding (GO:0005080),0.43455258978282124,1.1235223438289723,0.3010262257696693,0.741502445988134,1.0,14/43,16.86%,RACK1;HSPB1;HINT1;TIRAP;CAVIN3;NELL1;PKN1;YWHAG;ADCY4;HDAC5;CCDC88A;DACT3;HDAC9;SQSTM1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.45111999556938515,1.1228418162498226,0.31235154394299286,0.7398978482551156,1.0,8/30,15.43%,SLC30A1;SLC39A1;SLC39A10;SLC39A7;TTYH1;SLC40A1;SLC11A1;SLC31A1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4175094497600816,1.1217106942071622,0.3006535947712418,0.7397948577560723,1.0,12/53,12.67%,SLC38A5;SLC17A8;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC15A4;SLC3A2;SLC17A7;SLC17A6;SLC1A1;SLC25A22
prerank,kinase inhibitor activity (GO:0019210),0.4457580777399012,1.1198959054669289,0.3233890214797136,0.7417416670292686,1.0,16/33,27.11%,NPM1;YWHAB;PPP1R1B;CDKN1C;WARS1;ITPRIP;MAPK8IP1;HEXIM1;GMFB;PRKRIP1;QARS1;SNCA;SOCS3;DNAJC3;TRIB1;CDKN1A
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.4426395736119953,-1.1180918839116238,0.30344827586206896,0.6483458221516428,1.0,9/11,43.55%,SLC2A9;SLC5A11;SLC23A1;SLC23A2;SLC2A10;SLC5A10;SLC5A1;SLC5A2;SLC5A9
prerank,cation transmembrane transporter activity (GO:0008324),0.4166431773708383,1.1167686212298367,0.32222222222222224,0.7477591020405856,1.0,8/48,12.43%,SLC38A5;SLC39A1;SLC7A5;SLC1A4;SLC6A6;SLC15A4;SLC3A2;SLC1A1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5235205632162788,1.1159802164187655,0.35945945945945945,0.7464604258957461,1.0,3/12,13.31%,SLC25A5;LRRC8A;SLC19A1
prerank,titin binding (GO:0031432),0.525514683075,1.1132771090389462,0.3615894039735099,0.7511774712918268,1.0,2/13,2.58%,CALM1;CALM3
prerank,lipase activator activity (GO:0060229),-0.4418656469318648,-1.112642050353358,0.3116438356164384,0.6549121502845883,1.0,2/10,4.69%,ARHGAP6;PDPK1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.3969371188429784,1.1118761824386396,0.3020063357972545,0.7518143909598692,1.0,9/78,7.53%,CTSB;CTSL;CTSZ;CAPNS1;CTSS;LGMN;UCHL1;USP5;PDIA3
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.342464712339821,-1.1104985802205964,0.31155778894472363,0.6535566780109953,1.0,5/25,13.70%,MICAL3;MICAL2;FMO5;CYP27A1;POR
prerank,sodium channel activity (GO:0005272),0.4315305843767357,1.11022915816355,0.31645569620253167,0.7530872060717252,1.0,12/37,26.73%,ASIC2;SCN1A;GRIK5;GRIK2;SCN4B;HCN1;HCN3;PKD2L1;SCN9A;GRIK1;SCN8A;SCN2A
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.25999360965801427,-1.109973603614333,0.14285714285714285,0.6484548542631647,1.0,26/83,18.73%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;USP28;ZRANB1;USP46;STAMBPL1;UCHL5;USP45;USP37;USP53;USP33;USP9X
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5302244309080801,1.1094729758952353,0.3518005540166205,0.7519698715686783,1.0,4/11,27.61%,KCNE4;KCNE5;KCNJ3;KCNQ1
prerank,calcium-activated potassium channel activity (GO:0015269),0.5304631081033555,1.1060996333278306,0.35773480662983426,0.7587315504895514,1.0,5/11,26.89%,KCNN2;KCNMA1;PKD2L1;KCNN4;KCNMB4
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.2830766242473197,-1.1056701384340288,0.21951219512195122,0.6528927585016789,1.0,15/60,9.11%,EGFR;EPHA7;ROR1;EPHA3;CRIM1;NRP1;NTRK3;EPHA4;EFEMP1;IGF2R;INSR;MET;FGFR2;NRP2;PDGFRB
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.4501781443898981,-1.099993319892285,0.35106382978723405,0.6598802782861537,1.0,2/10,3.53%,SLC6A13;SLC6A12
prerank,mRNA 3'-UTR binding (GO:0003730),0.3950530954793562,1.099432258028987,0.32834224598930484,0.7753385666881032,1.0,17/79,15.64%,RPL41;RPS7;RPL5;ZFP36L1;MEX3D;ZFP36L2;PCBP4;HNRNPA0;ZFP36;TARDBP;ELAVL4;PABPC1;RNF40;HNRNPU;ELAVL3;CIRBP;YBX3
prerank,cytokine activity (GO:0005125),0.3778826032636774,1.0987672008781537,0.30368098159509205,0.7735894885559575,1.0,34/131,23.41%,CXCL12;CCL19;NRG1;TNF;MIF;LEFTY2;CXCL16;CXCL10;IL2;TIMP1;HMGB1;KITLG;WNT5A;IL11;BMP2;WNT10B;LEFTY1;CCL2;PF4;SLURP1;GDF15;CCL3;CCL28;CCL8;SCGB3A1;INHBA;IL6;TGFB1;GDF11;CRLF1;INHBB;SCG2;WNT7A;FAM3C
prerank,neuropeptide binding (GO:0042923),0.473530371122109,1.098070524436399,0.36528497409326427,0.7720235572153807,1.0,7/18,31.30%,SORL1;SSTR4;GPR149;SSTR2;NMUR2;OPRL1;GPR37
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.427169719304931,-1.0948996945753717,0.34296028880866425,0.665825442055673,1.0,5/11,18.51%,SASH1;PPEF2;STK38;ROR2;TRAF6
prerank,carbohydrate kinase activity (GO:0019200),-0.4271216627439435,-1.0930595283684292,0.3321554770318021,0.6641575681044705,1.0,5/11,19.29%,GALK2;HK2;FGGY;GNE;NAGK
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5213309184097802,1.0925488036243478,0.37552155771905427,0.7851196719326209,1.0,4/10,22.24%,LAPTM5;DNAJB2;ANKRD13D;FAAP20
prerank,Hsp90 protein binding (GO:0051879),0.42957416328938347,1.092473232418081,0.33490566037735847,0.7816513531653526,1.0,8/33,23.34%,RPS3;KDR;MAPT;UNC45B;PTGES3;AHSA1;STUB1;CYP2E1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.39032134274324515,1.0921449484176307,0.3404255319148936,0.7788843180684287,1.0,25/75,25.33%,MDH1;LDHA;HSD17B6;RDH5;PHGDH;HSD17B13;GRHPR;SPR;HSD17B4;PRXL2B;DCXR;AKR1B10;HSD3B2;UGDH;PGD;CBR3;IMPDH1;AKR1A1;CBR1;HSD17B11;NSDHL;KCNAB1;IMPDH2;EHHADH;LDHB
prerank,death domain binding (GO:0070513),0.5269104052185019,1.0920185299668346,0.3739612188365651,0.7756522236175648,1.0,2/11,11.32%,RACK1;BAX
prerank,hexose transmembrane transporter activity (GO:0015149),0.5143321634670067,1.0916611203047195,0.3609129814550642,0.7731631646315635,1.0,8/12,36.98%,SLC2A1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,cysteine-type peptidase activity (GO:0008234),0.3919306968847205,1.089925452299802,0.3442796610169492,0.7745246312893731,1.0,19/73,21.24%,CTSB;CTSL;CTSZ;CTSS;LGMN;UCHL1;USP5;PDIA3;OTULIN;TINAGL1;USP29;CTSH;USP26;USP8;CTSC;SFRP1;CAPN3;ATG4D;USP13
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4546084882034168,1.0888799995203384,0.3818849449204406,0.773960876480961,1.0,8/24,18.57%,NME1;AK4;AK3;NME4;NME2;CMPK2;NME3;IP6K1
prerank,methylation-dependent protein binding (GO:0140034),-0.2764340374281476,-1.0882328608413574,0.2916666666666667,0.6696956789178249,1.0,22/57,23.60%,KDM7A;ZMYND11;TDRD3;CDYL;PYGO1;CHD1;MBTD1;TRIM24;MORC3;ZCWPW2;LRWD1;PHF8;ING2;FMR1;KAT8;L3MBTL2;MORC4;ZCWPW1;NCAPD3;RRP8;CBX8;ZMYND8
prerank,actinin binding (GO:0042805),-0.3548446892675028,-1.088009027436234,0.34536082474226804,0.6640356958484133,1.0,7/21,14.17%,CACNA1C;PDLIM5;NFKB1;PDLIM4;PPARG;SYNPO2;CACNA1D
prerank,calcium-release channel activity (GO:0015278),-0.38246149881393926,-1.0843817450411226,0.3181818181818182,0.6666463478277236,1.0,2/17,1.63%,ITPR1;ITPR2
prerank,transcription coregulator binding (GO:0001221),-0.27998571244705783,-1.0823313088896669,0.2692307692307692,0.6660841213353861,1.0,18/50,14.95%,SMAD3;VGLL4;ZBTB16;PER2;THRB;USP11;PER3;EHMT1;LCOR;NEK6;TEAD2;ESR1;SMAD4;TERT;AR;RORA;EHMT2;EZH2
prerank,double-stranded RNA binding (GO:0003725),0.3936900952664644,1.0815355157718614,0.3573735199138859,0.7926878843934907,1.0,17/70,19.34%,VIM;TUBA1B;HSP90AB1;TUBB4B;TFRC;MSN;HSPD1;CLTC;SLC3A2;EIF4A1;ACTN1;HNRNPU;MRPL44;AGO1;PRKRIP1;OAS3;EIF4H
prerank,single-stranded DNA helicase activity (GO:0017116),0.4726794506499503,1.0786506510864204,0.38701622971285893,0.7976497418579317,1.0,11/19,35.02%,MCM5;RFC2;RFC4;PIF1;RAD51;MCM7;MCM2;DHX9;DNA2;CHTF18;RFC3
prerank,metalloaminopeptidase activity (GO:0070006),-0.3735555890386403,-1.076533023475711,0.3521739130434783,0.6742546272121092,1.0,3/16,5.90%,NPEPPS;XPNPEP3;ANPEP
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.40070236334995024,1.0755015328648534,0.3633369923161361,0.8033322829999513,1.0,18/54,21.46%,HDAC11;HINT1;TGM2;AMDHD2;HDAC5;GLS2;GLS;ACY1;NAAA;PDF;MIER2;NIT1;HDAC9;FAAH;ASAH2;ACY3;SIRT2;SUDS3
prerank,lysophospholipase activity (GO:0004622),0.46806899799116625,1.07549670568181,0.37922403003754696,0.7997487563003723,1.0,10/20,28.06%,LYPLA2;ENPP2;PNPLA7;GDE1;GDPD1;ABHD16A;GDPD3;ABHD12;PLA2G6;MGLL
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.4360858086475944,1.0753742130821198,0.3793103448275862,0.7965201729583525,1.0,8/29,13.31%,SLC1A4;SLC25A13;SLC26A4;SLC25A11;SLC1A1;SLC25A21;SLC25A22;SLC19A1
prerank,potassium ion leak channel activity (GO:0022841),-0.38313938998026664,-1.0741600013838464,0.3695652173913043,0.6736643707476976,1.0,2/15,2.21%,KCNK2;KCNK5
prerank,GTPase binding (GO:0051020),-0.23973991788939938,-1.07391117167366,0.0,0.668236686546741,1.0,35/194,8.22%,AKAP13;STRN3;AFDN;PLCE1;RAPGEF4;GOLGA4;LRRK2;RANBP2;EXOC4;RNF152;SPTBN1;SGSM2;BRAF;MAPKAP1;USP6NL;EPS8;FGD4;RAF1;ANKRD27;EXOC2;NOX1;DOCK7;UNC13B;NCKAP1;RAPGEF6;CDC42EP5;RADIL;RRAGB;RABGAP1;ANKFY1;AMBRA1;NUTF2;GGA2;TRIOBP;RNF41
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.41392643706894694,-1.0700900303013703,0.38235294117647056,0.6719332188679538,1.0,4/12,16.50%,LARP1;EIF4E3;CYFIP2;AGO2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.333378084289876,-1.0695860996797797,0.32653061224489793,0.6670744843382616,1.0,3/24,5.95%,OSBPL8;PLA2G4A;SESTD1
prerank,chloride channel inhibitor activity (GO:0019869),-0.41804256530747386,-1.068453240221753,0.33663366336633666,0.663942510165371,1.0,3/10,12.72%,STX8;WNK4;STX1A
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4117799668167385,-1.0677237235144836,0.36153846153846153,0.6599051175861166,1.0,5/11,14.79%,ITPR1;ITPR2;TRPC4;TRPC6;TRPC3
prerank,ephrin receptor activity (GO:0005003),-0.3734800627175488,-1.0676128113294556,0.35864978902953587,0.6488917681100561,1.0,4/17,10.73%,EPHA7;EPHA3;EPHA4;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.3734800627175488,-1.0676128113294556,0.35864978902953587,0.6488917681100561,1.0,4/17,10.73%,EPHA7;EPHA3;EPHA4;EPHB2
prerank,death receptor binding (GO:0005123),-0.3821681308870155,-1.0666003976699294,0.3671875,0.6457911436592131,1.0,4/15,15.41%,EDA;RIPK1;NGF;BDNF
prerank,phosphatidate phosphatase activity (GO:0008195),-0.40632500180490616,-1.066164880635414,0.36531365313653136,0.641308883995257,1.0,8/13,26.39%,PLPP3;PLPP5;PLPP1;PLPP2;PLPPR1;PLPPR3;LPIN2;LPIN3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3712770834666269,-1.0656860203145668,0.36554621848739494,0.6370121988546559,1.0,2/15,5.95%,PLA2G4A;SESTD1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.3793989252409629,-1.0640365314571703,0.3603238866396761,0.6354811864311362,1.0,9/15,18.12%,KMT2C;KMT2A;ASH2L;KMT2D;WDR82;SETD4;PRDM9;SETD1B;SETD3
prerank,myosin II binding (GO:0045159),0.5185731971245645,1.0637489910625824,0.40869565217391307,0.8277819162818254,1.0,2/10,9.95%,GSN;STXBP5L
prerank,phospholipase A2 activity (GO:0004623),0.4390319529127507,1.0615453031227167,0.3918918918918919,0.8304725716013683,1.0,4/26,10.56%,PRDX6;PLAAT3;PLA2G7;PLA2G4F
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.4869490883811224,1.0612868573785812,0.40110650069156295,0.827532983906918,1.0,5/12,27.52%,NDUFS7;DCXR;CBR1;NQO2;CRYZ
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.37942317522778946,-1.056876791290653,0.3649122807017544,0.6467384710960002,1.0,4/14,12.80%,MTMR3;MTMR11;PTEN;MTMR10
prerank,telomerase RNA binding (GO:0070034),-0.34067179660459296,-1.056354586581892,0.36574074074074076,0.6425155498108093,1.0,8/22,11.11%,SMG6;DHX36;TEP1;TENT4B;XRN1;PARN;SMG7;TERT
prerank,peptide hormone receptor binding (GO:0051428),0.5130472828782005,1.0558030837272485,0.4117647058823529,0.840442691327857,1.0,4/11,27.72%,CCK;ADCYAP1;PTHLH;PSMC5
prerank,ribonuclease activity (GO:0004540),0.3918851906160969,1.0540996162094247,0.40716612377850164,0.8416249504057867,1.0,15/56,21.53%,ENDOG;RNASE1;ELAC2;ANG;RNASE4;RNASEH2A;RNASEK;EXOSC2;RNASEH1;SND1;AGO1;EXOSC9;RNASE7;TSNAX;EXOSC4
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.41290843903218866,1.052130051450688,0.4116279069767442,0.8439416459048413,1.0,5/33,7.72%,RPS3;PARK7;TOLLIP;AUP1;FOXL2
prerank,omega peptidase activity (GO:0008242),-0.24525628863552434,-1.051436526365517,0.25,0.6492061536566209,1.0,26/89,18.73%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;USP28;ZRANB1;USP46;STAMBPL1;UCHL5;USP45;USP37;USP53;USP33;USP9X
prerank,NADPH binding (GO:0070402),0.49164939847576744,1.0510296718482468,0.4380165289256198,0.8434052661552367,1.0,7/13,32.90%,GRHPR;QDPR;CBR3;KCNAB1;CRYZ;DHFR;MTRR
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.47790049216745367,1.050293824292822,0.4389261744966443,0.8419670817065242,1.0,1/14,1.52%,CAPNS1
prerank,actin binding (GO:0003779),0.3548458085852089,1.0497425900677322,0.3929292929292929,0.8400466511396406,1.0,45/170,17.68%,TMSB4X;ALDOA;TMSB10;GSN;FXYD5;PRICKLE4;TPM2;MAP1A;MOBP;ANG;MRTFA;ADD2;PFN1;IQGAP2;CCR5;P4HB;CORO1A;VASH1;TLNRD1;FMN2;MAPT;COTL1;LCP1;SLC6A2;MICAL1;MYO1F;FHDC1;GC;ANLN;MSRB1;FLII;CXCR4;HNRNPU;CDK5R2;CCDC88A;CAP1;SPTBN4;TMOD1;DMTN;ADCY8;PFN2;RUSC1;SYNE1;KLHL1;SCIN
prerank,endonuclease activity (GO:0004519),0.3910093275272751,1.0497100866016178,0.413716814159292,0.8365357921500391,1.0,6/49,14.02%,RPS3;ENDOG;ANG;RNASEK;APEX1;SND1
prerank,ADP binding (GO:0043531),0.4358096858673683,1.049140404729498,0.39375,0.83457964953599,1.0,5/25,7.19%,ATP5F1D;ATP5F1A;ABCG1;PGK1;MYO3A
prerank,BMP binding (GO:0036122),0.5049867410503347,1.0487683051271453,0.41359773371104813,0.8321482162651526,1.0,1/11,2.02%,NBL1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3486428649820868,1.0477100582665169,0.343,0.8316893739473302,1.0,98/431,19.27%,EEF1A1;HSPA8;TUBB;TUBA1A;TUBA1B;HSP90AA1;HSP90AB1;ATP5F1D;TUBB4B;NDUFA13;RHOB;HSPA5;AKT1;ATP5F1A;NME1;TGM2;PINK1;TUBAL3;RAN;PFKL;RHOC;ARF5;RAC1;TUBA4A;ACVRL1;HSPA1B;ABCB6;ABCG1;UHMK1;TAP2;PGK1;RHOG;ATP1A3;RAB14;EPB42;P2RX7;ADSS1;MAST1;ARL11;TUBB4A;TUBB2B;SYN2;SCG5;P2RY1;ARF6;RHOV;SARS2;AARS2;MYO1F;BCKDK;GNAI1;ARL4C;P2RX6;ARL4D;ATP1A1;ARL1;HRAS;SYN1;RHEBL1;HSPA1A;RHOA;CARS1;HNRNPU;CDC42BPA;RHOU;STK11;GTPBP10;RRAS;ARF1;ARL2;TSSK6;TSSK4;PRPS1L1;PRPS1;RAB26;RRAGC;ARF4;PEX6;ABCA2;EIF4A3;RRAGD;NUDT16;BRSK2;HSPA4L;RAC2;TUBB2A;MAP4K2;ERCC6;GLUD1;GUK1;OAS3;AGAP2;TSR1;ANXA6;VPS4A;MKNK1;PSMA6;RAB31
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.38269043177814,-1.0449863378930502,0.4065934065934066,0.6587749518397686,1.0,2/13,2.19%,ALDH1A1;ALDH1A2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3303311962694966,-1.0436057495039257,0.38565022421524664,0.6566283080669708,1.0,5/23,7.04%,PDE1A;PDE7B;PDE5A;PDE8B;PDE7A
prerank,"DNA binding, bending (GO:0008301)",0.4788350210915116,1.042766633504217,0.42382271468144045,0.8426042629710003,1.0,3/14,9.82%,TERF1;HMGB3;HMGB1
prerank,C-C chemokine binding (GO:0019957),0.4352256559219252,1.0426903407694794,0.4042027194066749,0.8393145301071783,1.0,5/22,18.30%,CCR5;ZFP36;CXCR4;CX3CR1;CCR2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5034552650193319,1.0393654591351005,0.4369747899159664,0.8453926569077178,1.0,3/10,15.91%,CYBA;CYBB;NCF1
prerank,heme binding (GO:0020037),0.37393805923502027,1.0363299551810723,0.4360086767895879,0.8507990668377927,1.0,17/65,25.20%,HMOX1;PGRMC1;NR1D1;ABCB6;CYBB;STEAP4;PGRMC2;SLC48A1;CAT;NOS2;CYCS;CYB5A;TBXAS1;CYP2E1;SUOX;SDHD;HEBP2
prerank,metalloexopeptidase activity (GO:0008235),0.3848829238763904,1.0359443799824823,0.437219730941704,0.8483226598419006,1.0,13/51,17.33%,METAP1;CPXM1;CPD;CPE;VASH1;AGBL4;METAP2;AEBP1;CPXM2;LAP3;RNPEPL1;NUDT16;MMP14
prerank,Hsp70 protein binding (GO:0030544),0.41288179847065726,1.0347284545762832,0.45584725536992843,0.8484282096570406,1.0,11/31,26.06%,RPS3;DNAJA1;DNAJB2;SACS;DNAJB1;DNAJC10;SNCA;STUB1;CYP2E1;DNAJC8;IQCG
prerank,sulfotransferase activity (GO:0008146),-0.29554294322208957,-1.0311880447235189,0.3933333333333333,0.6813766371637126,1.0,6/33,10.27%,UST;HS3ST3A1;CHST15;HS2ST1;CHST11;TPST1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.49483755905798427,1.0296309733988875,0.4665718349928876,0.85971626255241,1.0,2/11,6.56%,PPP1R14A;PPP1R14B
prerank,receptor tyrosine kinase binding (GO:0030971),0.3808569690519252,1.029216506078652,0.4375,0.8573951486904575,1.0,8/56,6.27%,RACK1;NRG3;NRG1;GRB14;LRP4;DUSP3;HYAL2;SHC3
prerank,regulatory RNA binding (GO:0061980),-0.29143541055821737,-1.0281533489376757,0.4117647058823529,0.6830618656866351,1.0,13/38,21.34%,ZNF346;DICER1;ZC3H7A;TUT7;RBM4;ZC3H7B;PUM2;TARBP2;TUT4;AGO2;FMR1;AGO4;SOX2
prerank,thioesterase binding (GO:0031996),0.48991122599325765,1.0278002890661693,0.4341736694677871,0.8581327284172425,1.0,3/11,15.00%,RAC1;ARF6;TRAF3
prerank,pyridoxal phosphate binding (GO:0030170),0.4359466412878263,1.0263983583535674,0.43702770780856426,0.8586702206542163,1.0,6/20,21.88%,AGXT;OAT;SDS;PNPO;SHMT2;PYGL
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4131037001104867,1.0242960824554683,0.45538818076477405,0.860987463801184,1.0,9/35,20.52%,H3-3A;PARK7;NPM1;DRAP1;PIH1D1;UBTF;AGO1;TBP;MYC
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3533191238462659,1.023306838943322,0.4457953394123607,0.860397754160034,1.0,47/134,28.08%,SLC38A5;SLC17A8;LRRC8A;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;SLC25A13;SLC6A6;SLC26A4;MFSD2A;SLC15A4;SLCO4C1;SLC3A2;SLC17A7;SLC17A6;SLC1A1;SLC25A21;SLC25A22;GJA1;SLC19A1;SLC35A3;SLC16A1;SLC25A1;SLC2A2;MFSD10;SLC52A1;SLC19A2;SLC35A1;SLC25A18;SLC35B4;SLCO1B1;SLC25A23;MFSD12;SFXN1;SLC35B1;SLC6A8;SLC4A8;SLC38A3;SFXN5;ABCC5;SLC2A6;SLC6A9;SLC25A12;SLC16A7;SLC13A5;RTBDN
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.3673582163878957,-1.0224698323723371,0.42084942084942084,0.6916737050466666,1.0,2/15,2.19%,ALDH1A1;ALDH1A2
prerank,protein heterodimerization activity (GO:0046982),0.34557308474874493,1.0204692362863015,0.4462311557788945,0.8649573322212836,1.0,59/178,24.88%,ATF4;CYBA;TPM2;HEXA;RAN;PDGFB;FZD9;TRMT112;EPAS1;LSM6;YWHAH;PPP2R1A;YWHAE;ABCG1;TENM2;TENM3;ADD2;CYBB;P4HB;ATP1B2;TUBB2B;MLXIPL;MLX;BHLHE41;AOC3;NPAS3;SUPT4H1;TENM4;BAX;ATP1A1;TLR6;SDCBP;ATP1B1;RRAGC;PDGFA;ADRA1A;RRAGD;ADCY8;SRI;ZHX1;GCA;ERBB3;TFAP2B;VAPA;GABBR2;MEF2C;BAK1;GADD45A;DDIT3;KATNA1;VAPB;LSM5;MTTP;USF2;RCC1;METTL3;BARD1;TCF3;BOK
prerank,cytokine receptor activity (GO:0004896),0.36398186387775344,1.0195559407019683,0.4636459430979979,0.8641319709560087,1.0,26/83,23.51%,CD74;IL2RB;CSF3R;EPOR;CCR5;IL2RG;IL3RA;GFRA1;MPL;CX3CR1;IFNGR1;CSF2RB;IL17RB;GFRA2;CCR2;IL20RA;FLT3;IFNGR2;CSF2RA;IL10RB;IL1RAP;CRLF1;CRLF2;PRLR;IL12RB1;IL21R
prerank,phospholipase activator activity (GO:0016004),-0.4046698343098636,-1.0185850517123152,0.4195804195804196,0.6955072250297322,1.0,2/10,4.69%,ARHGAP6;PDPK1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.40851124151984086,-1.0177709305123352,0.42696629213483145,0.6921544237981708,1.0,1/11,0.15%,ITPR1
prerank,gamma-tubulin binding (GO:0043015),0.42458950041631854,1.0167596205373493,0.4538361508452536,0.8682266365888226,1.0,10/21,32.13%,NDRG1;PAK1;ARHGEF7;BRCA2;GIT1;BLOC1S2;B9D2;DIXDC1;TUBGCP2;DDX3X
prerank,protein homodimerization activity (GO:0042803),0.3367051696499904,1.0159871847129431,0.437,0.8671022983586123,1.0,105/589,15.62%,APOE;PSAP;S100A6;RACK1;B2M;S100A1;TYROBP;HSP90AA1;HSPB1;HSP90AB1;HMOX1;PARK7;PGRMC1;S100A11;GSTM1;AKT1;TXN;S100B;TPI1;S100A10;TPM2;CRYAB;ERBB4;TERF1;NPM1;AGXT;S100A13;S100A16;RASIP1;PDGFB;FZD9;NTRK2;ANG;CHEK2;ENO1;CAV2;ATP5IF1;FLNA;ABCG1;HES1;TENM2;TENM3;ADD2;SPPL2B;TFRC;RDH5;SDS;CEBPB;BNIP3L;CORO1A;CEBPA;PLN;GRHPR;TRIM9;LPL;HSD17B4;MLXIPL;MLX;HSPB8;SARS1;KARS1;BHLHE41;SYT6;MFSD1;CSF1R;PECAM1;TENM4;PDCD6;GSTM2;MGAT2;KLHL7;BAX;BANF1;CEP131;WARS1;FLT4;KCNN2;CADM3;MAP3K21;ACTN1;ACOT7;SYNDIG1;ODC1;GNPTG;SLC11A1;CLN6;BST2;HPGDS;LILRB1;CRYM;RIPK2;RNF40;MTCL1;PNPO;CAT;CCDC88A;IKZF3;ABCB10;PRPS1L1;PRPS1;MFF;GDF15;DSCAML1;PDGFA;ACHE
prerank,voltage-gated chloride channel activity (GO:0005247),-0.40658836350039973,-1.015047033927836,0.4101694915254237,0.6932641828326147,1.0,1/10,1.69%,ANO6
prerank,motor activity (GO:0003774),0.36852696077675523,1.014802890466052,0.4808743169398907,0.8668909008351907,1.0,11/60,14.29%,MYL6;PIN1;DYNLRB1;KIF26B;KIF5A;KIF26A;MYL6B;DNAH2;DNAH1;DYNLRB2;KIF21B
prerank,sialyltransferase activity (GO:0008373),-0.33311733007320454,-1.0138209115056624,0.4888888888888889,0.6911862220535678,1.0,8/20,19.97%,ST3GAL4;ST3GAL3;ST6GAL1;ST3GAL5;ST6GALNAC6;ST3GAL2;ST3GAL6;ST6GALNAC5
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.2868224574928083,-1.01217078623846,0.39416058394160586,0.6899259624285419,1.0,8/35,10.69%,FER;ABL1;YES1;DYRK1A;FRK;CLK1;ABL2;PTK2
prerank,tubulin binding (GO:0015631),0.3373550375489301,1.0113254450740736,0.4894894894894895,0.8729948528564379,1.0,68/295,20.55%,RPS3;ALDOA;GABARAP;GAPDH;TPPP3;PRNP;MAP1LC3B;TERF1;MAP1LC3A;MAP1A;GABARAPL2;S100A8;S100A9;GABARAPL1;NEFH;DNM3;STMN3;SBDS;NEFM;NDRG1;NAV3;PAK1;ABRAXAS2;AGBL4;CLASP1;MAST1;MAPT;MAP2;STMN4;UNC5C;CDK5R1;KIF26B;KIF5A;ARHGEF7;REEP2;KIF26A;ARL4C;ATF5;FHDC1;DCTN1;GJA1;CLIP3;MTCL1;STMN1;TTLL7;VBP1;CCDC88A;KIF21B;CETN3;MAPRE3;CDK5;TBCA;FGF13;DNM1L;PDCD5;BRCA2;TOGARAM2;HOOK1;FAM83D;KIF5C;KIFC2;TTLL5;SNCA;DCX;VAPA;GIT1;MAP1B;RAE1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.4052612650554676,1.010593501261991,0.4767726161369193,0.8714280527011758,1.0,9/29,21.95%,HYAL2;OVGP1;GUSB;GAA;MOGS;NEU1;HPSE;HPSE2;ENGASE
prerank,chemokine binding (GO:0019956),0.39759014302905565,1.0085831039793614,0.4611764705882353,0.8736406900349937,1.0,10/30,31.16%,CCR5;HMGB1;ZFP36;CXCR4;CX3CR1;CCR2;ACKR1;ITGB1;PLP2;ACKR3
prerank,protein phosphatase 2A binding (GO:0051721),-0.31700834763443286,-1.0083022695097092,0.4574468085106383,0.694821689166604,1.0,10/23,18.21%,STRN3;ANKLE2;STRN;ENSA;SMG7;BOD1L1;SPHK1;FOXO1;TP53;CTTNBP2NL
prerank,protein tyrosine kinase activity (GO:0004713),-0.23043038325710205,-1.0056326097223627,0.5384615384615384,0.6961995955878179,1.0,23/108,10.73%,EGFR;EPHA7;FER;ABL1;ROR1;EPHA3;NTRK3;EPHA4;INSR;YES1;DYRK1A;TYK2;BAZ1B;MET;FGFR2;WEE1;FRK;PDGFRB;HIPK3;CLK1;ABL2;PTK2;EPHB2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.3753912979727329,-1.0027296269566597,0.4612676056338028,0.6976064091550942,1.0,7/12,29.45%,PIEZO2;PIEZO1;TMC6;TMC7;TMC3;TMC4;TMC8
prerank,histone deacetylase binding (GO:0042826),0.3545542026047826,1.0025925177849078,0.5078534031413613,0.887273421738632,1.0,25/88,21.46%,HSP90AA1;HSP90AB1;YWHAB;SPI1;HSPA1B;YWHAE;HES1;CCND1;GMNN;PKN1;BHLHE41;NCOR2;HSPA1A;HDAC5;IKZF3;MIER2;HDAC9;CIR1;MTA2;ANKRA2;HIC1;MEF2C;TFAP4;SIRT2;SUDS3
prerank,pre-mRNA binding (GO:0036002),-0.3032800060589862,-1.0021635870753476,0.42857142857142855,0.6938614437922843,1.0,9/28,17.69%,CELF2;RBM41;ZRSR2;TRA2B;RBM4;HNRNPL;TARBP2;SLU7;CELF1
prerank,lipase activity (GO:0016298),0.3835761725053237,1.0020700144059913,0.48853211009174313,0.88524743346655,1.0,14/43,31.89%,PNPLA2;LIPG;LIPE;LPL;PLBD2;FAAH;ABHD16A;ABHD12;MGLL;PLBD1;PNPLA8;PITPNM3;CEL;LIPA
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.242400221882685,-1.0,1.0,0.6654449697399019,1.0,95/597,11.45%,ZBTB20;PBX1;FOXP1;NFAT5;SMAD3;TEAD1;NFIB;BNC2;NR3C2;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;ABL1;SMAD6;PRDM5;KLF12;TCF12;ARNT;SOX5;MBNL2;GABPB2;CUX1;BBX;GLI3;HLF;NR6A1;ZIC4;GLI2;DHX36;ARNT2;HOXB4;ELF1;ATF7;HDAC4;PER2;NFYC;THRB;HOXA5;MLH3;YAP1;PER3;KLF3;TEF;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;KDM5B;KAT7;NFATC4;NCOR1;TBX15;TFCP2;TBL1X;MEOX2;SP1;NFKB1;NR1D2;BCOR;FOXK2;HOXB5;ARID4B;ELF2;STAT3;VSX1;ARID5B;ASH2L;ZBTB26;ATF2;TBL1XR1;TEAD2;PPARG;CENPC;ESR1;NR2C2;FOXK1;XPA;ZNF23;SMAD4;ZIC1;ATF6;ELF4;HOXA6;CREB3L2;GMEB1;HNRNPL;BRD7;PRRX2;MZF1;NFATC3;KMT2D
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.27270854196566463,-1.0,1.0,0.6654449697399019,1.0,164/732,16.37%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;PRDM5;ZNF423;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;MXI1;FOXN3;GLI3;HLF;ZBTB16;NR6A1;ZIC4;HOXA3;GLI2;DHX36;CCAR1;ARNT2;MGA;SKI;HOXB4;ELF1;NR2F2;ATF7;HDAC4;NFYC;THRB;CHD2;HOXA5;HIVEP3;ZKSCAN2;KLF3;THRAP3;NRF1;TEF;PPARA;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;NFATC4;ZNF182;SMAD9;TBX15;TFCP2;FOXP4;MEOX2;SP1;NFKB1;NR1D2;FOXK2;HOXB5;ZSCAN26;STAT3;HIF3A;SMAD1;ZIC2;ZFHX3;ZBTB38;KCNIP3;ZFP30;TOP1;ZBTB1;MYNN;ZFHX4;EBF4;MEF2A;STAT2;PRDM15;ZBTB26;EBF1;MYBL1;ATF2;TEAD2;PPARG;SP4;KLF8;ESR1;NR2C2;FOXK1;HOXC6;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;HOXA6;GMEB1;PRRX2;MZF1;NFATC3;RBPJ;ZBTB34;AR;HOXC5;HIVEP1;IKZF2;ZNF8;RREB1;MKX;SIX1;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7;RORA;NFIC;SMAD2;ZFP62;TFCP2L1;PBX4;MLXIP;GMEB2;RUNX2;HEY2;FOXN2;STAT5A;ZBTB5;SOX13;IRF2;NFYB;ZSCAN12;ZBTB6;HOXA2;BATF;HINFP;ZNF483;ESRRA;FOXO1;FOXL1;TP53;NR3C1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.27061041233091115,-1.0,1.0,0.6654449697399019,1.0,164/731,16.37%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;PRDM5;ZNF423;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;MXI1;GLI3;HLF;ZBTB16;NR6A1;ZIC4;HOXA3;GLI2;DHX36;CCAR1;ARNT2;MGA;SKI;HOXB4;ELF1;NR2F2;ATF7;HDAC4;NFYC;THRB;CHD2;HOXA5;HIVEP3;ZKSCAN2;KLF3;THRAP3;NRF1;TEF;PPARA;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;NFATC4;ZNF182;SMAD9;TBX15;TFCP2;FOXP4;MEOX2;SP1;NFKB1;NR1D2;FOXK2;HOXB5;ZSCAN26;STAT3;HIF3A;SMAD1;ZIC2;ZFHX3;ZBTB38;KCNIP3;ZFP30;TOP1;ZBTB1;MYNN;ZFHX4;EBF4;MEF2A;STAT2;PRDM15;ZBTB26;EBF1;MYBL1;ATF2;TEAD2;PPARG;SP4;KLF8;ESR1;TRIM24;NR2C2;FOXK1;HOXC6;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;HOXA6;CREB3L2;GMEB1;PRRX2;MZF1;NFATC3;RBPJ;ZBTB34;AR;HOXC5;HIVEP1;IKZF2;ZNF8;RREB1;MKX;SIX1;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7;RORA;NFIC;SMAD2;ZFP62;TFCP2L1;PBX4;MLXIP;GMEB2;RUNX2;HEY2;STAT5A;ZBTB5;SOX13;IRF2;NFYB;ZSCAN12;ZBTB6;HOXA2;BATF;HINFP;ZNF483;ESRRA;FOXO1;FOXL1;TP53;NR3C1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.24455092005166112,-1.0,1.0,0.6654449697399019,1.0,146/831,13.20%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;PRDM5;ZNF423;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;MXI1;CUX1;BBX;GLI3;HLF;ZBTB16;NR6A1;ZIC4;HOXA3;GLI2;DHX36;CCAR1;ARNT2;MGA;SKI;HOXB4;ELF1;NR2F2;ATF7;HDAC4;NFYC;THRB;CHD2;NFXL1;HOXA5;HIVEP3;ZKSCAN2;KLF3;THRAP3;NRF1;TEF;PPARA;NFIX;HOXC4;CREB5;ZFP90;RARG;NFATC1;FOXO3;NFATC4;ZNF182;SMAD9;TBX15;TFCP2;FOXP4;MEOX2;SP1;NFKB1;NR1D2;FOXK2;HOXB5;ZSCAN26;STAT3;HIF3A;SMAD1;ZIC2;ZFHX3;ZBTB38;KCNIP3;ZFP30;TOP1;ZBTB1;MYNN;ZFHX4;EBF4;MEF2A;STAT2;RBAK;PRDM15;ZBTB26;EBF1;TFDP1;NFX1;MYBL1;ATF2;TEAD2;PPARG;CREBRF;ETV6;SP4;KLF8;ESR1;NR2C2;FOXK1;HOXC6;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;HOXA6;GMEB1;PRRX2;MZF1;NFATC3;RBPJ;ZBTB34;AR;HOXC5;HIVEP1;IKZF2;ZBTB8A;ZNF8;RREB1;MKX;SIX1;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7
prerank,protein serine/threonine kinase activity (GO:0004674),-0.2832324771944083,-1.0,1.0,0.6654449697399019,1.0,92/334,14.72%,ROCK2;GRK5;EGFR;MAPK4;STK3;ACVR1;DAPK1;BMPR1A;LRRK2;ROCK1;SIK3;FAM20A;BRD4;CAMK2D;BRAF;SIK2;PRKCE;CSNK1A1;MAP3K13;GRK3;CLK2;MARK1;SMG1;EIF2AK4;PDPK1;RAF1;ARAF;TLK2;TGFBR1;CASK;IRAK3;STK24;WNK4;SNRK;CDK12;CDK6;EIF2AK3;TLK1;MAST2;NEK4;CDC42BPB;DYRK1A;MYLK;MARK3;MAPKAPK3;TOP1;SIK1;PRKD3;TAOK3;BCR;PRKAA2;NEK6;AAK1;STK10;MAPK9;HIPK3;CLK1;NEK7;MAP4K4;ALPK1;NRK;RIPK1;MAP4K3;CCNK;TESK2;DMPK;PDIK1L;CDK13;NUAK1;SLK;DAPK2;TRIO;TBK1;LATS2;MAPK6;NEK3;STK38;CLK4;ATM;CSNK2A1;CSNK2A2;NLK;ULK2;PRKD1;SRPK2;IRAK4;GSK3B;MARK2;PRKCI;CDK7;CDKL3;TAOK1
prerank,sequence-specific DNA binding (GO:0043565),-0.23584563660784402,-1.0,1.0,0.6654449697399019,1.0,121/590,16.37%,ZBTB20;PBX1;FOXP1;NFAT5;SMAD3;FOXP2;TEAD1;NFIB;ZNF148;NR3C2;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;ABL1;PRDM5;ZNF423;KLF12;TCF12;ARNT;FOXD1;MBNL2;KDM2A;CUX1;SMG6;BBX;GLI3;HLF;NR6A1;ZIC4;GLI2;ARNT2;HOXB4;ELF1;NR2F2;ATF7;HDAC4;THRB;HOXA5;KLF3;TET3;SMG1;KMT2A;TEF;PPARA;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;KDM5B;NFATC4;TBX15;TFCP2;MEOX2;FBXL19;SP1;NR1D2;FOXK2;HOXB5;ELF2;VSX1;ZBTB38;MEF2A;ZBTB26;UPF2;ATF2;TEAD2;PPARG;SP4;ESR1;NR2C2;FOXK1;SMG7;XPA;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;TERT;HOXA6;GMEB1;PRRX2;NFATC3;TERF2;RBPJ;LRWD1;SLTM;BCL2;HIVEP1;CXXC5;SIX1;NR2F1;HSF2;TINF2;RORA;CBFB;NFIC;STN1;ZBTB21;TFCP2L1;ZNF276;PBX4;GMEB2;RUNX2;HEY2;FOXN2;PRDM9;SOX13;IRF2;HOXA2;BATF;MECP2;ESRRA;FOXO1;FOXL1;NR3C1
prerank,double-stranded DNA binding (GO:0003690),-0.2065753384086295,-1.0,1.0,0.6654449697399019,1.0,76/531,11.43%,ZBTB20;PBX1;FOXP1;NFAT5;RBMS1;TEAD1;NFIB;EGFR;NR3C2;TCF4;PKNOX2;RARB;HOXB6;ABL1;KLF12;TCF12;ARNT;MBNL2;CUX1;BBX;GLI3;HLF;NR6A1;ZIC4;GLI2;ARNT2;ZMYND11;HOXB4;ELF1;ATF7;THRB;HOXA5;KLF3;TEF;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;KDM5B;NFATC4;TBX15;TFCP2;MEOX2;SP1;NR1D2;HOXB5;ELF2;HDGFL3;VSX1;MSH3;TOP1;RBBP8;ZNF638;ZBTB26;TDG;ATF2;FBH1;TEAD2;PPARG;ESR1;NR2C2;FOXK1;XPA;ZNF23;ERCC5;ZIC1;ATF6;ELF4;HOXA6;RAD51B;GMEB1;PRRX2;NFATC3;TERF2
prerank,protein phosphatase regulator activity (GO:0019888),0.36615248947506174,0.9994756661367599,0.47902869757174393,0.8890410737311434,1.0,7/53,5.11%,CALM1;RCAN3;CALM3;PPP1R15B;LGALS3;PPP1R1B;PPP2R1A
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.3777917766751172,-0.9993960523223898,0.45357142857142857,0.6623634901394224,1.0,6/12,14.45%,BRD4;CDK12;CDK6;CCNK;CDK13;CDK7
prerank,PDZ domain binding (GO:0030165),-0.2545591639099522,-0.9986818950903247,0.47572815533980584,0.6595970980605319,1.0,13/61,11.47%,ARHGAP29;TGFBR3;CRIM1;RAPGEF2;PRKN;PLEKHA2;SLC22A4;GNG12;DLG4;PTEN;SRR;PSEN1;KIDINS220
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4431033214789252,0.9984974549529785,0.46866840731070497,0.8883677692239591,1.0,3/18,12.81%,HSD17B6;RDH5;HSD3B2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.396781149822699,0.994374952706231,0.5118203309692672,0.8964130547430083,1.0,11/31,20.00%,SLC12A5;AQP1;KCNA2;KCNK9;ABCC8;KCNF1;HCN1;KCNK3;KCNA1;KCNK10;TMEM38B
prerank,hormone receptor binding (GO:0051427),0.45257527071513104,0.9941722571994996,0.4881578947368421,0.8935579544709322,1.0,3/14,17.29%,NPPC;CCK;ADCYAP1
prerank,magnesium ion binding (GO:0000287),-0.22894691861138847,-0.9937243854840496,0.5333333333333333,0.6658536260183205,1.0,23/135,12.21%,EYA2;ABL1;STK3;LRRK2;SIK3;CLYBL;DHX36;SIK2;MARK1;NUDT5;IRAK3;FOXK2;SNRK;MAST2;CDC42BPB;SIK1;NEK6;TDG;ABL2;SRR;EPHX2;STK38;NLK
prerank,nuclease activity (GO:0004518),0.3689316600567333,0.9918367097492761,0.4911308203991131,0.8965775957628055,1.0,10/52,14.02%,NME1;ENDOG;RNASE1;ANG;RNASE4;RNASEH2A;RNASEH1;APEX1;PDE12;SND1
prerank,tRNA binding (GO:0000049),0.37920972886874454,0.9882159696000405,0.5124153498871332,0.9031962215596283,1.0,13/43,24.96%,EEF1A1;SARS2;SARS1;KARS1;AARS2;CARS1;CTU1;SEPSECS;RPUSD4;YARS2;TRNT1;TRMT10C;EIF2A
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4015201732190513,0.9856603727991384,0.49443757725587145,0.9065680207619056,1.0,5/26,9.53%,LGALS3;PPP1R1B;PPP1R14A;PPP1R14B;SET
prerank,glutamate receptor binding (GO:0035254),0.43276456177385414,0.9851475420211727,0.5025510204081632,0.9045430735772712,1.0,8/17,31.96%,HOMER2;SHISA7;SYNDIG1;SQSTM1;SHISA6;HOMER1;SHANK1;HOMER3
prerank,protein kinase C activity (GO:0004697),-0.36064881887299544,-0.9846989093517166,0.42063492063492064,0.6809750989420515,1.0,6/14,15.34%,PRKCE;SMG1;PRKD3;PRKD1;PRKCI;PRKCB
prerank,channel activity (GO:0015267),0.3718165692648543,0.9808159777089344,0.5172811059907834,0.9126021180971884,1.0,8/41,22.81%,AQP4;AQP1;P2RX6;BAX;SLC14A1;KCNK3;MPV17;PANX2
prerank,endopeptidase activity (GO:0004175),0.3281102587818629,0.976378623538338,0.5721442885771543,0.9212485352241888,1.0,57/257,20.35%,CTSB;CTSL;PSMB4;CTSZ;CTSS;LGMN;PSMB6;PSMB8;CD5L;RCE1;UCHL1;ADAMTS4;OMA1;MMP21;F9;PSMA7;USP5;PDIA3;KLK8;KLK1;KLK6;PIK3IP1;PCSK2;PSMB9;PMPCB;MMP3;PSMB3;PLAT;USP29;PSMB11;PSMB10;CTSH;ADAMTS16;SPG7;USP26;GZMM;HPR;HP;PSMB1;MMP27;PSMB5;NAPSA;BACE1;USP8;PLAU;PSEN2;F10;MMP14;ADAM17;ADAMTS1;CTSC;PRSS12;PSMA6;HGF;ADAMTS20;SFRP1;PSMA4
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.41339672729675964,0.9746381522775424,0.5173299101412067,0.9224473383610546,1.0,10/22,23.63%,ZFP36L1;MEX3D;ZFP36L2;HNRNPA0;ZFP36;ELAVL4;ELAVL3;EXOSC9;EXOSC4;ELAVL1
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.24588138256171055,-0.9707567964114212,0.5487804878048781,0.7082472293319036,1.0,4/55,1.63%,SLC24A3;ITPR1;MCU;ITPR2
prerank,damaged DNA binding (GO:0003684),0.36688723317445165,0.9701673744948663,0.5256696428571429,0.9307080532444956,1.0,13/44,26.73%,RPS3;RPA2;HMGB1;DDB1;APEX1;PCNA;DCLRE1C;ERCC1;POLD1;PNKP;RPA3;XPC;ERCC2
prerank,glucose transmembrane transporter activity (GO:0005355),0.42703403211638,0.9698589265233438,0.5137614678899083,0.9280996655674064,1.0,8/17,36.98%,SLC2A1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.34943124567486167,0.969526761168185,0.5509761388286334,0.9255319553113632,1.0,12/73,16.98%,GPR37L1;SCTR;APLNR;SORCS1;RXFP1;VIPR1;MC1R;SORCS3;GRPR;CX3CR1;CCKBR;HCRTR1
prerank,adenylyltransferase activity (GO:0070566),-0.303588529439389,-0.9671900337450446,0.4918918918918919,0.7116861443844763,1.0,9/21,21.13%,ABL1;TENT4B;FLAD1;TUT1;OAS2;PAPOLB;TENT2;NMNAT2;NMNAT3
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.44460159904269114,0.9647793171850633,0.5308804204993429,0.9344922231578625,1.0,3/14,13.83%,ELAC2;POP7;POP4
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.4268644875534909,0.9612120065866772,0.5455665024630542,0.9403805400375154,1.0,3/18,4.83%,PPP1CA;S100A11;TRIM29
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.423363227218268,0.9606104098073701,0.5357142857142857,0.938567312402438,1.0,2/18,3.05%,MT3;PRDX5
prerank,dynactin binding (GO:0034452),-0.36790054132654176,-0.9586178609242526,0.48514851485148514,0.7266413872631301,1.0,2/12,2.43%,SNX6;PAFAH1B1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.31887171476126963,-0.9581146741265745,0.512,0.7229412563505608,1.0,2/21,3.48%,FGF1;FRS2
prerank,serine-type endopeptidase activity (GO:0004252),0.3411173117181687,0.9574293834780561,0.5586061246040127,0.943429695661834,1.0,16/80,19.66%,CD5L;F9;KLK8;KLK1;KLK6;PIK3IP1;PCSK2;PLAT;CTSH;GZMM;HPR;HP;PLAU;F10;PRSS12;HGF
prerank,voltage-gated sodium channel activity (GO:0005248),0.40507553693583487,0.9561693561520687,0.5186567164179104,0.943400726858126,1.0,8/22,29.42%,SCN1A;SCN4B;HCN1;HCN3;SCN9A;SCN8A;SCN2A;SCN1B
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.31521493994865524,-0.9559025592314153,0.5230125523012552,0.7233358684620876,1.0,4/18,12.45%,ALDH1A1;ALDH1A2;FAR1;AKR1B1
prerank,miRNA binding (GO:0035198),-0.28638765543632994,-0.9544927504260482,0.5792682926829268,0.7217905579490655,1.0,11/30,21.34%,ZNF346;ZC3H7A;TUT7;RBM4;ZC3H7B;PUM2;TUT4;AGO2;FMR1;AGO4;SOX2
prerank,sequence-specific mRNA binding (GO:1990825),0.4659203863517406,0.9488092009302023,0.5497159090909091,0.9587420848634908,1.0,4/10,28.39%,SHFL;ETF1;DHFR;DHX9
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.2986918625290032,-0.9474020555989261,0.5440414507772021,0.7330030998197272,1.0,6/23,10.18%,MAPKAP1;PLEKHA4;SESTD1;GBF1;HIP1;KIF16B
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.230318261250642,-0.9468075742334732,0.5833333333333334,0.7297405879076956,1.0,18/91,10.91%,PARD3;SVIL;FCHO2;SLC9A1;ACTN2;FRMPD4;MAPKAP1;MYO1B;PLEKHA4;ADAP2;MARK1;SESTD1;GBF1;HIP1;PICALM;KIF16B;KRIT1;TULP3
prerank,leucine zipper domain binding (GO:0043522),0.4676626271471701,0.9444882458391767,0.5547752808988764,0.9660428699232819,1.0,4/10,21.15%,ATF4;MRTFA;NRL;DDIT3
prerank,palmitoyltransferase activity (GO:0016409),0.375995489698836,0.9371157126377534,0.5695284159613059,0.9808771516519725,1.0,10/28,29.54%,GLUL;YKT6;ZDHHC5;GOLGA7B;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.3628882600608385,-0.9365857690509954,0.5145985401459854,0.7482070430527585,1.0,3/11,9.86%,NAA40;NAA16;NAA15
prerank,myosin V binding (GO:0031489),0.42650385425084714,0.9325225934457715,0.5841059602649007,0.9887486364486525,1.0,6/15,22.13%,RAB14;RAB3C;RAB3D;RAB39B;RAB6B;RAB27B
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.42246082386241846,0.9320602465406316,0.5788079470198676,0.9864140287633918,1.0,8/14,32.10%,PYCR2;QDPR;CRYM;ALDH4A1;NOXRED1;BLVRB;DHFR;ALDH1L1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.42486233271980967,0.9311615760719881,0.5652173913043478,0.9851058533061267,1.0,2/14,6.68%,HSD17B6;RDH5
prerank,gated channel activity (GO:0022836),-0.3314454551924766,-0.930784976747925,0.5627376425855514,0.7572420673113941,1.0,3/14,11.28%,PIEZO2;PIEZO1;TMC6
prerank,C-C chemokine receptor activity (GO:0016493),0.3898683158983938,0.9290047933138524,0.558282208588957,0.9865871323518608,1.0,4/21,18.30%,CCR5;CXCR4;CX3CR1;CCR2
prerank,CoA hydrolase activity (GO:0016289),0.4102298856063953,0.9244513166161569,0.5704787234042553,0.9940785646562957,1.0,4/16,16.68%,ACAA2;ACOT1;ACOT7;ACOT4
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.29646165692411924,-0.924361134661122,0.5572139303482587,0.7672855305433637,1.0,9/22,15.83%,OTUD7B;UIMC1;ZBTB1;RNF169;OPTN;TAB2;ZRANB1;PARP10;TAB3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3141584318596945,-0.9232234367831897,0.569620253164557,0.7650681657834745,1.0,6/17,18.61%,DPYD;PTGR2;BDH2;PECR;TM7SF2;PTGR1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.36122117241663815,0.9208889988721626,0.5907514450867052,0.9990617049608105,1.0,5/34,7.70%,UBE2Z;UBE2G2;UBE2Q1;CDC34;UFC1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.35550473333835625,0.920592002625445,0.6114285714285714,0.9962849500627111,1.0,16/42,27.26%,CCNI;CCND2;CCND1;CDK5R1;CCNG1;CDK5R2;HEXIM1;CCNJL;CCNA2;CDKN2B;CCNC;CCNQ;CCNG2;CCNH;CDKN1A;CNPPD1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.4360901627785552,0.9204885078887907,0.5814917127071824,0.9930413398753448,1.0,5/12,22.15%,SPPL2B;NAPSA;BACE1;SPPL2A;CTSE
prerank,androgen receptor binding (GO:0050681),0.37664037732375677,0.9192738380265969,0.5916870415647921,0.9925060288260292,1.0,5/25,12.39%,CALR;PARK7;PKN1;ZBTB7A;SNW1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2732610433207888,-0.918122677155395,0.5828571428571429,0.7716506446880889,1.0,4/27,7.42%,SLC9A1;SLC9A2;SLC9B2;SLC8B1
prerank,O-methyltransferase activity (GO:0008171),0.4469908373474294,0.9166471381883667,0.6013888888888889,0.9951222647765691,1.0,3/10,21.77%,CMTR1;MEPCE;FTSJ3
prerank,signal sequence binding (GO:0005048),0.3581138714527209,0.9135542543877524,0.6120092378752887,0.9988354140566383,1.0,10/35,20.79%,PEX5L;AP2M1;KDELR1;SEC61A1;IPO4;CAT;TOMM20L;CABP1;BRAP;NFKBIA
prerank,E-box binding (GO:0070888),-0.26104194624232113,-0.9121801492378996,0.5935483870967742,0.7806719420736873,1.0,2/34,0.90%,ZEB1;TCF4
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.3519771155166661,-0.9121057946867652,0.5827067669172933,0.7762165287474434,1.0,7/12,23.21%,SULF1;ARSK;SULF2;ARSB;ARSI;ARSA;ARSJ
prerank,pseudouridine synthase activity (GO:0009982),0.4246600677857763,0.9116062374116012,0.5760111576011158,1.0,1.0,5/13,20.54%,TRUB2;PUSL1;DKC1;PUS7;RPUSD4
prerank,beta-tubulin binding (GO:0048487),0.3647398386221716,0.9102949147561249,0.5883720930232558,0.9997570240265922,1.0,7/31,17.19%,GABARAP;GABARAPL2;GABARAPL1;CDK5R1;TTLL7;FGF13;PDCD5
prerank,alpha-actinin binding (GO:0051393),-0.27701259840227277,-0.9079306883083088,0.5721649484536082,0.7811399593786083,1.0,7/24,16.87%,CACNA1C;PDLIM5;PDLIM4;PPARG;SYNPO2;CACNA1D;PDLIM2
prerank,single-stranded DNA binding (GO:0003697),0.3228758822509763,0.907027149373593,0.6663190823774765,1.0,1.0,37/93,29.78%,PCBP1;PARK7;POLR2D;MCM5;NUCKS1;RPA2;HSPD1;MAPT;HMGB1;POLR2G;DDX11;HNRNPU;HNRNPA1;SUB1;BRCA2;CTC1;WDR48;RAD23A;POU4F1;ERCC1;FAM111A;POLR2H;RADX;BLM;CDC45;LONP1;PCBP2;PURB;RPA3;XPC;RAD51;MCM7;MCM2;DHX9;WBP11;SMC6;POLR3C
prerank,phosphatidylglycerol binding (GO:1901611),0.41811007580448456,0.9036721163342369,0.5963302752293578,1.0,1.0,2/13,12.26%,PLTP;NME4
prerank,mRNA methyltransferase activity (GO:0008174),0.41632200357746596,0.8986980816274953,0.5906593406593407,1.0,1.0,5/12,25.03%,PCIF1;CMTR1;TRMT10C;METTL3;METTL14
prerank,deubiquitinase activity (GO:0101005),-0.20881691420288767,-0.8933181409264025,0.7777777777777778,0.8090666688551842,1.0,26/88,18.73%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;USP28;ZRANB1;USP46;STAMBPL1;UCHL5;USP45;USP37;USP53;USP33;USP9X
prerank,mannosyltransferase activity (GO:0000030),-0.28682360690393593,-0.8924070850644865,0.6243654822335025,0.8060675291876302,1.0,10/21,24.37%,TMTC1;TMTC4;PIGM;DPY19L4;POMT1;DPM1;TMTC3;POMT2;ALG1;PIGB
prerank,cytokine receptor binding (GO:0005126),0.3162168290170322,0.8919828905961962,0.6752136752136753,1.0,1.0,22/83,23.31%,CXCL12;CCL19;FKBP1A;MIF;DDT;IL2;KITLG;IL11;TIMM50;SDCBP;TLR5;CD300LF;ADAM17;SYK;IL6;IL1RAP;CRLF1;PYCARD;CRLF2;ERAP1;PRLR;IL12RB1
prerank,hydro-lyase activity (GO:0016836),0.342021803093921,0.8904244197564897,0.65,1.0,1.0,10/41,17.37%,PARK7;CA2;ENO1;HSD17B4;ALAD;CA4;FAHD2A;ENO3;NAXD;ECHS1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3605384462202843,0.8899981877779898,0.6462093862815884,1.0,1.0,7/29,16.89%,HSPB1;INKA2;YWHAG;PRKAR1A;PRKAR1B;HEXIM1;PRKAR2B
prerank,WW domain binding (GO:0050699),0.36712198869377327,0.8895303711390797,0.6329723225030084,1.0,1.0,9/26,28.93%,TCEAL9;DAZAP2;TCEAL7;TCEAL5;TCEAL8;KIF20B;TNK2;ENAH;WBP11
prerank,acyl-CoA hydrolase activity (GO:0047617),0.38870062370874425,0.8878695954799612,0.6127770534550195,1.0,1.0,6/17,26.52%,ACAA2;ACOT1;ACOT7;ACOT4;THEM4;PLA2G6
prerank,voltage-gated calcium channel activity (GO:0005245),-0.2512197347598465,-0.8868319632731567,0.664,0.8143388954228098,1.0,3/37,3.82%,CACNA2D3;CACNA1C;CACHD1
prerank,serine-type peptidase activity (GO:0008236),0.31083210007701045,0.8852977663800577,0.7114583333333333,1.0,1.0,18/96,19.66%,CD5L;F9;KLK8;KLK1;KLK6;PIK3IP1;PCSK2;PLAT;CTSH;GZMM;PRSS8;HPR;HP;KLK10;PLAU;F10;PRSS12;HGF
prerank,N-acyltransferase activity (GO:0016410),0.3481289063710223,0.8845451116922559,0.6592244418331374,1.0,1.0,6/32,17.43%,TGM2;CERS2;PLAAT3;NAA10;GLYAT;NAT8L
prerank,RNA stem-loop binding (GO:0035613),-0.33366096058318756,-0.8801527194112743,0.6,0.824437260004946,1.0,6/12,23.40%,MYH10;CPEB3;RC3H2;FMR1;METTL16;LARP6
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.25629769070289793,-0.8796901436435677,0.6685393258426966,0.8204739060179516,1.0,4/28,9.73%,EDA;BABAM2;TRAF5;RIPK1
prerank,transcription coactivator binding (GO:0001223),0.37960132594872026,0.8777262633841355,0.6520051746442432,1.0,1.0,1/20,0.13%,RPL23
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3640180990685001,0.8767085823506099,0.6298619824341279,1.0,1.0,8/24,28.67%,GLUL;YKT6;GOLGA7B;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,methyl-CpG binding (GO:0008327),-0.27709445131935106,-0.8759546434698285,0.6808510638297872,0.8227330174398012,1.0,15/22,34.08%,TET3;ZBTB38;LRWD1;CXXC5;ZBTB21;MECP2;ZCWPW1;WDR77;CHTOP;CXXC4;ERH;LHX4;TET1;MBD2;UHRF1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3969965449469872,0.8756734875599996,0.6412315930388219,1.0,1.0,4/14,27.61%,KCNE4;KCNE5;KCNJ3;KCNQ1
prerank,Wnt-activated receptor activity (GO:0042813),-0.31081798254863724,-0.8740409080884708,0.6431372549019608,0.8220516265609503,1.0,3/15,4.09%,ROR1;LRP5;FZD6
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3373848989354167,0.8736746019067557,0.6635404454865181,1.0,1.0,11/35,20.27%,PLD3;PDIA3;ENPP2;SMPD1;APEX1;GDE1;SMPDL3A;GPCPD1;GDPD1;ENPP6;PDE11A
prerank,ATP binding (GO:0005524),0.29403274988605516,0.8730692266055458,0.8308308308308309,1.0,1.0,77/266,26.66%,HSPA8;HSP90AA1;HSP90AB1;ATP5F1D;NDUFA13;HSPA5;AKT1;ATP5F1A;NME1;PINK1;PFKL;ACVRL1;HSPA1B;ABCB6;ABCG1;UHMK1;TAP2;PGK1;ATP1A3;EPB42;P2RX7;MAST1;SYN2;P2RY1;SARS2;AARS2;MYO1F;BCKDK;P2RX6;ATP1A1;SYN1;HSPA1A;CARS1;HNRNPU;CDC42BPA;STK11;TSSK6;TSSK4;PRPS1L1;PRPS1;PEX6;ABCA2;EIF4A3;BRSK2;HSPA4L;MAP4K2;ERCC6;GUK1;OAS3;AGAP2;VPS4A;MKNK1;TWF1;HSPA2;HSPA9;MTHFS;PYGL;BLM;YARS2;TWF2;LONP1;PMVK;TRNT1;ACLY;DYRK2;PNKP;LANCL2;HSPA14;PIF1;ABCG5;RAD51;PIM1;OXSR1;TRIB1;CDK11B;PEX1;GALK1
prerank,ionotropic glutamate receptor binding (GO:0035255),0.4190351611038157,0.8689571395820971,0.6231884057971014,1.0,1.0,7/10,39.95%,SHISA7;SQSTM1;SHISA6;SHANK1;NSF;GNAS;IGSF11
prerank,cyclic nucleotide binding (GO:0030551),0.37237081399283156,0.8686425567851088,0.6691823899371069,1.0,1.0,9/21,24.94%,PDE4B;CNGA3;CNGA4;SLC19A1;HCN1;CNGB1;PDE11A;POPDC3;PDE2A
prerank,ribonuclease P RNA binding (GO:0033204),0.4286994177338437,0.8684875378274203,0.6652719665271967,1.0,1.0,2/10,13.83%,POP7;POP4
prerank,receptor antagonist activity (GO:0048019),0.3804905899495155,0.8673332821430062,0.669260700389105,1.0,1.0,2/17,6.62%,LRPAP1;WFIKKN2
prerank,myosin binding (GO:0017022),0.3224161721414121,0.8659974843624939,0.7006651884700665,1.0,1.0,21/55,27.20%,GSN;MOBP;RAB14;CORO1A;RAB3C;STXBP5L;RAB3D;HAP1;RHOA;CXCR4;RAB39B;TRIM32;RAB6B;PYCARD;RAB27B;USH2A;LLGL1;NCKIPSD;NKD2;MYOC;RAB8A
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.4227455827066084,0.8657996132009681,0.651685393258427,1.0,1.0,5/11,24.22%,NUDT3;NUDT4;NUDT16;NUDT10;NUDT11
prerank,solute:proton symporter activity (GO:0015295),0.3946658915793985,0.8641477752311585,0.6675324675324675,1.0,1.0,4/16,15.42%,SLC15A4;SLC33A1;MFSD3;SLC15A2
prerank,adenyl ribonucleotide binding (GO:0032559),0.2899378572275035,0.8621024956916027,0.846,1.0,1.0,85/291,26.66%,HSPA8;HSP90AA1;HSP90AB1;ATP5F1D;NDUFA13;HSPA5;AKT1;PDE4B;ATP5F1A;NME1;PINK1;PFKL;ACVRL1;HSPA1B;ABCB6;ABCG1;UHMK1;TAP2;PGK1;APRT;ATP1A3;MYO3A;EPB42;P2RX7;MAST1;SYN2;P2RY1;SARS2;AARS2;MYO1F;BCKDK;P2RX6;ATP1A1;SYN1;HSPA1A;SLC19A1;CARS1;HNRNPU;CDC42BPA;STK11;TSSK6;TSSK4;PRPS1L1;PRPS1;HCN1;PEX6;ABCA2;EIF4A3;BRSK2;HSPA4L;MAP4K2;ERCC6;GLUD1;GUK1;OAS3;AGAP2;VPS4A;MKNK1;TWF1;HSPA2;HSPA9;MTHFS;PYGL;BLM;YARS2;TWF2;LONP1;PMVK;TRNT1;ACLY;DYRK2;PNKP;POPDC3;LANCL2;PDE2A;HSPA14;PIF1;ABCG5;RAD51;PIM1;OXSR1;TRIB1;CDK11B;PEX1;GALK1
prerank,GDP binding (GO:0019003),0.3121706847060287,0.859713977350329,0.7263948497854077,1.0,1.0,25/63,30.96%,RAN;RAB14;ARF6;GNAI1;HRAS;RHEBL1;NME2;RRAS;RRAGC;RRAGD;RAB5C;RAB18;RAB31;RAB4A;RALB;RERG;RAB27B;RAB28;RAB42;RAB8A;RAP1B;RAP2A;RAB9B;RIT2;RALA
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.2137791500412285,-0.8586820483574686,0.8414634146341463,0.8498504916967269,1.0,12/55,13.67%,SLC6A13;SLC7A2;SLC16A12;SLC38A9;SLC6A12;SLC16A9;SLC22A4;SLC38A6;SLC16A6;SLC16A13;SLC36A4;SLC38A11
prerank,phosphoric ester hydrolase activity (GO:0042578),0.32055375894619204,0.8570507266565293,0.7072892938496583,1.0,1.0,19/49,25.72%,PPP1CA;DUSP3;DUSP28;SMPD1;APEX1;SMPDL3A;GDPD1;ENPP6;PGP;PTPRO;DUSP23;DUSP12;DUSP15;SBF1;GDPD3;ACP2;PPP1CB;DUSP8;PGAM5
prerank,pyrophosphatase activity (GO:0016462),0.31958924595295635,0.8551287978885203,0.7112597547380156,1.0,1.0,12/50,19.20%,BNIP2;ENTPD3;NUDT3;TRPM2;NUDT22;NUDT4;PPA1;NUDT16;PRUNE2;ATCAY;NUDT10;NUDT9
prerank,cation channel activity (GO:0005261),0.2973026370384012,0.853823981796985,0.7375,1.0,1.0,28/94,21.59%,SLC24A4;SLC24A2;GRIN1;TMCO1;TMEM63B;AQP1;TMEM63C;HVCN1;KCNA2;TRPM2;KCNK9;SEC61A1;ABCC8;TRPC1;KCNF1;HCN1;KCNK3;RYR2;KCNA1;ORAI1;KCNK10;UNC80;ANXA6;CALHM6;PKD2L1;TMEM38B;PKDREJ;PKD1L2
prerank,calcium activated cation channel activity (GO:0005227),0.3824369901691346,0.8522035255055801,0.675392670157068,1.0,1.0,7/17,26.89%,TMEM63B;TMEM63C;KCNN2;KCNMA1;PKD2L1;KCNN4;KCNMB4
prerank,NAD binding (GO:0051287),-0.26205296183973387,-0.8494836124893304,0.7379679144385026,0.8632731504601162,1.0,8/26,16.50%,ALDH1A1;CRYL1;PARP9;BDH2;SIRT1;ME1;ZC3HAV1;NNT
prerank,ion gated channel activity (GO:0022839),0.3576372571983203,0.8480500460191236,0.6843373493975904,1.0,1.0,6/24,19.69%,TMEM63B;TTYH1;TMEM63C;TTYH3;ANO4;PKD2L1
prerank,histone acetyltransferase binding (GO:0035035),0.3560066713984532,0.8476899191170719,0.6721311475409836,1.0,1.0,8/21,22.66%,EID1;EPAS1;EGR1;ZBTB7A;PCNA;CITED2;SIRT2;TRIM68
prerank,protein phosphorylated amino acid binding (GO:0045309),0.3277157040449186,0.845564377713084,0.7150964812712827,1.0,1.0,12/42,22.39%,YWHAB;PIN1;YWHAE;PFN1;SHC3;HCK;FBXW7;VAV1;SYK;PTPN6;SHE;PTPN5
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.3375366919271239,-0.8446538893638136,0.6542372881355932,0.8677383726464952,1.0,2/10,6.12%,B4GALT1;B3GALT1
prerank,kinase activity (GO:0016301),0.2957674196293511,0.8431346327975863,0.7724922440537746,1.0,1.0,25/109,21.45%,CHKB;CKB;AKT1;RFK;PINK1;CKMT1A;PGK1;FN3KRP;DGKH;DGKI;CDK5R1;PIK3C2G;BCKDK;DOLK;CDK5;CCL3;PIK3CD;COASY;CERKL;IP6K1;MAPK15;NEK1;SPHK2;DGKK;DGKB
prerank,ribosomal large subunit binding (GO:0043023),0.39264099477561304,0.8427812236254462,0.6493688639551192,1.0,1.0,1/11,3.04%,NPM1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.27587255653770404,-0.8418114229604727,0.7070707070707071,0.8684186211250905,1.0,4/21,7.24%,ARFGEF1;AKAP7;AKAP9;ARFGEF2
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.23754007109922154,-0.840883375891564,0.732484076433121,0.86541558084041,1.0,8/34,13.81%,PAN3;CNOT1;PARN;ERI3;CNOT7;ERI2;DIS3L;ANGEL1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.33502209227255747,0.8402949826058915,0.7054631828978623,1.0,1.0,4/31,6.18%,UBE2Z;UBE2G2;UBE2Q1;CDC34
prerank,epidermal growth factor receptor binding (GO:0005154),-0.2563803408418243,-0.8402788835773148,0.7248677248677249,0.861683042515724,1.0,6/25,15.86%,FER;ATXN2;EFEMP1;HIP1;SNX2;SNX1
prerank,microtubule binding (GO:0008017),0.28373024347047887,0.8392255505555026,0.8605817452357071,1.0,1.0,57/222,25.38%,RPS3;GAPDH;PRNP;MAP1LC3B;TERF1;MAP1LC3A;MAP1A;GABARAPL2;S100A8;S100A9;NEFH;DNM3;SBDS;NEFM;NDRG1;NAV3;ABRAXAS2;CLASP1;MAST1;MAPT;MAP2;KIF26B;KIF5A;REEP2;KIF26A;FHDC1;DCTN1;CLIP3;MTCL1;CCDC88A;KIF21B;CETN3;MAPRE3;CDK5;FGF13;DNM1L;TOGARAM2;HOOK1;FAM83D;KIF5C;KIFC2;DCX;VAPA;MAP1B;RAE1;KATNA1;RCC2;SYBU;DNM1;SUN2;KIF1A;VAPB;SGIP1;KIF27;GAS2L3;MAPRE1;KIF20B
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4020435208905784,0.8387115731820853,0.6648351648351648,1.0,1.0,3/11,22.04%,LRRC8A;SLC19A1;SLC25A23
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.33691636028739846,-0.8373859969882717,0.6886446886446886,0.8626104275425927,1.0,1/10,0.05%,PRKAG2
prerank,hyaluronic acid binding (GO:0005540),0.4093208135879063,0.833902048497674,0.69164265129683,1.0,1.0,3/10,23.52%,HYAL2;LYVE1;C1QBP
prerank,voltage-gated ion channel activity (GO:0005244),0.3820134366864412,0.833154870866451,0.6794701986754967,1.0,1.0,5/14,22.84%,KCND2;HVCN1;HCN1;VDAC2;CACNA1E
prerank,tropomyosin binding (GO:0005523),0.3715185639106962,0.8321140785611933,0.6957087126137841,1.0,1.0,1/16,0.66%,S100A6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.34348606339311516,-0.8321098041428814,0.7066666666666667,0.8629707373181817,1.0,3/10,10.86%,DUSP16;DUSP10;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.34348606339311516,-0.8321098041428814,0.7066666666666667,0.8629707373181817,1.0,3/10,10.86%,DUSP16;DUSP10;DUSP7
prerank,phosphatidylcholine transporter activity (GO:0008525),0.3725763610334917,0.8311174297189391,0.6964520367936925,1.0,1.0,2/17,5.54%,PLTP;ABCG1
prerank,transforming growth factor beta binding (GO:0050431),0.348293522813814,0.8309025107060066,0.6967418546365914,1.0,1.0,4/23,6.62%,LTBP4;ACVRL1;HYAL2;WFIKKN2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.3130934438082576,-0.8294980279770968,0.6703703703703704,0.863157153326667,1.0,1/13,0.23%,BMP6
prerank,solute:anion antiporter activity (GO:0140323),-0.29323435205822873,-0.8294197852110059,0.6925795053003534,0.8586127122542183,1.0,3/14,12.83%,SLC26A7;SLC7A11;SLC26A2
prerank,single-stranded RNA binding (GO:0003727),0.3162561587364849,0.8261933228713865,0.7209567198177677,1.0,1.0,12/43,23.06%,POLR2D;POLR2G;DDX11;L1TD1;HNRNPU;HNRNPA1;AGO1;CNBP;EIF4H;RBM7;HNRNPF;LONP1
prerank,alkali metal ion binding (GO:0031420),-0.30164957015821015,-0.8251084036858657,0.7366412213740458,0.8624119260705491,1.0,3/13,8.98%,HDAC4;ATP1A2;TDG
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.3986380810307151,0.8246115718771169,0.7088607594936709,1.0,1.0,6/10,29.63%,CRMP1;OPLAH;DPYS;DPYSL2;DPYSL5;CAD
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3981956737597109,0.8240724727242198,0.6802919708029197,1.0,1.0,2/11,16.45%,DDAH1;DDAH2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.3025102743529773,-0.8230738264135757,0.6986301369863014,0.8615195025252763,1.0,6/13,17.51%,ITGA5;PDGFRB;IL1R1;VEGFD;PDGFC;PDGFRA
prerank,CARD domain binding (GO:0050700),-0.2944603872461495,-0.8205833995062125,0.7020408163265306,0.8614662224242189,1.0,2/14,5.60%,CARD16;CARD14
prerank,vinculin binding (GO:0017166),-0.3221943829136,-0.8164211400396281,0.6606498194945848,0.8640953637879464,1.0,4/11,13.83%,SORBS3;PXN;UTRN;CTNNA1
prerank,phosphotyrosine residue binding (GO:0001784),-0.22824949601105549,-0.8154367171012258,0.8028169014084507,0.8612721340904042,1.0,7/37,10.19%,ABL1;IRS1;PTPN3;YES1;VAV2;BCAR3;ABL2
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.3152972192580503,-0.8146115229353219,0.6754716981132075,0.8582034976410334,1.0,12/12,68.50%,GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4;OPN3;GPR88;ELOVL4
prerank,general transcription initiation factor binding (GO:0140296),0.33721343678000687,0.8145093102735866,0.7326139088729017,1.0,1.0,10/25,30.41%,DRAP1;THRA;TBP;PSMC1;RELA;HHEX;RUVBL2;TAF13;PSMC5;PSMC2
prerank,RNA polymerase binding (GO:0070063),0.3510242164138585,0.8130153111592416,0.7233502538071066,1.0,1.0,3/18,10.02%,PPIB;TAF10;ZFP36
prerank,UDP-glycosyltransferase activity (GO:0008194),0.29589718686202376,0.8128312032438736,0.7808807733619764,1.0,1.0,18/70,24.71%,HEXB;HEXA;B4GALNT1;B4GALNT4;POGLUT3;B3GNT9;CHPF2;B3GAT3;CHPF;GCNT1;B3GNT3;RFNG;CSGALNACT2;CHSY3;B3GALT5;LFNG;B3GALT2;MGAT4B
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.3671751106909674,0.8126325872407875,0.7070967741935484,1.0,1.0,3/15,18.30%,CCR5;CX3CR1;CCR2
prerank,cAMP binding (GO:0030552),-0.3220491673965208,-0.8099323642910466,0.7303754266211604,0.8616206509297333,1.0,3/11,9.52%,RAPGEF4;RAPGEF2;CNBD2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.3762573875176791,0.8099139570454267,0.7198879551820728,1.0,1.0,2/12,5.48%,PDE4B;PDE3B
prerank,cardiolipin binding (GO:1901612),0.393129532136972,0.8090643439769329,0.7170068027210884,1.0,1.0,3/10,27.02%,NME4;STOML2;PLEKHN1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3709331713786325,0.8073221225561868,0.7018716577540107,1.0,1.0,4/12,16.80%,CADM4;CCDC88A;DAB2IP;CDH5
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3372723295275908,0.807314410212141,0.7383647798742138,1.0,1.0,10/22,25.90%,DUSP3;DUSP2;DUSP23;PPM1F;DUSP12;DUSP1;DUSP15;SBF1;DUSP8;DUSP6
prerank,TBP-class protein binding (GO:0017025),0.3477588752156003,0.8067196356386195,0.7383059418457648,1.0,1.0,9/21,33.25%,DRAP1;THRA;PSMC1;HHEX;RUVBL2;TAF13;PSMC5;PSMC2;TAF11
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3892514923836441,0.8045905761209922,0.7191977077363897,1.0,1.0,2/10,16.91%,PIK3C2G;PIK3CD
prerank,syntaxin-1 binding (GO:0017075),0.33800432185406626,0.8028076862905709,0.7453874538745388,1.0,1.0,5/22,9.25%,SNAP25;SYT1;SYPL1;VAMP3;VAMP2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3275163587723133,0.8016562677266265,0.7546468401486989,1.0,1.0,11/28,28.98%,AKT1;SGK1;PAK3;MAPK10;MAP2K2;MAP2K7;PRKACA;TNK2;MAP3K9;RPS6KA1;AURKB
prerank,DNA secondary structure binding (GO:0000217),-0.23128898926383656,-0.7992783792519378,0.8343949044585988,0.8746191019757612,1.0,11/31,21.78%,ABL1;KMT2A;RBBP8;ERCC5;RAD51B;CLSPN;FANCM;YY1;WRN;XRCC3;XRCC2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.2998509708954082,-0.7985220969560499,0.7793594306049823,0.8714066906298421,1.0,7/13,23.90%,THUMPD3;TRMT5;FTSJ1;TRMT1L;TARBP1;TRMT1;TRMT10B
prerank,RNA polymerase core enzyme binding (GO:0043175),0.31636208877524835,0.7967720514772302,0.7675233644859814,1.0,1.0,9/33,19.53%,MAF1;ELOF1;RTRAF;SUPT4H1;HNRNPU;RECQL5;AGO1;CCAR2;ESRRB
prerank,lipid phosphatase activity (GO:0042577),-0.2904640854097866,-0.7966215902328085,0.7248062015503876,0.8700092587756348,1.0,7/14,22.10%,PLPP3;EPHX2;PLPP1;PLPP7;PLPP2;PLPPR1;PLPPR3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.3883819873434404,0.7963250054284833,0.7138728323699421,1.0,1.0,1/10,5.31%,SIRPA
prerank,5'-nucleotidase activity (GO:0008253),-0.30705617052151263,-0.7963105499691564,0.7162629757785467,0.8659886919985169,1.0,5/13,19.86%,NT5DC1;NT5C2;NT5C1A;NT5M;ACP3
prerank,BMP receptor binding (GO:0070700),-0.31309358172253576,-0.7960414963906517,0.7311827956989247,0.8619919447829028,1.0,1/12,0.23%,BMP6
prerank,O-acyltransferase activity (GO:0008374),0.32046895755403493,0.7928396344910835,0.7518159806295399,1.0,1.0,10/30,27.15%,PRDX6;MOGAT2;DGAT2L6;LRAT;SOAT2;DGAT1;LPCAT2;MOGAT1;MBOAT7;GPAM
prerank,frizzled binding (GO:0005109),-0.23582734200426975,-0.7922014268264236,0.849624060150376,0.8639761662006025,1.0,12/34,21.54%,LRP6;WNT5B;WNT16;RNF43;DVL3;WNT11;WNT4;WNT9A;RYK;FZD7;ZNRF3;WNT2B
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.32584443234326577,-0.7915845001435899,0.7226277372262774,0.8605579720390999,1.0,1/10,0.51%,CACNA1C
prerank,store-operated calcium channel activity (GO:0015279),0.38596504496907436,0.7912334159542662,0.7307152875175316,1.0,1.0,3/10,16.88%,TRPC7;TRPC1;ORAI1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.2950606145063869,0.7907786865216145,0.7827050997782705,1.0,1.0,16/49,25.42%,UBXN1;VCP;TNFAIP3;ABRAXAS2;OTUD7A;PRPF8;UBQLN2;SQSTM1;RAD23A;FAAP20;TNIP1;ZFAND2B;UBQLN4;ATRIP;MINDY1;PSMD4
prerank,amino acid transmembrane transporter activity (GO:0015171),0.29789745341848817,0.7876783974243854,0.7724215246636771,1.0,1.0,6/47,11.28%,SLC38A5;SLC7A5;SLC25A29;SLC6A6;SLC3A2;SLC7A14
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3364288859521,0.7859366193623477,0.7674714104193139,1.0,1.0,5/20,18.08%,DLG2;AK4;AK3;CMPK2;GUK1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3784605378149564,0.7852928718705392,0.7417127071823204,1.0,1.0,4/11,25.35%,AKR1B10;DHRS13;AKR1A1;RDH14
prerank,aminopeptidase activity (GO:0004177),0.32328261460531005,0.7849254660961467,0.7838827838827839,1.0,1.0,6/26,17.33%,METAP1;METAP2;LAP3;CTSH;RNPEPL1;MMP14
prerank,calcium:sodium antiporter activity (GO:0005432),0.38829180234151894,0.784654103183939,0.7485549132947977,1.0,1.0,4/10,15.37%,SLC24A4;SLC24A2;SLC3A2;SLC8A1
prerank,symporter activity (GO:0015293),0.38216351665490095,0.784268856253514,0.7405857740585774,1.0,1.0,2/10,20.59%,MFSD2A;SLC46A2
prerank,adrenergic receptor binding (GO:0031690),0.35013514151734826,0.7814439220832629,0.7597840755735492,1.0,1.0,5/16,23.52%,UCHL1;APLP1;ARRDC3;GRK2;C1QBP
prerank,antiporter activity (GO:0015297),0.328328646507421,0.7814131270181828,0.7701005025125628,1.0,1.0,6/20,23.83%,ATP1A3;SLC25A11;SLC35E1;SLC35A1;SLC25A14;SLC25A16
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.3178609921458969,0.778117631109865,0.7888349514563107,1.0,1.0,3/27,9.20%,LRRC8A;SLC26A4;SLC25A11
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.30781282119658177,0.7778761368936375,0.7917146144994246,1.0,1.0,10/33,19.53%,ELOF1;DRAP1;RTRAF;SUPT4H1;HNRNPU;RECQL5;AGO1;CCAR2;TBP;ESRRB
prerank,Notch binding (GO:0005112),0.3333754979928865,0.7776245964005521,0.7920918367346939,1.0,1.0,7/22,17.48%,KCTD10;DNER;SNW1;NCOR2;DLL1;JAG2;ADAM17
prerank,nuclear export signal receptor activity (GO:0005049),0.3715624646198039,0.7738220393355599,0.7534626038781164,1.0,1.0,3/11,17.31%,RAN;XPO1;EIF4ENIF1
prerank,LRR domain binding (GO:0030275),0.35776408048502195,0.7730782330799482,0.7435897435897436,1.0,1.0,5/14,21.70%,ATF4;MRTFA;NRL;DDIT3;ZXDC
prerank,SH2 domain binding (GO:0042169),0.30721179537949334,0.7727531930568811,0.7878077373974208,1.0,1.0,7/31,17.00%,RACK1;LILRB1;CCDC88A;SH2B2;DLC1;SQSTM1;SKAP1
prerank,histone deacetylase activity (GO:0004407),0.336884992714492,0.7698147115607421,0.7727272727272727,1.0,1.0,6/19,21.46%,HDAC11;HDAC5;MIER2;HDAC9;SIRT2;SUDS3
prerank,phospholipase C activity (GO:0004629),-0.23816853346445363,-0.7692125967568564,0.8383233532934131,0.8895602951233058,1.0,4/25,7.49%,PLCE1;EDNRA;PLCL1;PLCD3
prerank,protein phosphatase binding (GO:0019903),0.26779115065816317,0.7689165754112649,0.881511746680286,1.0,1.0,23/117,18.08%,RACK1;SOD1;HSP90B1;LGALS3;SIRPA;CTNNB1;VCP;RPA2;GRIN3A;MAPT;CD22;MTMR9;FLT4;LILRB1;TRAF3;BAD;ARPP19;DAB2IP;ADCY8;CDH5;SKAP1;PPP1R3D;PPP1R15A
prerank,phosphatase binding (GO:0019902),0.27152600285138245,0.768218065107074,0.8703319502074689,1.0,1.0,20/105,18.53%,RACK1;MAPK3;RCAN3;HSP90B1;LGALS3;SIRPA;CTNNB1;VCP;RPA2;CD22;MTMR9;SYTL2;FLT4;TRAF3;BAD;SPTBN4;CDH5;SKAP1;CTSC;TERF2IP
prerank,insulin-like growth factor receptor binding (GO:0005159),0.36622647527290086,0.7678361515815104,0.7524339360222532,1.0,1.0,3/12,15.42%,YWHAH;YWHAG;IGF2
prerank,vitamin D receptor binding (GO:0042809),-0.27751146614917777,-0.7670241068122146,0.8052434456928839,0.8884849931472042,1.0,2/14,4.37%,MED13;THRAP3
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.29414582002002404,0.7647017603755506,0.8159371492704826,1.0,1.0,13/46,24.71%,HEXB;HEXA;PIGQ;MGAT2;B3GNT9;GCNT1;B3GNT3;RFNG;B3GALT5;MGAT1;LFNG;B3GALT2;MGAT4B
prerank,chemokine receptor activity (GO:0004950),0.3131941263231993,0.7644525766673967,0.7940119760479042,1.0,1.0,7/24,31.16%,CCR5;CXCR4;CX3CR1;CCR2;GPR17;GPR35;ACKR3
prerank,chloride transmembrane transporter activity (GO:0015108),0.33839498466439205,0.7626162274035935,0.7620915032679738,1.0,1.0,3/16,12.43%,SLC12A5;SLC26A4;SLC1A1
prerank,phosphatase activity (GO:0016791),0.2742126723946653,0.7624917052372817,0.8510182207931404,1.0,1.0,25/73,29.30%,PPP1CA;DUSP3;BPNT2;DUSP28;DUSP26;NUDT16;NT5C;PLPP6;PLPPR2;PGP;PTPRO;PTPMT1;DUSP23;DUSP12;DUSP15;SBF1;ACP2;PPP1CB;PLPPR4;DUSP8;PGAM5;ENOPH1;ACP5;PLPP4;ACP4
prerank,four-way junction DNA binding (GO:0000400),-0.2596421979225021,-0.7582265814266081,0.8681818181818182,0.8962543259494449,1.0,7/17,21.78%,ABL1;RAD51B;FANCM;YY1;WRN;XRCC3;XRCC2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.27505530804559786,0.752666282368216,0.8507135016465422,1.0,1.0,16/60,19.63%,ERBB4;ACVRL1;NTRK2;LTK;MUSK;KDR;EPHA5;CSF1R;FLT4;TIE1;EPHB1;FLT1;TYRO3;DDR2;ERBB3;FLT3
prerank,nuclear import signal receptor activity (GO:0061608),-0.2699011790413405,-0.7493375614884512,0.8127853881278538,0.9037964747858436,1.0,10/15,35.36%,KPNA4;KPNA2;TNPO2;KPNA3;KPNA6;HIKESHI;TNPO3;IPO5;KPNA7;IPO9
prerank,ribonuclease P activity (GO:0004526),0.36252310188467396,0.7430085000862757,0.7855153203342619,1.0,1.0,2/11,13.83%,POP7;POP4
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.34726233355853975,0.74256124930959,0.8052486187845304,1.0,1.0,6/12,37.81%,PIK3C2G;PIK3CD;PIK3R6;IPMK;PIK3C2B;PIK3CB
prerank,cGMP binding (GO:0030553),0.3644978042833148,0.7422526943953826,0.811373092926491,1.0,1.0,5/11,24.94%,CNGA3;CNGA4;CNGB1;PDE11A;PDE2A
prerank,MAP kinase activity (GO:0004707),0.3377830274536382,0.7371967069290499,0.7883597883597884,1.0,1.0,4/14,19.80%,MAPK3;MAPK10;MAPK11;MAPK15
prerank,phospholipid transfer activity (GO:0120014),0.3133679368929673,0.7366469673268755,0.8266494178525227,1.0,1.0,10/21,31.05%,PLTP;GLTP;PRELID1;MTTP;ABCA3;PRELID3B;CERT1;CPTP;C2CD2L;PRELID2
prerank,ligand-gated calcium channel activity (GO:0099604),0.32183065057644544,0.7341181487713854,0.8292682926829268,1.0,1.0,5/19,18.26%,GRIN1;GRIN2A;TRPM2;RYR2;GRIN2B
prerank,phosphatase inhibitor activity (GO:0019212),0.31149968336728373,0.7333643831460935,0.8227848101265823,1.0,1.0,6/20,23.14%,LGALS3;PPP1R1B;SET;ARPP19;ANP32E;PTN
prerank,hexosyltransferase activity (GO:0016758),0.2563308651048718,0.7315873273988225,0.8963730569948186,1.0,1.0,23/101,23.44%,HEXB;HEXA;TMTC2;B4GALNT1;PIGZ;B4GALNT4;B4GALT6;POGLUT3;B3GNT9;CHPF2;B3GAT3;CHPF;GCNT1;FUT9;B3GNT3;DPY19L1;RFNG;CSGALNACT2;CHSY3;B3GALT5;LFNG;B3GALT2;B4GALT3
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.29281652347774606,0.7283062584441846,0.8339100346020761,1.0,1.0,7/34,19.10%,CALM1;CALM3;CDK5R1;CDK5R2;IGF2;MAP2K2;CALM2
prerank,syntaxin binding (GO:0019905),0.26630865923726543,0.7264869719831022,0.8806451612903226,1.0,1.0,15/61,16.40%,SNAP25;CACNA1A;SYT1;SYPL1;SYT12;VAMP3;VAMP2;SYT6;STXBP5L;TMED9;VAMP8;SYP;SYT10;NAPA;SYT2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.23088771693117047,-0.7260965390885671,0.8531073446327684,0.9290571589242503,1.0,3/23,7.49%,PLCE1;EDNRA;PLCD3
prerank,DNA-binding transcription factor binding (GO:0140297),0.24796015385575704,0.725792819337328,0.9535822401614531,1.0,1.0,25/189,13.79%,PTMA;HSPB1;CHCHD2;PARK7;ATF4;NPM1;BEX1;HCLS1;SPI1;TLE5;CTNNB1;HES1;HIPK2;HES6;DUSP26;JUN;HMGB1;BHLHE41;ZBTB49;TAF9;CTBP1;ZBTB7A;KLF4;YWHAZ;HDAC5
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.30096274607328843,-0.7244573896685436,0.7952218430034129,0.9263379936572008,1.0,3/10,18.15%,NAA40;ATF2;KAT8
prerank,inward rectifier potassium channel activity (GO:0005242),0.2947667590648,0.7197177873323518,0.8459657701711492,1.0,1.0,5/24,24.68%,KCNJ10;KCNN2;ABCC8;KCNJ3;KCNJ6
prerank,alpha-tubulin binding (GO:0043014),-0.20886453987748071,-0.7163761137120711,0.8881987577639752,0.9313527520294529,1.0,6/31,14.72%,EML4;SETD2;OFD1;INO80;WASHC1;TAOK1
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.29982900952382086,-0.7157614518620524,0.8277153558052435,0.9274946621153797,1.0,3/10,10.88%,ECHDC1;ECHDC3;AUH
prerank,GTPase inhibitor activity (GO:0005095),0.33701084818361643,0.7156973259658396,0.8133514986376021,1.0,1.0,7/13,33.63%,IQGAP2;ARL2;CDC42SE1;RTKN;TNK2;GPS1;GPS2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3225798323010065,0.7152668243028303,0.8280254777070064,1.0,1.0,3/16,18.11%,TTYH1;TTYH3;ANO4
prerank,intracellular chloride channel activity (GO:0061778),0.3225798323010065,0.7152668243028303,0.8280254777070064,1.0,1.0,3/16,18.11%,TTYH1;TTYH3;ANO4
prerank,SH3 domain binding (GO:0017124),0.26110013540291555,0.7144392674091298,0.9067982456140351,1.0,1.0,11/62,17.17%,GPX1;CYBA;ADAM15;ADAM12;ELMO1;MAPT;MICAL1;NCF1;DAB2IP;SKAP1;CRB3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.24297452191855415,0.7094229975079229,0.96579476861167,1.0,1.0,31/181,19.19%,ACTB;HSPB1;ATF4;NPM1;BEX1;HCLS1;SPI1;GABARAPL1;CTNNB1;HES1;HIPK2;HES6;DUSP26;PROX1;JUN;BHLHE41;DNAJA1;SNW1;NCOR2;KLF4;HDAC5;MIER2;DLL1;GATA4;TRIM32;PPARGC1A;COMMD7;MTA2;TBP;PSMA6;DDRGK1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3208738933763051,0.7085666881300602,0.8185430463576159,1.0,1.0,5/14,28.68%,SDHB;ISCU;RSAD2;EXO5;CIAO3
prerank,metallopeptidase activity (GO:0008237),0.24921238015329455,0.7079761462627856,0.9373716632443532,1.0,1.0,22/113,18.07%,RCE1;COPS6;ADAM15;METAP1;ADAM23;ADAMTS4;ADAM12;OMA1;MMP21;METAP2;PMPCB;PRPF8;MMP3;LAP3;ADAMTS16;SPG7;MMP27;NUDT16;MMP14;ADAM18;ADAM17;ADAMTS1
prerank,DNA replication origin binding (GO:0003688),0.29882752185762534,0.70775624105724,0.8578371810449574,1.0,1.0,7/23,28.39%,MCM5;HSPD1;DDX11;CDC45;MCM7;MCM2;DHX9
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2933036933703283,0.707663220220615,0.8557213930348259,1.0,1.0,6/24,19.12%,PNCK;CAMK1D;CAMK1;CAMKV;CAMKK1;MKNK1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.34390591581113483,0.7068629923415448,0.8162393162393162,1.0,1.0,2/10,9.48%,SLCO1C1;SLCO4C1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.34342872871473984,0.7057054498090819,0.826950354609929,1.0,1.0,2/10,7.87%,DPP10;DPP6
prerank,nucleotidase activity (GO:0008252),0.318400879046849,0.7005327027664525,0.837465564738292,1.0,1.0,2/15,6.02%,NT5C3A;BPNT2
prerank,NF-kappaB binding (GO:0051059),0.29321648311273635,0.6985620106056246,0.851581508515815,1.0,1.0,6/24,27.39%,NPM1;COMMD7;PSMA6;NFKBIA;RELA;HIF1AN
prerank,anion transmembrane transporter activity (GO:0008509),0.32973901429676705,0.696933738230656,0.8524590163934426,1.0,1.0,5/12,28.61%,SLC19A1;MFSD10;SLC4A2;ABCC5;SLC26A11
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3099146753917193,0.694537912966595,0.8274456521739131,1.0,1.0,6/15,25.67%,HS6ST3;HS3ST6;HS3ST5;HS3ST2;HS6ST1;HS6ST2
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.2541682349199407,-0.6925901194596772,0.8921933085501859,0.9472161758565102,1.0,2/12,5.94%,BABAM2;TRAF5
prerank,voltage-gated anion channel activity (GO:0008308),-0.2501458516464856,-0.688870352046613,0.8883928571428571,0.9466589881198463,1.0,1/15,1.69%,ANO6
prerank,3'-5' exonuclease activity (GO:0008408),0.26154918132326344,0.6883398077485909,0.9100227790432802,1.0,1.0,15/45,26.95%,EXOSC2;APEX1;TOE1;PDE12;EXOSC9;USB1;POLG;EXOSC4;ISG20;ERI1;POLD1;PAN2;PNPT1;TRIR;RAD9A
prerank,diacylglycerol kinase activity (GO:0004143),0.3342754873070837,0.6882150020141431,0.872278664731495,1.0,1.0,6/11,30.98%,DGKH;DGKI;DGKK;DGKB;DGKZ;DGKG
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.24604100716472965,-0.6850817771549855,0.889763779527559,0.945639177847237,1.0,2/14,4.66%,MINDY3;OTUD7B
prerank,filamin binding (GO:0031005),0.3345523137171953,0.6834245985448754,0.8515406162464986,1.0,1.0,2/11,6.92%,RFLNB;CRMP1
prerank,P-type ion transporter activity (GO:0015662),0.32291190332351216,0.6825010069726574,0.8583333333333333,1.0,1.0,5/12,29.22%,ATP2B1;ATP2A2;ATP2B4;ATP2B2;ATP2C1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.23701170567973712,-0.6803381640945482,0.9070631970260223,0.9457612763139659,1.0,2/15,12.01%,PI4KA;ATM
prerank,microtubule motor activity (GO:0003777),0.25198593594665886,0.6803229215885134,0.9178690344062154,1.0,1.0,16/51,29.38%,DYNLRB1;KIF26B;KIF5A;KIF26A;DNAH2;DNAH1;DYNLRB2;KIF21B;KIF5C;KIFC2;KIF1A;KIF27;KIF20B;DNAH17;KIF6;KIF1B
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.23387957556350852,-0.6780786086217122,0.9066147859922179,0.9431890128726297,1.0,16/16,76.64%,SLC22A4;SLC25A26;SLC25A42;SLC22A5;SLC22A1;SLC22A3;SLC25A17;SLC22A16;SLC44A4;SLC22A2;SLC18A3;SLC7A8;SLC29A4;SLC44A1;SLC44A2;SLC5A7
prerank,MAP kinase phosphatase activity (GO:0033549),0.32600054954680446,0.6762782111420439,0.8538681948424068,1.0,1.0,5/12,25.90%,DUSP3;DUSP2;DUSP1;DUSP8;DUSP6
prerank,glycerophospholipid flippase activity (GO:0140333),0.332091692949266,0.6728149415264744,0.8659058487874465,1.0,1.0,2/11,10.95%,ATP8A2;ATP8A1
prerank,exoribonuclease activity (GO:0004532),0.3178306327397812,0.671335438930179,0.8586956521739131,1.0,1.0,3/12,21.53%,EXOSC2;EXOSC9;EXOSC4
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.2570123177919288,-0.6695556754910618,0.8996282527881041,0.9465110741586694,1.0,4/11,17.60%,SGMS2;PIGN;PIGO;PIGF
prerank,transcription cis-regulatory region binding (GO:0000976),0.22216335322472563,0.6656457481029784,0.996,1.0,1.0,78/406,22.29%,RPS3;JUND;PARK7;ATF4;SOX18;ERBB4;NPM1;PRDX5;TNF;DRAP1;NR1D1;SPI1;EPAS1;ENO1;NKX2-2;TBX22;KLF17;FOXF2;CEBPB;ARID4A;FOXD3;SALL2;CREBZF;CEBPA;PROX1;BASP1;CREB3;MLX;EGR1;HOXD4;JUN;HMGB1;TAF9;PHOX2A;NPAS3;AEBP1;SOX17;ATF5;MSX1;DBP;THRA;KLF4;HOXD8;SOX9;ZBTB43;HDAC5;ATMIN;IKZF5;NONO;GATA4;GLIS2;TWIST1;RBBP5;AGO1;ZNF22;SOX11;TBP;SNCA;ZFP41;ZBTB14;ESRRB;TFAP2B;KLF11;CHD3;MEF2C;FOXA2;TFAP4;MYC;FOSL2;CDC5L;DDIT3;SOX10;FOXA1;DACH1;MEN1;REST;HOXB8;GRHL2
prerank,C2H2 zinc finger domain binding (GO:0070742),0.31806886043796223,0.6635535169000107,0.8692528735632183,1.0,1.0,4/11,26.78%,GATA2;TAF9;ZXDC;LEF1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3171682560142794,0.6611665436868487,0.8839941262848752,1.0,1.0,1/11,6.94%,SLC25A29
prerank,DNA binding (GO:0003677),0.21903922704541726,0.660076623727568,1.0,1.0,1.0,148/694,24.63%,RPS3;RPS15;RPS27;RPL6;RPL7;PCBP1;CALR;CHCHD2;PARK7;ATF4;KLF2;POLR2D;TERF1;LYL1;ETS2;MBD3;DRAP1;SYCP2;ANG;EPAS1;JUNB;GTF3C6;MCM5;CENPB;HMGB3;HES1;NUCKS1;RPA2;HMGN1;TBX22;FOXF2;CEBPB;PQBP1;ARID4A;TRIM28;CENPX;FOXL2;HSPD1;CREBZF;CEBPA;APLP2;PROX1;NR2F6;CSRNP3;MAPT;YBX1;IKZF1;NUPR1;MLXIPL;MLX;EGR1;JUN;HMGB1;ZBTB49;DDB1;TAF9;H1-0;TARDBP;POLR2G;MYRF;APEX1;ATF5;BANF1;POU3F1;ZBTB7A;PCNA;DDX11;SOX8;MAEL;THAP11;SOX9;PAX3;NME2;FOXS1;HNRNPU;TSN;MAFA;IKZF3;HNRNPA1;IRF7;REPIN1;ZMYM3;NR1H2;SUB1;E2F4;GATA4;PCID2;BRCA2;PPARGC1A;DCLRE1C;ERCC6;CNBP;ZNF22;CTC1;NRL;TIGD4;IMPDH1;HIC1;ZBTB14;WDR48;NLRP3;ESRRB;TFAP2B;RAD23A;MLF1;CHD3;POU4F1;RNF11;FOXA2;TFAP4;MYC;ERCC1;FAM111A;TSNAX;CAMTA1;CDC5L;POLR2H;DDIT3;CEBPZ;CDK9;SOX10;FOXA1;POLG;PHF1;MEN1;IRF5;HLX;RADX;BLM;GRHL2;SOX1;CDC45;CSRNP1;SAFB;ERF;LONP1;MEIS2;POLD1;PCBP2;OSR2;PURB;PNKP;RELA;MAFB;USF2;APP;TCF7L1;TCF3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.3133399580431846,0.6594948045787848,0.8700410396716827,1.0,1.0,4/12,22.03%,SDHB;ISCU;CIAPIN1;CISD1
prerank,calcium channel activity (GO:0005262),0.23341570467432438,0.6587209429864335,0.9505783385909569,1.0,1.0,24/84,25.27%,SLC24A4;SLC24A2;GRIN1;CACNA1A;TMCO1;TRPM2;TRPC7;SEC61A1;TRPC1;RYR2;CACNG8;ORAI1;NCS1;ANXA6;CACNG5;PKD2L1;PKDREJ;CACNB4;PKD1L2;CACNA1E;SLC24A5;CACNG2;CACNA2D1;CACNA1B
prerank,RNA polymerase II complex binding (GO:0000993),0.26039180799637,0.6562836520233899,0.91725768321513,1.0,1.0,9/32,19.53%,ELOF1;RTRAF;SUPT4H1;PCIF1;HNRNPU;RECQL5;AGO1;CCAR2;ESRRB
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.30788618605432017,0.6531460131456325,0.8702702702702703,1.0,1.0,4/12,23.31%,B3GNT9;B3GNT3;B3GALT5;B3GALT2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.27906717500146416,0.6506397977108715,0.8946047678795483,1.0,1.0,1/20,1.82%,EIF3F
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.23799508220469964,0.649943863862469,0.9384449244060475,1.0,1.0,20/60,26.68%,PPP1CA;CTDSP2;CTDNEP1;CTDSP1;PHLPP1;TIMM50;PDP2;PPP1R3D;PPM1J;PDP1;TAB1;PPP3CA;PPEF1;PPM1F;DUSP1;PPP3R1;CAMK2G;PPP1CB;PGAM5;MTMR6
prerank,neuropeptide receptor binding (GO:0071855),0.2909581836902606,0.6492311003434266,0.8860927152317881,1.0,1.0,5/14,31.80%,PPY;NTS;NPY;NMU;SHANK1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.31547174165572145,0.647891228657412,0.8729729729729729,1.0,1.0,2/10,19.29%,TNFAIP3;DESI2
prerank,exonuclease activity (GO:0004527),0.24139361757785952,0.641319884002474,0.9284916201117318,1.0,1.0,12/46,26.95%,ENPP2;EXOSC2;APEX1;PDE12;DCLRE1C;EXOSC9;POLG;EXOSC4;ISG20;ERI1;TRIR;RAD9A
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.22723716054671456,-0.6409704154012522,0.915057915057915,0.9638619402944608,1.0,1/15,3.64%,PLA2G4A
prerank,5'-3' exonuclease activity (GO:0008409),-0.23177805630199763,-0.6344280226770602,0.9389312977099237,0.9637784083753931,1.0,8/14,36.44%,XRN1;EXOG;DXO;EXO1;DCLRE1A;CPSF3;DCP2;MRE11
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.2721766654421687,0.6297762643699644,0.9133247089262613,1.0,1.0,4/18,25.16%,CCKBR;AGAP2;SOCS3;PIK3R5
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.22819283397544654,-0.6286685390487439,0.9455252918287937,0.9629819384870703,1.0,10/15,38.52%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A11;SLC26A3;SLC26A5;SLC26A1;CFTR;SLC26A9
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.27168761591440627,0.6286683411423034,0.9182389937106918,1.0,1.0,6/20,23.70%,MOGAT2;AGPAT5;DGAT1;LPCAT2;MOGAT1;AGPAT2
prerank,RNA cap binding (GO:0000339),0.28411486956004606,0.6266472779053771,0.9054593874833555,1.0,1.0,2/16,10.68%,EIF3D;EIF4A1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.23087204320805796,0.623566605897628,0.9665551839464883,1.0,1.0,11/51,23.83%,SLC7A5;SLCO1C1;MFSD2A;SLC25A11;SLCO4C1;SLC35E1;SLC35A1;SLCO1B1;SLC46A2;SLC25A14;SLC25A16
prerank,FMN binding (GO:0010181),0.3037963109135985,0.6229699289840457,0.8972503617945007,1.0,1.0,2/11,17.55%,PNPO;NOS2
prerank,muscle alpha-actinin binding (GO:0051371),0.28524043208342686,0.6204075803520049,0.9067567567567567,1.0,1.0,1/15,2.04%,PRICKLE4
prerank,sulfate transmembrane transporter activity (GO:0015116),0.2840018915084956,0.6203773824476566,0.9183400267737617,1.0,1.0,2/14,9.20%,SLC26A4;SLC25A11
prerank,NADP binding (GO:0050661),0.24567975133399328,0.6163677815475973,0.9456018518518519,1.0,1.0,8/32,18.50%,GRHPR;SPR;QDPR;CRYM;CAT;PGD;NOS2;CBR3
prerank,N-acetyltransferase activity (GO:0008080),-0.20343709997807224,-0.6132598546973248,0.9705882352941176,0.9674779872115367,1.0,3/19,12.67%,KAT2B;SMARCE1;ESCO1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.22999861871978933,0.6125697269053519,0.9547960308710033,1.0,1.0,14/53,24.87%,ACADVL;CYB5R3;CYBB;STEAP4;MICAL1;PPOX;KDM1B;NOS2;CYB5R1;QSOX1;SDHA;ILVBL;ACOX3;NQO2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.22001651141577463,0.6109494238802502,0.9763694951664876,1.0,1.0,14/74,21.45%,CHKB;RFK;PKM;NT5C3A;DGKH;DGKI;PIK3C2G;DOLK;PIK3CD;COASY;SPHK2;KHK;DGKK;DGKB
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.21937108167642183,0.6083147413625148,0.9709677419354839,1.0,1.0,15/69,22.74%,CERS2;SCP2;PLAAT3;ZDHHC5;NAA10;MOGAT2;ELP3;GLYAT;DGAT2L6;SOAT2;PORCN;DGAT1;ZDHHC12;ZDHHC8;MOGAT1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.2941783118399303,0.6074371913591927,0.9213483146067416,1.0,1.0,4/11,21.86%,PRPF19;RBX1;STUB1;AMFR
prerank,RNA methyltransferase activity (GO:0008173),0.2604534505600061,0.6064805516433045,0.9141414141414141,1.0,1.0,6/19,26.12%,FBL;MEPCE;FTSJ3;METTL3;LCMT2;TYW3
prerank,microtubule plus-end binding (GO:0051010),0.2586916025961689,0.6033184021739502,0.925,1.0,1.0,4/20,15.68%,CLASP1;DCTN1;CLIP3;MAPRE3
prerank,N-methyltransferase activity (GO:0008170),0.2562893187419404,0.6027816309238153,0.9311224489795918,1.0,1.0,3/20,13.19%,ZCCHC4;PRMT1;METTL18
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.29516544182545856,0.6022430139068018,0.9227467811158798,1.0,1.0,4/10,30.85%,APEX1;DCLRE1C;POLD1;MGME1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.22598356906520928,0.6015039671785747,0.9675615212527964,1.0,1.0,8/48,19.69%,ATP6V1F;SLC39A1;AQP1;TRPM2;TRPC1;UNC80;CALHM6;PKD2L1
prerank,carboxy-lyase activity (GO:0016831),0.24841212178980746,0.5943935808825892,0.9522012578616352,1.0,1.0,8/23,35.76%,ODC1;UROD;GAD1;FAHD1;ACOD1;PISD;AZIN1;BCKDHA
prerank,ephrin receptor binding (GO:0046875),0.2558296522493309,0.593695101474528,0.9448621553884712,1.0,1.0,10/21,33.36%,ANKS1B;EFNB1;EFNA1;PTPN1;CRK;EFNA2;EFNB3;ANKS1A;GRB2;FYN
prerank,telomeric DNA binding (GO:0042162),0.23558934385813113,0.593268115704769,0.9654761904761905,1.0,1.0,12/32,32.71%,TERF1;NCL;APEX1;CTC1;TERF2IP;BLM;PIF1;XRCC6;HNRNPA2B1;UPF1;HNRNPD;ACD
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.22262535561272612,-0.5917106176156042,0.9726962457337884,0.9741239452999785,1.0,4/12,21.97%,NUDT5;ENTPD5;ENTPD7;SLC25A42
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.26786904077797324,0.5887284780615809,0.9445910290237467,1.0,1.0,4/15,23.70%,ABHD8;AGPAT5;LPCAT2;AGPAT2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.23252797826713306,0.5870311610279284,0.9643705463182898,1.0,1.0,10/33,25.42%,EXOSC2;TOE1;PDE12;EXOSC9;USB1;EXOSC4;ISG20;ERI1;PAN2;PNPT1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.24737061424786524,0.5807604940379008,0.9525593008739076,1.0,1.0,7/21,26.46%,CDK8;CDK19;CDKL4;CDK5;CDK9;CDK10;CDK11B
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.24737061424786524,0.5807604940379008,0.9525593008739076,1.0,1.0,7/21,26.46%,CDK8;CDK19;CDKL4;CDK5;CDK9;CDK10;CDK11B
prerank,nucleotide diphosphatase activity (GO:0004551),0.26158002506497147,0.572532074086697,0.9355263157894737,1.0,1.0,5/14,24.22%,NUDT3;NUDT4;ENPP5;NUDT10;NUDT11
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.2635418509849557,0.5717925150779043,0.9457579972183588,1.0,1.0,2/13,16.91%,PIK3C2G;PIK3CD
prerank,growth factor receptor binding (GO:0070851),0.19805144503445732,0.5701685104425921,0.9926701570680628,1.0,1.0,21/95,25.44%,ERBB4;PDGFB;IL2;IL11;TIMM50;CCDC88A;SDCBP;TLR5;ARF4;PDGFA;CD300LF;ADAM17;KLB;IL6;IL1RAP;PYCARD;TGFA;ERAP1;IL12RB1;FGF22;TNK2
prerank,chloride channel regulator activity (GO:0017081),0.2611733943782397,0.5668398647340048,0.9572763684913218,1.0,1.0,2/14,11.89%,SGK1;VAMP8
prerank,clathrin adaptor activity (GO:0035615),0.26126840746863317,0.5586478311947106,0.949535192563081,1.0,1.0,2/15,9.52%,AP2M1;AP2S1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.22126294528827548,0.5583121141116709,0.9766355140186916,1.0,1.0,4/35,12.31%,ELAC2;NT5C3A;AARS2;MRPL58
prerank,peptide N-acetyltransferase activity (GO:0034212),0.2798173801638303,0.5577844227352142,0.9407616361071932,1.0,1.0,4/10,31.87%,NAA10;NAA25;NAA30;NAA60
prerank,solute:sodium symporter activity (GO:0015370),-0.16654715907835466,-0.5506917371681036,0.9939024390243902,0.9853654558341868,1.0,1/27,1.99%,SLC4A10
prerank,3'-5' DNA helicase activity (GO:0043138),0.24671772033807704,0.5489026818778995,0.9601542416452442,1.0,1.0,6/16,28.39%,MCM5;RECQL5;BLM;MCM7;MCM2;DHX9
prerank,MAP kinase kinase activity (GO:0004708),0.24938752195558195,0.5479129631953963,0.9558823529411765,1.0,1.0,5/15,25.85%,PAK3;MAPK10;MAP2K2;MAP2K7;MAP3K9
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.24471559141187724,0.5417689149964747,0.9650067294751009,1.0,1.0,3/15,25.16%,CCKBR;SOCS3;PIK3R5
prerank,nuclear localization sequence binding (GO:0008139),0.2342518107899584,0.5389302975664572,0.9696202531645569,0.9989363886959151,1.0,6/18,28.34%,IPO4;CABP1;BRAP;NFKBIA;KPNB1;RANBP6
prerank,endoribonuclease activity (GO:0004521),0.21320270871735963,0.5374807054207003,0.9799054373522459,0.9973094760468719,1.0,5/32,20.97%,ENDOG;RNASEK;SND1;AGO1;TSNAX
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.1885061818730772,-0.5307413729127208,1.0,0.9866254985601429,1.0,4/13,21.01%,AGPAT4;GPAT3;ABHD5;PNPLA3
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.2536876218549052,0.5134338449537388,0.9692532942898975,1.0,1.0,6/10,39.28%,HEXIM1;CDKN2B;CDKN1A;CDKN2D;HEXIM2;CDKN2C
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.19674030229424705,0.5102692403151128,0.9907407407407407,1.0,1.0,6/40,19.62%,FBL;ICMT;METTL18;MEPCE;DNMT3B;GAMT
prerank,death receptor activity (GO:0005035),0.24364948157640468,0.5074628820605012,0.9815340909090909,0.9997336921510239,1.0,4/11,32.57%,TNFRSF1A;TNFRSF11A;TNFRSF1B;TNFRSF25
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.2170150490764527,0.5021977005119993,0.9763975155279503,0.9987363697387193,1.0,8/21,31.56%,POLE4;POLD4;POLG;POLD1;POLE3;POLN;POLD3;POLK
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.21674639354261932,0.4779064698964026,0.9867724867724867,1.0,1.0,3/16,27.44%,IDO2;BCO2;ADI1
prerank,methyltransferase activity (GO:0008168),0.1768049197203464,0.47195994286456994,0.9988751406074241,1.0,1.0,16/46,35.41%,EEF1AKMT2;PRMT1;MEPCE;DNMT3B;GAMT;FTSJ3;EEF1AKMT4;METTL3;EEF1AKMT3;COMTD1;LCMT1;DNMT1;NSUN2;NNMT;GCSH;PRMT5
prerank,protein phosphatase 1 binding (GO:0008157),0.2011309624151585,0.4701272931288755,0.9886649874055415,0.9983651589618611,1.0,8/21,32.68%,LILRB1;PPP1R3D;PPP1R15A;KCNQ1;PPP1R9B;PPP1R11;PPP1R16B;PPP1R3E
prerank,cation:chloride symporter activity (GO:0015377),0.22496069036722188,0.4561331334728978,0.9855907780979827,0.9982365094015748,1.0,1/10,7.90%,SLC12A5
prerank,steroid hydroxylase activity (GO:0008395),0.19356412955462518,0.4353710144912666,0.9959514170040485,0.9983620060038061,1.0,5/16,30.69%,CH25H;CYP2E1;CYP2U1;CYP39A1;CYP46A1
prerank,DNA polymerase activity (GO:0034061),0.18186827686605797,0.42468498774323116,0.9987577639751553,0.9971664118219438,1.0,8/22,31.56%,POLE4;POLD4;POLG;POLD1;POLE3;POLN;POLD3;POLK
